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ABSTRACT
Introduction
The aim of endovascular aortic aneurysm repair (EVAR), is to isolate the aneurysm
sac from the rest of the blood circulation and thereby eliminate the risk of aneurysm
rupture. Proximal Type | endoleak and endovascularstent-graft migration are the two
commonest causesforfailure of the procedure; leading to aneurysm re-
pressurisation, and rupture.
Aim
The aims of this research were to examinethe relationship between migration and
stent-graft oversizing of the proximal aortic neck; the modeofstent-graft migration; to
compare the proximal fixation strength between standard and fenestrated stent-graft;
to examine the relationship between oversizing and aortic neck length for a proximal
seal in standard and fenestrated EVAR; andfinally, to measure the longitudinal
haemodynamic force (LF) acting on the bifurcated stent-graft in EVAR.
Method
The bench top experimental model for the measurement of proximal displacement
force (the force required to displace the stent-graft) comprised a proximalportion of
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standard or fenestrated Zenith stent-graft (Cook Europe, Bjaeverskov, Denmark),
which was deployedinto a prepared, pressurised bovine aorta, a linear drive and a
calibrated digital force gauge. Force wasapplied to the stent-graft and measured
with the force gauge. The mode of migration was observed. To investigate the
proximal sealin different aortic neck lengths, a sealed proximal portion of standard or
fenestrated stent-graft was deployed into the prepared bovine aorta and then placed
into a pulsatile circulating system. Under humanphysiological flow conditions, the
leak between the aorta and the stent-graft was observedat different aortic “neck”
lengths. In the experiment of measurementof longitudinal haemodynamic force
acting on the stent-graft in EVAR,a bifurcated stent-graft model was machined and
bondedwith a strain gauge. The model wasplaced into the same pulsatile flow
system under humanphysiological conditions, and the force was measured.
Results
The results of forces required to cause stent-graft migration by 5 mm have revealed
that the maximal force is reached at oversizing by 20% in stent-graft with barbs and
30% without barbs. The barbsincrease the overall proximalfixation strength. The
mode of migration was observedin two phases. Phase oneis due to the barbs
embeddinginto the aortic wall, with migration limited to a few millimetres, and it only
requires relatively small forces. Phase two occurs whenthefull fixation strength of
the device has been exceeded. The fenestrated stent-graft configuration confers
greater proximalfixation strength than conventional devices.
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The proximal seal in fenestrated and standard stent-graft was observed, and it was
found that the optimal oversize is inversely related to seal zone length. For
fenestrated EVAR with bare stent, a seal can be achieved at aortic neck length as
short as 5 mm.Theresults of the measurementof the longitudinal haemodynamic
force acting on a bifurcated stent-graft model revealed that the force is strongly
dependenton pressure. Thefluid viscosity, momentum andpulsatility contribute
between 6 and 18% ofthe total LF. These results confirm that under certain
conditions, LF can exceedthe fixation strength of some of the current endovascular
stent-grafts.
Conclusion
Adequate oversizing improves the proximalfixation strength. Barbs also increase the
proximalfixation strength. The modeof stent-graft migration occurs in two stages.
The fenestrated stent-graft configuration confers greater proximalfixation strength
than conventional devices. The optimal oversize in both fenestrated and standard
stent-graft is inversely related to seal zone length. For fenestrated EVAR with bare
stent, a seal can be achieved at aortic neck length as short as 5mm. The
longitudinal haemodynamic force acting on a bifurcated stent-graft modelis strongly
dependent on pressure, andit can exceed thefixation force in some of the current
endovascular stent-grafts.
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CHAPTER1
ABDOMINAL AORTIC ANEURYSM AND CONVENTIONAL
MANAGEMENT
1.1. Aneurysm
A true aneurysm is described as a pathological, dilatation of a segmentof a blood
vessel, (which can beanartery, vein, or lymphatic duct); caused by a congenital or
acquired weakness.It involvesall three layers of aortic wall (tunica adventitia,
tunica media, and tunica intima).
Onthe other hand, a false aneurysm involvesdisruption of the intimal and medial
layers, with the dilatation lined by adventitia and sometimes by a perivascularclot
(Dzau et al 1991), or surrounding tissues.
    A B
Figure 1.1: Diagram of true aneurysm (A) and false aneurysm (B).
Aneurysm can occurin any part of the human body; howeverthe infrarenal aorta is one of the
commonestsites (this diagram is kindly provided by the department of medicalillustration, Aberdeen
Royal Infirmary, UK).
Despite many established standards, a consensusdefinition of abdominalaortic
aneurysm (AAA) doesnotexist (Verloes et al 1995). Normal abdominalaortic
diameters have been studied previously. In studies of anatomical specimens, the
diameterof the inferior aspect of the normal abdominal aorta was less than 15
mm. Radiological studies have found the diameter of the normal abdominalaorta
to measure, on average, 19 mm (Williams et al 1989). An increase in diameterof
50% is one acceptedcriterion for defining an abdominal aortic aneurysm
(Appleberg et al, 1994). Other definitions include an infrarenal aorta measurement
of 30 mm or more (Yochumet al 1996; Holdsworth et al 1994; Verloes et al 1995)
or a ratio of infrarenal to suprarenal diameter greater than 1.5:1 (Verloesetal
1995).
 
Figure 1.2: A diagram of infrarenal abdominalaortic (kindly provided by the department of medical
illustration, Aberdeen Royal Infirmary).
1.2 Prevalence and Incidence of Abdominal Aortic Aneurysm
Aortic aneurysm is a commondisease in the Western World. It mainly affects the
elderly population. The commonestsite for aortic aneurysm is in the abdominal
segment, especially infrarenal.
1.2.1 Prevalence
Estimates of the prevalence of AAA can be obtained from population screening
surveys and autopsy studies. The prevalence of screen-detected aneurysm in
menin England varies between 1.3% and 12.7% (Collin et al 1988; Lucarotti et
al1993; Smith et al 1993; Scott et al 1995) depending on the age group screened
andthe criteria used for the definition of AAA.
A generally accepted definition of a small AAA is an aorta with a diameter from 30
mm to 54mm (Scott et al 1991; Lucarotti et al 1993; Smith et al 1993; Morris et al
1994; VanderVliet et al 1997). The prevalence defined by an infrarenal aortic
diameter = 30mm based onusing ultrasound imaging, varied between 4.5% and
8% in men aged between60 and 80years(Boll et al 1998; Ashtonet al 2001).
Whilst the prevalence of AAA greater than 4.0 cm in diameter in men aged
between 65 and 75years is approximately 3% (Crawford et al 2003). Other
studies have estimated the prevalence of unsuspected AAA to be 5.4% (Collin et
al 1988). Studies have reported prevalencerates of 12% to 33% in first-degree
relatives (Appleberg et al 1994; Verloes et al 1995). Increased awarenessof
abdominalaortic aneurysms,screening programs, and the ageing population are
also having contributed to an increasein the incidence of asymptomatic AAA's.
1.2.2 Incidence
Reported incidences of asymptomatic AAA in the literature vary between 3-0 and
117-2 per 100 000 person-years (Melton et al 1984; Castleden et al 1985; Fowkes
et al 1989; Pleumeekerset al 1994). All studies report sharprises in the age-
adjusted incidence of AAA in recent years. The average increasein incidence
ranges from 4:2% per yearin Australia to 11% per year in a report from
Rochester, Minnesota, USA. A nationwide study from Denmark reported an
increasein the incidence of asymptomatic aneurysm from 7-1 per 100 000 to 25:8
per 100 000 person-years from 1977 to 1990 (Eickhoff et al 1993). This increase
was constantoverall age groups examined.
The reported incidence of ruptured AAA varies from 1 to 21 per 100,000 person-
years (Castledenet al 1985; Ingoldby et al 1986; Mealy et al 1988; Thomasetal
1988; Buddet al 1989; Drott et al 1992). The Goteborg study (Drott et al 1992)
found a sevenfold rise in incidence overa period of 36 years. In the UK, the high
incidence of AAA wasconfirmed by the UK small aneurysmtrial. Ultrasonic
screening studies of the general population show that 1.5% - 3% of men overthe
age of 60 years have anoccult aortic aneurysm in the size range 4.0-5.9cm (Trial
Participants 1998). AAA is 10 times more commonin 65- to 75-year-old men
compared to womenof the same age (Crawford et al 2003). The gender-related
difference in AAA incidence diminishes to about 3:1 in the 85 to 89-year-old age
group (Collin et al 1988).
1.3. Death from Abdominal Aortic Aneurysm
AAA (with elective repair or rupture) is the 10th to 13th leading cause of deathin
the United States (Reilly et al 1989). The death rate for AAA (rupture) in the
United Kingdom peaksat 65 to 75 years of age; rupture accounts for 1.7% of all
deaths in menin this age groupin the United Kingdom. Death from AAA in
England and Wales showeda progressive and continuing increase over a 30-year
period to 1988 (Collin 1988; Fowkes 1989). Age standardised death rates from
ruptured AAA also rose by 2:4 per cent per year (Wilmink et al 1998), 20-fold in
men and 11-fold in women between 1950 and 1984 (Fowkeset al 1989). Similar
trends have been reported in other Western countries. The scale of the increase
suggeststhatit is probably not simply an artefact of improved diagnosis (Coggon
et al 1996). Moreover, a review of all post mortem examinations at Malmo
General Hospital in Sweden during 1958-86 showeda clearrise in the prevalence
of aortic aneurysmal disease when assessed by standard examination techniques
(Bengtssonet al 1992).
Rupture of AAA often has fatal consequences. Suddenlossof a large amountof
blood results in haemorrhagic shock, with irreversible damageofvital organs, and
cardiac arrest. Overall, an estimated 90% death rate if the rupture happenedin
the community or 50-60% death rate if the rupture occurred in a hospital having an
emergency vascular service. Ruptured abdominal aortic aneurysms are estimated
to contribute 1-2% of all male deaths over 65 years in Western countries
(Goldstone et al 1993; Greenhalgh et al 1990). In the United States and the
United Kingdom, approximately 15,000 and 10,000 people, respectively, die from
ruptured abdominalaortic aneurysms each year (Goldstoneet al 1993;
Greenhalgh et al 1990). The overall mortality of ruptured abdominalaortic
aneurysmsvaries between 85% and 95% (Johanssonet al 1986; Buddet al
1989). The majority of patients die without ever reaching hospital and, of those
whoreach hospital alive, between 30% and 70% survive. A further reduction of
the mortality has not been achievedin vascular surgery centres despite increasing
experience, standardisation of the surgical technique and major advancesin
anaesthesia and intensive care medicine (Kniemeyeret al 2000).
1.4 Classification, Pathogenesis and Risk Factors for Abdominal Aortic
Aneurysm
1.4.1 Classification
An aneurysm canbeclassified according to its site, morphology, and aetiology.
75% of abdominal aortic aneurysmsare located below the renal arteries in the
distal abdominal aorta (Dzau et al 1991).
According to its morphology, AAA canbeclassified as fusiform or saccular.
Fusiform is the most common morphologyof aneurysm.It is described as ovoid
swelling affecting the entire circumference of a segmentof arterial wall. Saccularis
the less commonform. It is an eccentric, localised, distended sac affecting only
part of the circumferenceof the arterial wall (Zarins et al 2004).
A dissecting aneurysm usually occurs in the thoracic aorta. With the aortic
dilatation, it has an intimal tear and separation of the layers of aortic wall, as a
result, a false lumen within the aortic wall is created and compressedonthe true
lumen (Zarins et al 2004) (Figure 1.3).
Types of Aneurysm      
A B C
Fusiform Saccular Dissecting
Figure 1.3: Diagram to show the different types of aortic aneurysm.(kindly provided by the
department of medicalillustration, Aberdeen Royal Infirmary).
Traditionally, AAA’s have beenassociated with atherosclerotic disease and
frequently referred to as atherosclerotic aneurysms. However, the atherosclerotic
changes may be secondary to abdominal aortic aneurysmsrather than being
primary (Reilly et al 1989). Epidemiological characteristics and genetic risk factors
are different in patients with AAA comparedto those with stenosing arterial
disease (MacSweeneyet al 1994). The nutritional supply of the lower abdominal
aorta dependsondiffusion of nutrients from the aortic lumen, because the vasa
vasorum (a network of small blood vessels that supply large blood vessels)is
deficientin this part of the aorta (Appleberg 1994). Impaired diffusion through
damagedintima, atherosclerotic plaques and overlying thrombi, and vessel wall
vibration may further weakenthe aortic media and facilitate the development of
infrarenal abdominal aortic aneurysm (Appleberg et al 1994; MacSweeneyet al
1994).
Aninflammatory aneurysmis defined by presenceof a thickened aneurysm wall,
marked peri-aneurysmal andretroperitoneal fibrosis and dense adhesionsto
adjacent abdominalorgans(Sterpetti et al 1989). Althoughthis inflammationis
more pronouncedin ‘Inflammatory AAA’s’ current understanding favours one
pathological process with varying degreesof inflammation, rather than the distinct
clinical entity (Rose et al1981). Contemporary study hascorroboratedthis theory
by demonstrating identical HLAalleles functioning in both inflammatory and
degenerative AAA's, supporting the concept of a common immune-mediated
pathogenesis (Rasmussen 2001).
Aneurysm canalso occurin patients with Ehlers-Danlos and Marfan’s syndrome.
Marfan’s syndromeresults from a mutation in the gene codesforfibrillin, a family
of connective tissue proteins that serve as scaffolding for the deposition of elastin
during embryonic development. This genetic mutation weakensthe aortic media
and dilatation occurs,resulting in a high incidence of dissecting aneurysms,
especially in the ascending aorta. The Ehlers-Danlosare a rare groupof disorders
characterized by hyperelasticity and fragility of the skin, joint hypermobility, and a
bleeding diathesis. Ehlers-Danlos IV is associated with a tendencyto
spontaneousruptureoflarge arteries (Farber et al 1995).
Mycotic aneurysm is referred to as segmentarterial wall dilatation as the result of
localised sepsis. Most patients are elderly men with multiple comorbidities at
presentation, most notably diabetes and hypertension, it can also occurin
intravenous drug users (Luis et al 2010).
1.4.2 Pathogenesis
The pathogenesis of AAA is a multifactorial process. It involves genetic factors,
ageing, atherosclerosis, inflammation, and localised proteolytic enzymeactivation
(Zarins et al 2004).
Elastin and collagen are important structural componentsofthe aortic wall. Elastin
is easily stretched and providesthe elastic recoil of large arteries, while aortic
collagenis coiled suchthatthe initial load in the aorta is borne by elastin. As the
vessel continuesto stretch, collagen fibres become load bearing. Aortic collagen
has a tensile strength over 20 times greater than that of elastin, but cannot extend
beyond a small proportionofits original length before structural damage occurs.
Initially, destruction of elastin shifts the load of pulsatile blood flow in the lower
aorta from elastin to collagen. Part of the markedstiffness or inelasticity of dilated
or aneurysmalvesselsis attributable to this loss of elastin. Years of pulsatile
blood flow through the degenerated vessel wall exacerbate the process, and the
collagen is continuously exposed to the expansile force of intraluminal blood
pressure.
Familial clustering of AAA suggests a genetic basis to this disease. Inherited
defects in elastin and collagen might weakenthe aortic wall, or genetic variables
may increase enzymatic destruction of vessel wall constituents (Kent et al, 2010).
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Both X-linked and autosomal dominant modesof inheritance have been suggested
(Tilson et al 1984).
1.4.3 Risk factors
Documentedrisk factors for AAA are age, male sex, family history, previous
vascular disease, smoking, hypercholesterolaemia and excessive weight (Kent et
al, 2010; Lindholt et al 1996; R Darling et al; Adamset al 1993; Fitzgerald et al
1995).
Advancing ageis an importantrisk factor for the development of an AAA (Wilmink,
1998). In population screening surveys, an AAA is six times commonerin men
than women (Pleumeekerset al, 1995; Scott et al, 1995), but it is only twice as
commonin menin post mortem studies (McFarlane 1991; Bengtsson 1992). In
England and Wales, the age-standardized mortality rate of AAA is twice as high in
men as women(Statistics 1995). AAA is uncommonbefore 50 years of age.
Normalageing is associated with alterations in the structure and, consequently,
the mechanical properties of the aortic wall. Thus, the ageing aorta maybeless
able to withstand the force of pulsatile blood flow, resulting in aneurysmal
dilatation (MacSweeneyetal 1994).
Cigarette smoking has beenstrongly associated with the presence of AAA,
aneurysm expansionrates, and death from aneurysm rupture. The mechanism is
thought to be enhancementof proteolytic enzyme degradation of the aortic wall by
gaseous andblood-borne products of tobacco combustion (Collin et al, 1988;
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MacSweeneyetal, 1994). The only prophylactic advice that appears useful is
cessation of smoking (Cheatle et al 1989).
Hypertension is associated with increased prevalence and increasedrisk of
rupture. Hypertension mayberelated directly to pathogenesis or may merely
exacerbate the effect of blood flow forces on an already weakenedaortic wall
(MacSweeneyet al 1994).
1.5 Clinical Presentation and Examination
Most unruptured AAA’s are asymptomatic. Approximately 75% of abdominal
aortic aneurysms are asymptomaticatinitial diagnosis (Thompsonet al 2001). A
feeling of fullness or pulsations in the abdomen may beearly symptoms(Zipeset
al 1990). Inflammatory aneurysm maypresent with history of vague abdominalor
back pain, general malaise and weight loss, sometimes it can present as ureteric
obstruction as the primary complaint. Rapid expansion of an abdominal aneurysm
may causeintensepain that is exacerbated by pressure over the aorta (Thompson
et al 2001).
Typically, ruptured abdominal aortic aneurysm presents with sudden onset, acute
epigastric pain, with or without back pain. Often the patient will have a history of
collapse, but haemodynamic disturbance may not presentat all in some cases.
The clinician should consider the possibility of rupture of an AAA in any male
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patient over the age of 60 years who presents with suddenonsetepigastric and/or
back pain with or without shock and/or collapse (Duthie et al 1988; Applebergetal
1994). In addition, patient characteristics which mayraiseclinical suspicion of
AAA include being a current smokeror with a significant smoking history, a history
of myocardial infarction (Lederle et al 1988) and claudication (Simonet al 1996).
As discussed above,a strong familial occurrence of AAA should also raise
diagnostic suspicion, as should the presence of hypertension (Reilly et al 1989).
Physical examination of AAA haslow overall sensitivity. A study to determine the
accuracyof physical examination in AAA detection found that abdominal palpation
detected only half of 18 previously unsuspected aneurysmsin 201 patients. This
study found that abdominalgirth was an important factor in detecting AAA by
physical examination (Lederle et al 1988).
1.6 Unusual Clinical Presentations
Unusualclinical presentations of AAA mayresult from chronic contained rupture,
aortoenteralfistula, and thrombo-embolism. These manifestations may complicate
surgery andraise operative morbidity and mortality. A chronic contained rupture
may, in addition to abdominalor low back pain, cause pressureeffects resulting in
jaundice from commonbile duct compressionor ureteric obstruction, femoral
neuropathy, or extension of the haematomainto the femoral sheath, simulating a
groin hernia. (Boweret al, 1989).
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Aortocaval and aortorenalvein fistulas result from rupture of an AAA into the
inferior vena cavaortheleft renal vein. Clinical presentation includes high-output
heart failure, cardiomegaly, a palpable abdominal mass, audible continuousbruit,
hypotension, oliguria, and abdominal and back pain(Boweretal. 1989).
Mycotic aneurysmsare rare and mayresult from superimposedinfection or arise
secondarily from an infection. Clinically, infected aneurysms may presentwith the
sudden appearanceofa pulsatile mass or recent enlargement of a known AAA in
combination with fever or recentfebrile illness (Boweret al. 1989).
Thrombo-embolism from an abdominalaortic aneurysm to one or both of the lower
extremities is a well recognised phenomenon,(Boweret al 1989). Thrombuswithin
the lumen of the aneurysm orcholesterol debris from within the intima of the wall
can be the source of macroemboli or microemboli, respectively. Macroembolism
presents with symptoms andsigns of large-vessel occlusion and sudden ischemia
of the lowerlimbs. Small-vessel occlusion resulting from microemboli presents as
slowly evolving livedoreticularis, painful cyanotic toes, and palpable pedal pulses.
Microembolism has been termed blue toe syndrome becauseofthe characteristic
cyanosis of the toes; if both lower extremities are involved, an aortic or cardiac
source should be considered (Boweret al 1989).
Other unusual complications of AAA's include recurrent ischaemic myelopathy
and/or paraparesis. Ischemic spinal cord lesions may present with bladder
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incontinence and patchy sensory loss (Desai et al 1989). Paraparesis may result
from anterior spinal artery syndrome, which presents as a varying degree of
muscle weaknessand associated sensory loss of pain with sparing of
proprioception (Josephet al 1989).
1.7. Imaging for Abdominal Aortic Aneurysm
There are many methodsavailable for imaging the aorta; each with strengths and
weaknesses.The choice is dependent onindividual cases, equipmentavailability,
technical expertise, and surgeon preference;all should influence imaging modality
selection (LaRoy, Cormieret al. 1989).
1.7.1 Plain abdominal X ray
Abdominal aortic aneurysms can benoted on antero-posterior (Amparoetal,
1985) plain x-ray. Most AAA’s occur betweenthe renalarteries andtheiliac
bifurcation; that is, between the L2 and L4 vertebral levels, respectively. In the
frontal (AP) projection, an AAA is usually seen ontheleft side of the spine and
appearsas a soft tissue density demarcated by a thin, curvilinear rim of
continuous or discontinuouscalcification (figure 1.4). Calcification is noted in 55%
to 85% of AAA's (Brewster 1976; LaRoy, Cormieret al. 1989); in the remainder, a
soft tissue density may beidentifiable. Erosion of the anterior margins of the
vertebral bodies maybe noted with inflammatory and saccular aneurysms, and
those involving contained rupture (Nonamiet al, 1996; Yochumet al 1996).
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Fig1.4. Antero-posterior plain abdominal
pelvis X-ray showing: Curvilinear rim of
discontinuouscalcification in the wall of an
AAA(twored arrows); maximum transverse
diameter 7.5 cm.
1.7.2 Ultrasound / Duplex
Ultrasound scanningis currently the most practical and accurate way of detecting
abdominal aortic aneurysmsin large numbers of people (Graham and Chan 1988),
and has become the most commonly used method of screening (Graham and
Chan 1988; LaRoy, Cormieret al. 1989; Wong 2000). Ultrasound enables
diagnostic confirmation, evaluation of size, and monitoring of progression (Graham
and Chan 1988). However, the accuracy of ultrasound is operator-dependent and
the results may vary between vascular centres or even within centres, especially
when the aneurysm is small (Ellis et al 1991: Andrew et al 1995).
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 Figure 1.5: Ultrasound of a large AAA. The Anteroposterior diameter of this AAA
measures7.91 cm; intraluminal diameteris 4.73 cm. Intraluminal thrombusis
clearly visible.
1.7.3. Computed tomography(CT)
With the improvementof technology, especially the availability of new high speed
spiral CT, CT has becomethe “gold standard”in the preoperative assessment and
postoperative evaluation of AAA’s. Enhanced with contrast, CT can accurately
demonstrate the size and craniocaudal extent of an abdominal aortic aneurysm
andis able to detect intraluminal thrombus. Aortic aneurysm neck, iliac artery
dimensions, angulation and presence of thrombosescan also be demonstrated
accurately. Furthermore, contrast enhanced spiral CT (CTA) scanning can also
produce a computerized 3D model which canprovide the level of accuracy needed
for successful endovasculartreatment of AAA’s ( Beebeetal, 2000).
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 Figure 1.6 CT scan with contrast in the patent lumen (small arrow) of a typical AAA;
thrombus(large arrow).
1.7.4 Magnetic resonance imaging (MRI)
The multiplanar display capability of magnetic resonance imaging (MRI) can
demonstrate the aorta and surrounding soft tissue anatomy accurately without the
need for contrast. It allows accurate measurement, isolates flow abnormalities,
identifies clot, and allows assessmentofvisceral involvement (Yochum 1996).
Gadolinium-enhanced magnetic resonance angiography (MRA)is a variation of
standard MRI, utilizing a paramagnetic contrast agent. This modality provides
anatomic information for aortic reconstructive surgery without the contrast-related
renal toxicity or catheterization-related complications as seen in CTA and
conventional angiography, (Prince, Narasimhametal. 1995).
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As with contrast enhancedspiral CT (CTA), MRA has becomethe “gold standard”
for the preoperative assessment and postoperative evaluation of AAA’s in some
centres. The choice between CTA and MRAislargely dependentonlocal
experience andthe availability of the latest scanner. At present there is no
consensusto indicate the superiority of either modality (Hirsch et al, 2006)
1.7.5 Aortic digital subtraction angiography
Aortoangiographyis used to evaluate the state of the renal arteries and other
vesselsin theiliac artery system in patients with AAA (Appleberg 1994). (Figure
1.7) However,its role in the preoperative assessment and postoperative
evaluation of AAA haslargely been replaced by CTA and MRA.
However, aortoangiography may underdemonstrate the size and extentof the
thrombus-filled aneurysm,as only the lumen is demonstrated (LaRoy, Cormieret
al. 1989). Currently, aortoangiography is only sometimes used for anatomical
measurements in planning for endovascular repair of abdominal aortic aneurysm.
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 Figure 1.7 Angiogram showinga large abdominal aortic aneurysm.
1.8 Natural History of Abdominal Aortic Aneurysm
Most AAA's continue to enlarge progressively. Small aneurysmsincreasein
transverse diameter by 2-3 mm onaverage, per year (Cronenwettet al 1985;
Cooket al 1996); whilst the anteroposterior diameter increases by an average of
2.2 mm,per year (Cronenwett et al 1985). Large aneurysms expand morerapidly
than smaller ones (Appleberg et al 1994; Cook et al 1996).
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The estimated aneurysm expansion rate based onits diameteris given in Table
 
1.1
Size Annual expansion rate
Less than 4
cm 0.2 - 0.4cm
4-5 cm 0.2 - 0.5cm
More than
5cm 0.3 - 0.7cm    
Table 1.1 Aneurysm annualexpansion rate based on its diameter (Hallin 2001)
The mostestablished method to assess probability of rupture of AAA is the
diameterof the aneurysm, butit is still unclear whether the rate of aneurysm
rupture correlates with the aneurysm size. In particular, in aneurysmslarger than
5.0cm diameter a study has suggestedthat rupture rate is typically 25-40% at 5
years, but only 5—7% for aneurysmsof 3.5-5.0cm, and approaching 0% for
aneurysmsless than 3.5cm (Wyffels et al 2000).
Life expectancyof aortic aneurysm patients is shorter than in those of similar age
and sex whodo not have anaortic aneurysm, duetotheirlife threatening co-
morbidities (Koskas et al 1997). Deaths from the other cardiovascular conditions
are the major reasonfor the reduction oflife expectancy (Brady et al 2001).
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1.9 Principle of Management of Abdominal Aortic Aneurysm
Since ruptured abdominalaortic aneurysms causesignificant mortality, especially
outside the hospital environment, the principal aim of managing AAA’s must
therefore be to decrease the rate of aneurysmalrupture.
Evidenceof risk of rupture of small AAA's (4.0 to 5.4cm) has been provided by a
small aneurysmtrial in the UK and ADAM (Aneurysm Detection and Management
Study) from the USA (Trial Participants 1998; Lederle et al. 2002). The results and
design of the two studies are very similar. Both trials concluded that surveillance of
AAA's of 4.0 to 5.5cm wassafe in compliant patients, and that early surgery did
not result in any long-term survival advantage. An additional important observation
from the UK small aneurysmstrial was that death wasattributable to ruptured AAA
in 5% of men whodied, but 14% of women whodied (Trial Participants 1998).
Therisk of rupture was 4 times higher among women, than men. Thetrial
participants concluded that the threshold of 5.5 cm diameter maybetoo high for
women.
The following principles of management of AAA have been suggested to reduce
the mortality from rupture (Thompson 2001).
1): Adoption of national screening programmesto identify patients with
asymptomatic aneurysms in a communitysetting.
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2): Medicaltreatment of small aneurysmsdetected in a screening programmeto
reduce expansion and rupture rates.
3): Selection of appropriate patients for surgery so that operative risk is balanced
againstthe risk of rupture.
4): Reductionin the mortality rates of elective and emergency surgery for AAA’s.
1.10 Conventional Surgical Management of Uncomplicated Abdominal
Aortic Aneurysm
1.10.1 Historic review
Arterial aneurysms have beenrecognized since ancient times. One of the earliest
texts known, the Ebers Papyrus (200 BC), contains a description of traumatic
aneurysmsofthe peripheral arteries (Osler 1905). However, not until the 16"
century, camethefirst description of abdominal aortic aneurysm, by anatomist
Vesalius (Leonando 1943). Thefirst elective operation for treatment of an
aneurysm wasreported by Antyllus in the 2"? century AD. He recommended
ligating the artery above and below the aneurysm andthenincising the sac and
evacuating its contents (Osler 1915).
There were a few early attempts to repair the aneurysm. Cooper attempted to
ligate the aneurysm in 1817. Matas performed endoaneurysmorrhaphy, which
2
consisted of imbrication of the opened aneurysm edges in1906. Rea, in1948,
performed cellophane wrapping (Zarins et al 2004).
The 1°‘ modern repair of an abdominalaortic aneurysm wasperformed on March
29" 1951, in Paris, by French physician Charles Dubost. His patient was a 50-
year-old man, and the operation was performedvia a left thoracoabdominal
incision. A 15-cm homograft, taken from the thoracic aorta of a 20-year-old woman
whodied 3 weeks earlier, was anastomosedto the aorta and right commoniliac
artery. An endarterectomy of the occluded left commoniliac artery was performed
before its anastomosis to the homograft (Dubost, 1952). The patient survived for 8
years and died from a myocardial infarction at his home,in Brittany. The report of
this operation rocked the surgical world and inspired surgeons throughout Europe
and the United States. Several years later, Michael DeBakey performed a similar
operation with a polyester fabric prosthesis and coinedit “Dubost’s operation”
(Friedman, 2001). However, dissection and removalof the aneurysmstill was a
major operation with a large volumeof blood loss. Greech introducedthe ‘inlay
graft technique’ which is a simplified version of “Dubost’s operation” (Greech
1996). This technique was popularized by Orr and Davies (Orret al. 1974).
Initially, the mortality rate following open surgery was 20 percent, but gradually
improved, so that surgical repair became standard treatment (Crawfordetal.
1981)
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1.10.2 Patient selection
The indication for surgical repair for asymptomatic AAA’s is based onsize =
5.9cm. This was based onthe results of UK small aneurysm trials and it was
further confirmed by the ADAMtrial from the United States and patients’ general
fitness. However, there is no universal standard for selection of patients for
surgical intervention. The Joint Council of the American Association for Vascular
Surgery and Society for Vascular Surgery has produced guidelines with
recommendationsfor the treatment of abdominal aortic aneurysm (Hirschetal,
2006).
1: The arbitrary setting of a single threshold diameterfor elective AAA repair
applicable to all patients is not appropriate, as the decision for repair must be
individualized.
2: Randomizedtrials have shownthatthe risk of rupture of small (5 cm) AAA’sis
quite low, and thata policy of careful surveillance up to a diameterof 5.5 cm is
safe, unless rapid expansion (1 cm/yr), or symptoms, develop. However, early
surgery is comparable to surveillance with later surgery, so that patient
preference is important, especially for AAA’s 4.5 cm to 5.5 cm in diameter.
3: Based on the best available current evidence, 5.5cm diameter appears to be an
appropriate threshold for repair in an “average” patient. However, subsets of
youngerlow-risk patients, with long projected life expectancy, may prefer early
repair. If the surgeon’s personal documented operative mortality rate is low,
repair may beindicated at smaller sizes (4.5-5.4 cm)if that is the patient's
preference.
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4: For women, or AAA with greater than average rupturerisk, elective repair at 4.5
cm to 5.0 cm is an appropriate threshold for repair.
5: For high-risk patients, delay in repair until larger diameter is warranted.
1.10.3 Standard open surgical technique- ‘Inlay Graft Repair’
Figure 1.9 briefly describes the techniques of abdominal aortic aneurysm repair.
A large abdominal midline or transverse incision was madeto accessthe
abdominalcavity. This was then followed by mobilising the retroperitoneum and
duodenum to exposethe aortic aneurysm with normal aorta above and bothiliac
arteries below. After isolating the aneurysm by clamping the aorta just above the
aneurysm andbothiliac arteries, the aneurysm wasthen openedalongits axial
direction and its content was removed. Any back bleeding from branches which
openinto the aneurysm sac, such as lumbararteries and inferior mesenteric
artery, were sutured; some surgeonspreferto ligate the inferior mesenteric artery
before opening the aneurysm sac. After a normal segmentof aorta betweenthe
clamps was adequately exposed,a prosthetic tube graft was then sutured ontoit
by hand anastomosis and blood flow restored by releasing the clamps.
Sometimes, when there were no normal segments in the distal end of aorta or
eventheiliac arteries available, it was necessary to use bifurcated prosthetic graft
to suture the distal end onto theiliac arteries, or even more distally. After thorough
checksfor any bleeding with further necessary sutures, the aneurysm sac was
then closed to coverthe prosthetic graft and the suturing sites.
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Figure 1.9: Operative technique of open abdominal aortic aneurysm repair, A, The Aneurysm is
approached through a midline or transverse transabdominalincision or a left flank retroperitoneal
incision. B: Proximal and distal control is obtained, the aneurysm is opened, mural thrombusis
removed, and back bleeding lumbarorifices are oversewn, C: The proximal anastomosis is started
along the back wall of the aorta as shown, or the proximal neck is transacted and end-to-end
anastomosis is created. D, The distal anastomosis is constructed in a similar fashion; if backbleeding
from the inferior mesenteric artery (IMA)is pulsatile and the hypogastric arteries are patent, the IMA
maybeoversewn.E.If theiliac arteries are aneurysmal, a bifurcated prosthetic graft is used. (Zarins
et al 2004)
In repair of abdominal aortic aneurysm, the aneurysm canalso be accessed by
smaller incisions (mini laparotomyincision), retroperitoneal approach, laparoscopic
or laparoscopic assisted approaches. However,all these different approaches
have a similar way to repair the aneurysm, and they all have different advantages
and disadvantages.
aa
1.11 Outcomes of Open Repair of Abdominal Aortic Aneurysm
Open abdominal aortic aneurysm repair carries a considerably high risk of
mortality and morbidity. To repair the abdominal aortic aneurysm,a large
abdominalincision is required. This can causesignificant pain andrestrict
respiratory movement. In addition, a high numberof patients suffer undiagnosed
COPD (Chronic Obstructive Pulmonary Disease), so, respiratory complications
after open abdominalaortic aneurysm repair are common. Clamping and de-
clamping the aorta hasa significant impact on the heart, due to the sudden
changein circulating volume which, may cause cardiac complications.
Furthermore, open abdominalaortic surgery can cause systemic inflammatory
response syndromewhichis the reason for developing multiple organfailure
(MOF). MOFis oneof the leading causes of death after open abdominal aortic
aneurysm repair.
1.11.1 Perioperative mortality
The operative mortality rate after open AAA repair has changedlittle over the last
two decades,despite the advancesin perioperative care (Bradbury et al 1998).
The reported mortality rate varies among hospitals and groups.
In the United Kingdom there are two multicentre, randomized, controlledtrials
compare the outcomesof endovascular or open repair of abdominal aortic
aneurysms(details will be discussed in chapter 2). The reported 30-day mortality
from one trial is 4.7% in the open-repair group (Greenhalgh et al, 2004). Another
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study reviewed 37,654 patients in seventy-two papers. The authors analysed the
results according to the type of study designs. They found that there is clear and
consistent disagreementin reported mortality rates between hospital-based and
population-basedstudies of elective surgery for AAA. The mortality in the
population-based study was 7.0%-10.6% with a mean of 8.2%, while hospital-
based mortality was 3.0% - 4.8% with a mean of 3.6% (Blankensteijn et al 1998).
Furthermore, since the hospitals and groups with high mortality are unlikely to
publish their results, the actual mortality rate is likely to be higher in everyday
vascular surgical practice than those reported in medical journals.
1.11.2 Perioperative morbidity
The overall morbidity rate after elective aneurysm repair is 10% to 30%. The most
frequent complication is myocardial ischaemia, which usually occurs within thefirst
2-4 days after surgery. Myocardialinfarction is also the most commoncauseof
postoperative death (Zarins et al 2004). Irregular heart rhythm and heart failure
are also commonly occurring cardiac complications. Mild renal failure is the
second mostfrequent complication. It is more frequent with pre-existing renal
disease and may occurasa result of hypoperfusion, systemic inflammatory
response syndromeand occasionally, atheroembolism. However, severe renal
failure, requiring long term dialysis, is rare. The third most common groupof
complications is respiratory. Post operative acute lung injury from the systemic
inflammatory response syndromeis one of the most commonly occurring
respiratory complications. Acute lung injury may lead to “Acute respiratory distress
syndrome”andbeing proneto infection. Post operative pneumonia and acute
pulmonary embolism following a deep vein thrombosis are also frequent
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occurrences. However, with properpatient selection and care, respiratory failure
as the principal cause of death is rare (Zarins C K et al 2004).
Other complicationsincluding bleeding (from aneurysm repair site or gastro-
intestinal tract), cerebrovascular accident, prolonged boweldysfunction, and bowel
ischaemia mayalso occur postoperatively. Sexual dysfunction is also frequently-
occurring after open repair of AAA. Symptoms mainly present as impotence,
which may be psychological, neurological, or relating to reduced internal iliac
artery perfusion; or as retrograde ejaculation, which is related to nerveinjury in the
vicinity of the left commoniliac artery.
Local complications after open repair of AAA include limb ischaemia, bleeding
from anastomosis, woundinfection, graft infection, thrombosis and wound
dehiscence. A study reviewed 37,654 patients in seventy-two papers concerning
results of open AAA repair over an eleven year period. The systemic andlocal
complication rates are given in Table 1.2 (Blankensteijn 1998).
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System complications Frequency (%) medial
(Range)
Cardiac 12.0 (10.5-13.9)
Pulmonary 9.8 (8.3-11.6)
Renal 4.8 (3.8-6.2)
Gastrointestinal 13.0 (11.3-14.9)
Cerebral 0.6 (0.3-1.5)
Local vascular complications
Limb ischaemia 5.8 (4.2-7.9)
Bleeding 6.2 4.7-8.1)
Woundinfection 1.5 (0.9-2.5)
Graft infection 0.3 (0.1-1.0)
Thrombosis 1.1 (0.6-2.0)
Wound dehiscence 0.6 (0.3-1.3)
Table 1.2 Reported complications following elective open repair of AAA.
1.11.3 Long-term results of open repair
In general, the long term outcome of open abdominalaortic aneurysm repairis
good. A population based study followed 208 patients after open repair oftheir
abdominalaortic aneurysm. Patients were followed for 15 years. The 5-year, 10-
year and 15-year survival, free from any vascular reintervention rates were 91.5%,
86.2% and 72.0% (Biancari et al 2002). Authors concluded that open repair of
Infrarenal AAA’s can achievesatisfactory 15-year follow-up rates of survival, free
from reintervention for any graft-related complications. A study from Crawford etal
has also produced similar results, (Crawford 1981).
Long term complications include aorto-enteric fistula, graft infection, false
aneurysm formation and aneurysm rupture. These complications are generally
rare, though can befatal when occurring.
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1.12 Summary
Aortic aneurysm is a common disorder amongtheelderly population. The
incidence of aortic aneurysm hasincreased rapidly over recent years. Most aortic
aneurysmsdo not present any symptoms, until rupture. If untreated, aortic
aneurysmswill continuously grow and mostof them will eventually rupture. Open
surgical repair has becomea well established techniqueforoverfifty years. It is
effective to prevent aneurysm rupture, butit is a complicated major operation,
carrying significant morbidity and mortality. The outcomeof openrepair of aortic
aneurysm has changedlittle over the last two decades.
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CHAPTER2
ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM
REPAIR (EVAR)
2.1. Development of Endovascular Abdominal Aortic Aneurysm Repair
2.1.1 Historical Review
As mentioned in the previous chapter, the natural history of an abdominal aortic
aneurysm (AAA)is progressive enlargement, until it ruptures. The mortality is
around 50% in patients who have a contained rupture and makeit to hospital
(Johansen, et al, 1991; Kniemeyer, et al, 2000; Noel, et al 2000; Heller,etal,
2001), the overall mortality may be as high as 90% (Johansen, et al, 1991;
Kniemeyer, et al, 2000; Noel, et al, 2000). Therefore, the primary objective in the
managementof a diagnosed AAA,is to prevent death from rupture. Deaths from
ruptured AAA are the third commonest cause of non-accidental sudden death in
the United Kingdom,after coronary artery disease and stroke (Noel, et al 2000).
The managementoptions for an unruptured abdominal aortic aneurysm previously
consisted of open repair or “best medical treatment” which included regular
ultrasound scan surveillance and risk factor modifications. Standard surgical
repair, involving a large abdominalincision and cross-clampingof the aorta, is
frequently complicated and has an averagein-hospital mortality of approximately
2% to 6% (Hollier, et al 1986). With an ageing population, the numberof high risk
casesalso increasesthereby resulting in higher mortality. Average bloodlossis
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2-3 units in 95% of cases, with an average hospital stay of 6 days (Wyffels P, et
al; 2000; Hollier, et al 1986). Laparoscopic aortic aneurysm repair has been
developed recently, and a lower perioperative mortality has been reported (Cau, et
al, 2006). However, due to the complexity of the technique and the lengthy
operation, this technique has not gained popularity.
Since endovascularaortic aneurysm repair (EVAR) has been developed, it has
provided vascular surgeonswith an alternative method to conventional open
surgery in treating aortic aneurysm disease.
Endovascular approachto arteries is a long established techniquein clinical
practice; with introduction of guide-wires and catheters. By injecting radio-opaque
contrast media, the relevant arteries can be imaged and subsequent therapeutic
procedures performed. With the introduction of digital subtraction angiography,
(DSA), (a method in X-Ray imaging, which allowsirrelevant parts of the anatomy
to be “subtracted”, so the relevant parts can be shown much moreclearly), the
quality of vascular imaging using X-rays has becomebetter than everbefore.
With this technology, Parodi, and independently Volodos, proposed a new method
of treating AAA. Their concept was to combine endovascular and minimally
invasive techniques (Parodi, et al, 1991; Volodos,et al, 1991). This new
technique involved the transfemoralor transiliac placement of a stent-graft within
the aneurysm, via two small incisions madein the patient's groin. The aim of the
treatmentis to achieve complete exclusion of the aneurysm sac from the
circulation, thereby protecting the aneurysm from rupture. At the sametime the
aneurysm sac andits contents remain in situ. The stent-graft is usually
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compressedinto a plastic sheath, inside whichit is delivered into the aneurysm
and manoeuvredinto position under X-ray (fluoroscopy) guidance. It is then
deployed by withdrawalof the sheath, and othertriggering devices. Afterfinal
fixation at the proximal and distal endsofthe stent-graft, it is sometimes necessary
to inflate a moulding ballooninside the stent-graft at the attachment zone to ensure
a secure seal. Some devices also have additionalfixation appendages to anchor
the stent-graft to the aortic wall. This operation can be performed undergeneral,
regional or local anaesthesia. Nowadays, some devices can even beeninserted
percutaneously without an incision in the groin.
The stent-graft is a prosthetic vasculargraft, (typically made of Dacron or
polytetrafluoroethylene), whichis reinforced by metallic struts. In general,
endovascularstent-grafts fall into three broad categories: (i) bifurcated or tubular
unibodygrafts. (ii) Modular multicomponentgrafts. (iii) aorto unilateral grafts with a
contralateraliliac occlude, which are followed by surgical femoro-femoral bypass
(Veith,et al, 1999).
2.1.2 Development of stent-graft for endovascular abdominal aortic
aneurysm repair
Following the publication from Parodi and Volodos of results using their “home
made”device, the endovascularstent-graft became rapidly commercialised. The
first tube graft development by Endovascular Technologies(later to be taken over
by Guidant, Menlo Park, CA, USA) wasimplanted in 1993. This graft was then
further developed into the Ancure device, which has now been withdrawn from the
market due to a high incidence of device malfunction and other adverse events,
and failing to report to the FDA. Since 1993, around 15 other types of stent-grafts
have been developed and cometo the market. All these stent-grafts claim an
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advantageoverthe others (Rutherford et al, 2004). Some, however, have
followed the Ancure stent-graft and have been withdrawn from the market. These
include the Vanguard (Boston Scientific, Natick, MA, USA), all of which had design
flaws, and causedanincreasedrisk to the patient as compared with openrepair.
In addition, high developmentcosts have seen the withdrawal of the Lifepath by
EdwardsLifescience (part of Baxter Healthcare Corp.Irvine, CA, USA), even
though the Lifepath later had positive results from its clinical trial (Carpenteretal,
2004).
2.2. Principle of Endovascular Repair of Abdominal Aortic Aneurysm
2.2.1. Aim of endovascular repair of abdominal aortic aneurysm
As mentioned before, the aim of EVARis to prevent the aneurysm from rupturing
by completely and permanently excludingit from the pressure and flow of the
blood circulation, without causing disruption to any important visceral blood
supply. To achievethis,it is essential to meet the followingcriteria:
(i) Seal: The aneurysm sac must be completely sealed from the blood
pressure andflow.
(ii) Fixation: The seal must be maintained by a goodfixation against the
downstream blood flow throughoutthe patient'slife.
(iii) Maintenance:All important visceral blood supply must be maintained.
2.2.2. Patient selection
Currently, there are no generally agreed indications for EVAR betweendifferent
units and countries. But, as for open repair, patients with infrarenal abdominal
aortic aneurysms more than 5.5cm in diameter are considered for EVAR in most
centres.
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Due to the minimally invasive nature, patients selected for EVAR have fewer
requirements on cardiovascular function, pulmonary function and generalfitness.
However, there are no commonly agreedselectioncriteria for patients receiving
EVAR. Thebest evidenceavailable is from the UK EVAR-2 trial which suggested
that patients who arenotfit for open repair will not benefit from EVAR since most
patients will die from causesother than their aneurysm (EVARtrial participants,
2005). But due to controversies surrounding the trial design and data
interpretation, many vascular centres do notfollow this recommendation.
2.2.3. Anatomical consideration
Anatomical suitability for EVAR is based principally on the morphology of the
aneurysm, the length and characterof proximal (aortic neck) and distal landing
zones, such as degree of angulation, calcification, thrombosis and conical shape
of aortic neck and thetortuosityofiliac arteries. The diameter, length, angulation,
presenceofcalcification and mural thrombusin the aortic neck are the most
frequent cause of exclusion from EVAR(Arko et al, 2004; Lezzi R et al, 2006). A
study suggests that 55% patients were considered suitable for EVAR and 45%
patients deemedineligible (Arko et al 2004). The most commonanatomical
reasonforineligibility was a short infrarenal neck (44%), a large proximal neck
diameter(25%), iliac aneurysms (10%), extremely tortuousorcalcified neck (7%),
iliac occlusion (6%), and small distal aortic bifurcation and accessory renal arteries
(5%). Similarly, Carpenter et al (Carpenter et al, 2001) reported short aneurysm
neck (54%), inadequate access from small iliac arteries (47%), wide aneurysm
neck (40%), bilateral commoniliac artery aneurysms (21%), excessive neck
angulation (14%), excessive mural thrombus in aneurysm neck (10%), and
accessory renal arteries (6%) with many patients having a combination of factors.
With increasingclinical experience, and improvementin stent-graft design thatis
constantly providing new andversatile devices, the numberof patients eligible for
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EVARhasincreased and more and more anatomicallimitations have been
overcome. However, complex aortic anatomywill still be a significant limitation for
the foreseeable future.
2.3.
The following lists the currently commonly usedstent-graft devices in the UK, and
Currently Commonly Used Stent-grafts and their Configurations
their configurations (Table 2.1)
 
 
      
Company Device Fixation Graft Stent Stent
location materials materials Expansion
Medtronic AneuRx Infrarenal Woven Nitinol Self-
polyester Expanding
Lombard Aorfix Infrarenal Woven Nitinol Self-
medical polyester Expanding
Gore Excluder Infrarenal ePTFE Nitinol Self-
Expanding
Medtronic Endurant Suprarenal Woven Nitinol Self-
polyester Expanding/
Suprarenal
barbs
Endologix Powerlink Infrarenal or ePTFE Stainless Self-
Suprarenal steel alloy Expanding
Medtronic Talent Suprarenal Woven Nitinol Self-
polyester Expanding
Cook Zenith Suprarenal Woven Stainless Self-
polyester Steel Expanding/
Suprarenal
barbs  
Table 2.1: Currently Commonly Used Stent-grafts in the UK, and their Configurations.
2.4. Early and Mid-term Results of EVAR
Since EVARwasfirst described in 1991, there have been manyclinical papers
dedicated to EVAR. Mostof the studies have largely consisted of small case
series investigating specific aspects of EVAR (usually in direct comparison with
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conventional AAA repair). The smaller studies have provided some convincing
evidencethat the minimally invasive nature of EVAR,with no cross clamping at
the aortic neck, in conjunction with obviation of the need for laparotomy and
complex abdominaldissection, results in less physiological insult than open AAA
repair. Biological markers of inflammatory pathways and stress responses such as
proinflammatory cytokines, adrenaline, cortisol, and complementactivity are
reduced (Thompson,et al, 1999; Boyle, et al, 2000; Thompsonetal, 1996). There
is convincing evidence that EVARis associated with reduced cardiac,respiratory,
and renal complications, reduced needfor blood transfusion and analgesia, shorter
postoperative hospital stay, lower needfor intensive care, a faster return to normal
function, and lowerinfection rates (Prinssen, et al, 2004; Faries, et al, 2002; Boyle
et al, 1997; Zarins, et al, 1999; Zeebregts et al, 2004; Elkouri et al, 2004).
Until the last few years, in the absence of evidence from large national randomised
controlled trials, evidence on the efficacy and durability of EVAR relied upon
individual institutional experience and data from large voluntary registries, such as
the UK Registry for Endovascular Treatment of Aneurysms (RETA), andin
particular, the European Collaborators on Stent Graft Techniques for Abdominal
Aortic Aneurysm Repair (EUROSTAR)Registry (Carpenter et al, 2002; Thomaset
al, 1999). EUROSTARis a voluntary registry that has been prospectively
collecting data on EVAR proceduresperformed in Europe since 1999, and has
provided much of the current EVAR outcome data (Thomasetal, 1999: Harris et
al, 1997). These sources have suggestedthattheinitial operative mortality of
EVAR was comparableto that of open AAA repair, but has consistently fallen, and
may now beaslow as 1% (Holzenbeinet al, 2001; Harris et al, 2000; Zarinset al,
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2002; Fammatteret al, 2002; Blum et al, 1997). However,it has beendifficult to
make early meaningfulinterpretation and comparison of the data from these
registries and case series, becauseof factors such as publication bias, lack of
patient randomisation,the likelihood of a large numberof patients having small
aneurysms,the inclusion of patients considered unfit for open AAA repair, and
patients with less challenging anatomy (Carpenter, et al, 2000; Collin et al, 2001:
Buth,et al, 2001).
In the United Kingdom there have been two multicentre, randomized, controlled
trials; EVAR 1 and EVAR2, both of which started in 1999. The trials,
commissioned by the UK National Health Service's Health Technology
AssessmentProgram at a cost of £1.7 million, were the largestof their kind in the
world. EVAR1 wasthefirst trial to compare the two techniques and has been
successful in recruiting a large numberof patients and doctors.
EVAR1 randomised patients with an AAA >5.5 cm, who were medically fit, and
anatomically suitable for both open AAA repair (OR) and EVAR,to undergo one or
other procedure. EVAR 2 randomised patients who were considered medically unfit
for open AAA repair (but anatomically suitable for EVAR), to undergo EVARor
receive no intervention, between September 1999 and December 2003. EVAR1
recruited 1082 patients (543 EVAR v 539 OR), EVAR2 recruited 338 patients (166
EVARv 172 no intervention), 60 years or older, from 41 centres. Also in Europe,
the smaller Dutch DREAMtrial randomised 345 patients to either open AAA repair
or EVAR.
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The short term (30 day mortality) outcomeof thesetrials was published in 2004,
with the EVAR1 trial reporting a significantly improved 30 day mortality in patients
undergoing EVAR, compared with patients undergoing open AAA repair (1.7%
EVAR v 4.7% OR) (Greenhalghet al, 2004); the DREAMtrial reported similar
improved 30 day mortality in EVAR versus open AAA patients (1.2% EVAR v 4.6%
OR) (Prinssen, et al, 2004). The DREAMtrial was, however, underpowered, with
the result that improved mortality rates did not reach statistical significance.
Although the DREAMtrial madethe point that when combining their results with
EVAR1, the resulting operative mortality of 5.8% for open AAA repair and 1.9%for
EVAR,yields a risk ratio of 3.1 (Prinssen, et al, 2004).
Following on from theinitial data, during 2005, EVAR 1 and EVAR 2 both
published their 4 years mortality data (EVARtrial participants et al, 2005;
Prinssen, et al, 2004); EVAR 1 demonstrated that all-cause mortality was similar in
the two groups,but that there wasa persistent reduction in aneurysm related
deaths in the EVAR group (4% v 7%). EVAR 2 demonstrated that no benefit was
shownin patients undergoing EVAR compared with those receiving "best medical
treatment"(EVARtrial participants, 2005). The underpowered DREAMtrial has
also published further survival data (Marc et al, 2008), but initial (30 day)
perioperative survival advantage of EVAR over open AAA repair was not sustained
after the first year.
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The UK EVARtrial has provided much neededlevel one evidencefor the
endovascularrepair of abdominalaortic aneurysm. However, the controversy
around the patients crossing from different arms and the interpretation of the
results raised concerns and debateonits conclusions.
Firstly, for various reasons,only 1082 of 4789 evaluated patients were randomized
into this trial. In total, 54% of the patients with AAA were unsuited for EVAR due
to their aneurysm anatomical morphology. But only 1.4% patients were unfit for
open repair.
This suggests that, regardlessof thetrial outcome, openrepairstill played a role
for about one-half of patients presenting with larger AAAs (2 5.5cm).
The EVAR1 trial concludedthat there was nosignificantdifference in the primary
end point ofall cause mortality, which was about 28% for both groups,at 4 years.
There wasalso nodifference in quality of life (QOL) at 12 months, oneof the
important secondary end points. But the remaining end points showedsignificant
differences. The most importantdifference was a 3% advantagefor EVARin
aneurysm-related death from short, 30 day mortality (1.7% EVAR v 4.7% OR) and
this survival advantage remained at 4 years (26% EVAR v 29% OR).
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The EVAR2 trial enrolled many patients rejected from the EVAR trial because
they were unfit for open repair (n = 338). Theinitial EVAR mortality was high (9%),
and 64% of patients died during the 4 years of observation with no significant
differences betweenthe two groups. Theintent-to-treat analysis found no
significant differencein all cause mortality between the two groups (45% EVAR v
40% no intervention). There wasalso no significant difference in AAA-related
death (14% EVARv 19% nointervention), although there wasa crossoverin the
curve midway,with the trend favouring EVAR. Interventions were higherwith
EVARat 46% v 26% for no intervention, and hospital costs were three times
higher for the EVAR group (£13,632 EVAR v £4934 nointervention). Thetrialists
concludedthat there was no advantage to EVAR overnotreatmentin patients
unfit for open repair. But it needed to point out that there was an excessive delay
of 57 days between randomisation and procedure in the EVAR arm, andprotocol
violations in EVAR 2, because 27% of patients assigned to no treatment crossed
overto receive aneurysm repair without clear, valid reasons.14 (80%) died even
before receiving EVAR,including 6 AAA ruptures. Another 3 ruptures occurredin
the EVARtreated patients. In contrast, the 47 patients who crossed over(35
EVAR, 12 OR) had an operative mortality of only 2% and only about half the
mortality at 4 years (23%). In an intent-to-treat analysis, these results are credited
to no treatment. These results have raised the suspicion that it biased against
EVAR. Furthermore, thetrialists found no significant differencesin all-cause
mortality (P =0.7), and AAA related deaths (P=0.43). Butif we eliminate those
patients who died before they even received their EVAR treatment, and include
those whocrossedoverto receive a repair, the 31% mortality of those receiving a
repair (61/197)is significantly lower than the 45% mortality (57/125) of no
intervention.
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The results of EVAR 1 and EVAR2 trials have suggested that EVARis technically
effective and safe, with a lowershort-term morbidity and mortality than open
repair. But the long-term success of EVARin preventing aneurysm-related deaths
is still uncertain.
Worldwide,in addition to the UK EVARtrial and the Dutch DREAMtrial, the
French Aneurisme de l'aorte abdominale: Chirurgie versus Endoprothese (ACE)
study and the United States Open Versus Endovascular Repair (OVER)study are
yet to be published. But, there is a comparative prospective cohort study using
administrative data from Medicare beneficiaries in the USA (Lyratzopoulos,etal,
2009). In this study both the open and EVARpatients were followed for 4 years.
The perioperative rates of death and complications, long-term survival, rupture,
and reinterventions after both methods of repair were compared. The data was
propensity-score—matched from 2001 to 2004 andin follow-up until 2005. There
were a total of 45,660 patients and 22,830 matched patients in each cohort group.
The average ageof the patients was 76 years, and approximately 20% were
women. The results show that perioperative mortality was lower after EVAR than
after open repair (1.2% vs. 4.8%, P<0.001), and the reduction in mortality
increased with age (2.1% difference for those 67 to 69 years old vs. 8.5% for those
85 years or older, P<0.001). Late survival was similar in the two cohorts groups,
although the survival curves did not converge until after 3 years. By 4 years,
rupture was morelikely in the EVAR cohort than in the open-repair cohort (1.8%
vs. 0.5%, P<0.001), as wasreintervention related to abdominal aortic aneurysm
(9.0% vs. 1.7%, P<0.001), although mostreinterventions were minor. In contrast,
by 4 years, surgery for laparotomy-related complications was morelikely among
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patients who had undergoneopenrepair compared with those who had undergone
EVAR(9.7% v 4.1%, P<0.001), as was hospitalization without surgery for bowel
obstruction or abdominal-wall hernia (14.2% v 8.1%, P<0.001). The author
concludesthat compared with open repair, EVARis associated with lower short-
term rates of death and complications. The survival advantage is more durable
amongolderpatients. Late reinterventions related to abdominal aortic aneurysm
are more commonafter EVAR,but are balanced byanincreasein laparotomy-
related reinterventions and hospitalizations after open surgery.
2.5. Long-term Results and Future of EVAR
Currently, there is no convincing evidence about the long-term outcome of EVAR.
The future of EVARwill no longer need to be held in comparison with conventional
open surgery; instead, the focus will be on the improvementof technological
design of endovascular prostheses andtheir delivery systems. The long-term
outcomewill not just rely on the mechanical but biological durability of
endovascularprostheses.
2.6. Recommendationsfrom the National Institute for Health and Clinical
Excellence (NICE) in the UK on Asymptomatic, Unruptured, Large(at
least 5.5 cm in diameter) Infra-renal AAAs
In the United Kingdom, the National Health Service (NHS) is the main providerfor
delivery of care for patients with AAA, therefore the position of the NHS towards
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EVARdetermines whetherall endovascularpractitioners can continue to offer
EVARto their AAA patients. The NHSis nationally funded, run and controlled by
the UK government. It offers free health care for all EU citizens.
2.6.1 Recommendations
The NationalInstitute for Health and Clinical Excellence (NICE) is the
independentorganisation, under the NHS,responsible for providing national
guidance onthe promotion of good health and the prevention and treatmentofill
health. NICE has produced guidelines in reference to the use of endovascular
stent-grafts or open surgical repair only for the treatmentof infrarenal abdominal
aortic aneurysmswith the following statement(http://www.nice.org.uk):
1: Endovascular stent—grafts are recommendedasa treatmentoption for patients
with unruptured infrarenal abdominal aortic aneurysms, for whom surgical
intervention (open surgical repair or endovascular aneurysm repair) is considered
appropriate.
2: The decision on whether endovascular aneurysm repair is preferred over open
surgical repair should be madejointly by the patient andtheirclinician after
assessmentof a numberof factors including: aneurysm size and morphology,
patient age, generallife expectancy andfitness for open surgery the short- and
long-term benefits and risks of the procedures including aneurysm-related
mortality and operative mortality.
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3: Endovascular aneurysm repair should only be performedin specialist centres by
clinical teams experienced in the managementof abdominal aortic aneurysms.
The teams should have appropriate expertise in all aspects of patient assessment
and the use of endovascularaortic stent—grafts.
4: Endovascular aortic stent-grafts are not recommendedfor patients with
ruptured aneurysmsexceptin the context of research. Given thedifficulties of
conducting randomized controlled trials, it is recommended that data should be
collected through existing registries to enable further research.
In this guideline there are five stent—grafts which are included. These are the
Talent stent-graft (Medtronic), Excluder AAA endoprosthesis (WL Gore), Aorfix
AAA stent-graft (Lombard Medical), Zenith AAA endovasculargraft (Cook
Medical) and Endologix Powerlink Systems (Le Maitre). All have been granted
Conformité Européene (CE) marking, for use within European Union (EU)
countries. Four of the manufacturers stated that their list prices were commercial-
in confidence. Lombard Medical stated that the price of their Aorfix AAA stent-
graft was £5000, which wasa fixed price per patient irrespective of the numberof
components used. A price to the NHS of £5000 was supported by limited sample
data for 2007/08 collected by the NHS Purchasing and Supply Agency from some
NHSorganisations in England. These data confirmed that the average price of an
endovascular stent-graft, irrespective of the number of components used, was
£5000.
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The NICE guideline has indicated that EVAR is now evidence based medical
practice and is an established treatment option to all NHS patients.
2.6.2. Evidence andinterpretation of the recommendations
(http://www.nice.org.uk)
The AssessmentGroup of NICE guideline committee has assessed randomised
controlled trials (RCTs) and large registries relevant to UK practice. The registries
included were the National Vascular Database (NVD)for open surgery, the
Registry of Endovascular Treatment of Abdominal Aortic Aneurysms (RETA) and
the European Collaborators on Stent—Graft Techniques for Abdominal Aortic
Repair (EUROSTAR). Where appropriate, the Assessment Group used meta-
analysis to estimate a summary measure of treatmenteffect on relevant
outcomes,basedonintention-to-treat (ITT) analyses.
To identify criteria for selecting patients appropriate for EVAR, the Assessment
Group also reviewed studies that modelled a large rangeofrisk factors. Risk-
modelling studies were specific to AAA, focused on risk of mortality following
EVAR,and used appropriate statistical modelling techniques. Studies were
required to be based ona trial, registry or a series of at least 500 patients, from
developed countries of relevance to UK practice.
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There are four RCTs in EVARversus OR, comparing EVARwith ORin patients
with unruptured AAA (EVAR1, n=1082; DREAM,n=351; Cuypers and co-workers,
n=76; and Soulez and co-workers, n=40). Most patients in the RCTs were men,
reflecting the disease profile, and the average age of patients ranged from late 60s
to mid-70s. The four RCTs wererelatively homogeneousin terms of average
aneurysm diameter (6.5cm, 6.0cm, 5.4cm and 5.2cm, respectively).
All four RCTs reported 30-day mortality. The pooled estimate of effect suggested a
significantly lower rate of 30-day mortality in the EVAR group: pooled oddsratio
(OR) 0.35 (95% confidenceinterval [Cl] 0.19 to 0.63). The 30-day mortality rate of
2.3% in the EUROSTARregistry was comparable with the 1.7% in the EVAR arm
of EVAR 1. In the UK NVDcrude operative mortality following OR of unruptured
aneurysms was 6.8%, compared with 4.7% in the OR arm of EVAR1.
EVAR 1 and DREAMprovidedinformation on all-cause mortality at follow-up (at
4 years and 2 years, respectively). Both RCTs reported no significant difference in
medium-term mortality (at 42 and 35 months, respectively) in patients treated with
EVAR comparedwith OR.A pooled analysis of the two trials confirmed there was
no statistically significant difference between EVAR and OR,for all-cause mortality
at medium-term follow-up.
The four RCTs provided limited information on rupture as a separate outcome.
The limited data available suggest that rupture may be moreof an issue following
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EVARthan following OR. The cumulative rate of rupture in patients from
EUROSTARwas3.1% over7 years.
Only the EVAR1 and Soulez and co-workerstrials reported endoleak as an
outcome. Across these RCTs, some form of endoleak occurred at varying
frequencies (up to approximately 20%)following EVAR.TypeII endoleaks were
most common, followed by type I. The cumulative rate of endoleaksin patients
from the EUROSTARregistry was higher (32.5%).
Only EVAR1 reported on device migration following EVAR.In thetrial, 12 of 529
patients (2.3%), experienced device migration during follow-up, of whom seven
(1%) required re-intervention.
The EVAR 1 and DREAMtrials compared overall re-intervention rates between
patients treated with EVAR and OR.In DREAM, therisk of re-intervention was
significantly higher in the EVARgroupforthe first 9 months (hazard ratio 2.9; 95%
Cl 1.1 to 6.2, p=0.03) but the groups were notsignificantly different thereafter
(hazard ratio 1.1; 95% Cl 0.1 to 9.3, p=0.95). At the medium-term follow-upin
EVAR1, the hazard ratio for re-intervention was 2.7 (95% Cl 1.8 to 4.1) indicating
a higherrisk in the EVAR group. The 4-year point estimates for re-intervention in
this trial were 20% for the EVAR group compared with 6% for the OR group. The
cumulative rate of re-intervention in the EUROSTARregistry was similar to the 4-
yearpoint estimate for the EVAR group in EVAR1.
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Onlythetrial by Cuypers and co-workers reported cardiac events: three (5%) in
the EVARgroup, and two (11%) in the OR group.
All four RCTs reported some details of health-related quality oflife (HRQoL).All
used the Medical Outcomes Study short form 36 (SF-36) questionnaire, but
different components werereported, makingit difficult to compare results across
studies. Overall, data from thesetrials suggested that there may be a short-term
quality-of-life advantage for EVAR patients compared with those who have OR.
Longer-term quality-of-life data tended to favour OR.
In assessment of EVARversus non-surgical management, the Assessment Group
identified one published RCT (EVAR 2, n=338) that compared EVARand non-
surgical managementin patients judged to be unfit for OR. The Assessment
Group consideredthetrial to be of high quality. The primary endpoint wasall-
cause mortality and secondary endpoints were aneurysm-related mortality,
HRQoL,postoperative complications and hospital costs. The trial found no
differences in AAA-related and all-cause mortality outcomes between groupsat
medium term. However,this finding cannot be taken as definitive because
substantial numbersof patients randomised to non-surgical management crossed
overto receive surgical repair of their aneurysm.
In assessmentofrisk factors for adverse outcomes following EVAR, the
Assessment Group identified 32 studies investigating specific risk factors for
adverse outcomesafter EVAR. The Assessment Groupstated that the studies did
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not provide definitive evidence; but age, gender, renal impairment, fitness,
American Society of Anesthesiologists (ASA) score, and aneurysm size, may be
predictive of lower 30-day survival. There may be an association betweenfitness
for the open procedure, aneurysm size and device type and aneurysm-related
mortality. Pulmonary status, renal impairment, ASA score, and aneurysm size
might adversely affect all-cause mortality. The Assessment Group did notfind any
consistentrisk factors for re-intervention.
In summary, compared with OR, EVAR reduced operative mortality (OR 0.35; 95%
Cl 0.19 to 0.73) and aneurysm-related mortality over the medium term (OR 0.49;
95% Cl 0.29 to 0.83) but offered no significant differencein all-cause mortality at
medium term. EVAR wasassociated with an increased rate of complications and
re-interventions. There waslimited RCT evidence comparing EVARwith non-
surgical managementin patients unfit for OR. Although the EVAR2 trial found no
differences in mortality outcomes betweengroupsthis finding should not be taken
as definitive.
2.7. Complications of EVAR
The overall complications of EVAR have reduced overthe yearssinceits
introduction in 1991; in particular, since the newly designed second generation of
devices wentonto the market in 2001(Van Marrewijk et al, 2005; Curci J A et al,
2007; England A et al, 2008; Hiramoto et al, 2007; Greenberg et al, 2008.).
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However, despite the survival benefit in short and midterm, perioperative
advantage and general public acceptance of EVAR overopen repair, EVAR has
more complications than open repair (Hobo,et al, 2006); indeed, this procedure
has created a group of complications that are EVAR specific. One of the obvious
reasonsis that aortic aneurysmis a biological problem and EVARis merely a
mechanical solution. The biological issue around the aortic aneurysm cannot be
addressedat the current status of EVAR.
The overall complication rate was reported by the EVAR1 trial. By 4 years, the
proportion of patients with at least one complication following AAA repair was 41%
in the EVAR group and 9% in the open repair group. Overall complication rates
were 17.6 per 100 person years in the EVAR group and 3.3 per 100 person years
in the open repair group, hazard ratio 4.9 (95% Cl 3.5, 6.8), p<0.001 (EVARTrial
Participants, 2005).
2.7.1 Commontechnical complications
The commontechnical complications are listed below:
Stent migration
Stent fracture
Stent wire fracture
Graft stenosis
Type | endoleak
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TypeII endoleak
TypeIll endoleak
Type IV endoleak
Endotension
Contrast reaction
2.7.2. Commonnon-technical complications
The commonnon-technical complications are listed here:
Cardiac event
Renal impairment
Graft-limb thrombosis
Graft infection
Colonic ischaemia
Lowerlimb ischaemia
Pulmonary complications
Haemorrhage
Local wound complications
2.7.3 Secondary intervention after EVAR
The rate of secondary intervention after EVAR has beenreported by the
EUROSTARRegistry (Hobo,et al, 2006). The results show that the annual
cumulative rate for secondary intervention was 6%, 8.7%, 12%, and 14% at 1, 2, 3,
and 4 years, respectively, resulting in an annual mean secondary intervention rate
of 4.6%. This has meant thatlifelong surveillance of EVARpatients is necessary.
Among the EVAR complications that are specific to the stent-graft, the most
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important are endoleak and migration. The details of these complications will be
discussed below.
2.7.4 Endoleak
Endoleakis defined as persistence of blood flow outside the lumen of the
Endoluminalgraft but within the aneurysm sac, as determined by an imaging study
(White et al. 1996: White et al. 1997)
Endoleak remains oneof the main reasonsfor the existence of EVAR being
challenged. It is one of the technical complications specific to EVAR, andis one of
the commonest causesof stent-graft failure. The result of endoleakis lack of
complete exclusion of blood flow within the aneurysm sac. It represents thefailure
in the goal of EVAR. Endoleak maycontinue to pressurize the aneurysm sac and
therefore lead to possible ongoing aneurysm enlargement and rupture. In many
respects, the phenomenaof endoleak remain unclear.It is vitally important to
understand the mechanism of endoleak, so that permanentsolutions resolving this
phenomenon can becomepossible.
There are four types of endoleak according to the origin andsite:
Type | endoleak (Figure1A) is attachmentsite leaks. It is perigraft channelof
blood flow caused by inadequate orineffective seal at either the proximal (Type|
A) or distal attachment zones (Type IB). In the case of aorto-mono-iliac stent
grafts, Type IC endoleak can occur. Type IC endoleakis due to the aneurysm
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being reperfused by the nonoccludediliac artery in patients with aorto-mono-iliac
stent and femoral-femoral bypass.
TypeIl endoleak (Figure 1B)is due to the retrograde filling of the aneurysm sac
from its patent branches. This commonly occurs from lumbararteries and/or IMA,
but alsoin rare situations from sacral, gonadal, accessory renalartery,orinternal
iliac artery. Some authors havefurther divided TypeII endoleak into TypeIIA
whenthey are simple andrelated to only one patent branch, and Type IIB when
they are complex, with 2 or more patent branches (Caoetal, 2010).
TypeIll endoleak (Figure 1C) are caused bya structural failure of the implanted
device, including junctional separation of modular components (TypeIIIA), due to
migration or changesin vessel morphology with aneurysm shrinkage, holes in the
fabric, and fabric tears due to graft strut fracture or erosion (TypeIIIB).
TypeIV endoleak (Figure 1D) is caused by porosity of the graft fabric. This is
seen at the time of device implantation as a faint blush on the post implantation
angiogram when patientsare fully anticoagulated. This type of endoleak can
usually only be detected <30daysafter graft implant. They are rarely seen with
current devices and seal spontaneously.
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Figure 1: Diagramsto show the four types of endoleaks. Type I endoleak (FigureA)is perigraft
channel ofblood flow caused by inadequateorineffective seal at either the proximal(TypeI A)or
distal attachmentzones (Type IB). Type II endoleak (Figure 1B) is due to the retrogradefilling of the
aneurysm sac from its patent branches. Type III endoleak (Figure 1C) is caused by structural failure
of the implanted device, including junctional separation of modular componentsdue to migration or
changesin vessel morphology with aneurysm shrinkage, holes in the fabric, and fabric tears due to
stent strut fracture or erosion. Type IV endoleak (Figure 1D) is caused by porosity of the graft fabric.
This is seen at the time of device implantation as a faint blush on the postimplantation angiogram
whenpatients are fully anticoagulated.
Endotension sometimesis referred to as Type V endoleak.It constitutes tension
on the aortic aneurysm sac, and has beendefined as anyrise of intrasac pressure
or expansion of the aneurysm after EVAR,that occurs without visualized endoleak
on delayed contrast imaging (computed tomography, magnetic resonance) scans.
It was first described by Gilling-Smith et al (Gilling-Smith et al, 1999). According to
the consensus document(Veith et al, 2002), classification scheme of endoleaks
includes a category of endotension without any endoleak, even during open
surgical conversion (endotension Type A); and a category with a sealed orclotted
endoleak (endotension, Type B). Here, the leak becomes apparent only when a
clot is removed from the branchorifice at operation. In addition, patients with a
Type| or TypeIll endoleak may not have leaks visualized on CT or MRI scan but
still have a high intrasac pressure (endotension, Type C); similarly, patients with
Type Il endoleak may not havea visualized leak but still have high intrasac
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pressure (endotension, Type D). In these two latter categories, the endoleak
becomesapparent only when the aneurysm sac is opened. Whetherpatients with
Type C and Type D endotension behavelike those with Type1, Ill, or Il leaks,
respectively, remains to be determined.
Endoleaks canalso beclassified according to the time of first detection.
Perioperative endoleaks occurwithin 24 hours of endovascular repair of aortic
aneurysm; early endoleaks occur between1 and 90 days after endovascular
repair and late endoleaks occur more than 90 days after endovascularrepair.
Endoleakscanalso be described as primary,if they are detected at the time of
endovascularrepair or secondary if they appearat a later date.
Endoleak remains the most common causeof secondary intervention after EVAR.
Accordingto the individual studies that have been reported, the overall incidence
of endoleak dependson the device used and the duration offollow up.
EUROSTARdata has reviewed 2,463 patients of which 171 (6.9%) had endoleak
by the first month postoperative assessment and 317 (12.9%) patients had a new-
onset endoleakat later dates. In total, there were 488 (19.8%) patients in whom
an endoleak wasobservedat any time after the endograft implantation. The
prevalence of endoleaks during follow-up was approximately 20%.
Type | endoleak is manifestation of sealing failure at one of the attachmentsites of
the graft to the aortic wall. Type | endoleak is associated with significant pressure
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increase in the sac. The perigraft space is therefore under systemic pressure,
representing a failure in the treatment of the aneurysm that continues to be
pressurized andatrisk for continued expansion and rupture (Harris et al, 2000;
Buth et al, 2000, Dias et al, 2007).
Incidence of Type | endoleak has beenreported to be as high as 10% after EVAR
(Veith et al, 2002; van Marrewijk et al, 2002) with 4.2% at 30 days, 3-5% within 1
year and 6.7% beyond 1 year(Wilt et al, 2006).
A Proximal Type | endoleak,in particular, may result in serious consequencesifit
remains untreated. The results from the EUROSTARregistry have suggestedthat
proximal Type | endoleaks have muchhigherrisks of late conversion (Harris et al
2000; Vallabhaneniet al 2001) and rupture (Marrewijk et al 2002). Also,
compared with distal Type | endoleak, the proximal type one endoleak has a
significantly higher risk of aneurysm rupture (Mohanetal 2001).
Clinical observation suggests that an aortic neck length less than 15 mm is
associated with increased risk of Type IA proximal endoleak (Stanley et al, 2001;
Sternbergh et al, 2002; Zarins et al, 2003) and 15-20% of stent-graft proximal
attachmentoversizing can help to achieve excellent sealing (Cao et al, 2010).
Clearly, 15-20% oversizing may not be sufficient for neck length less than 15mm
(Stanley et al, 2001; Sternbergh et al, 2002; Zarins et al, 2003). But does the 15-
20% “rule” apply to all aortic necks longer than 15 mm? Whataboutthe aortic
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necks shorter than 15 mm? Should oversizing be increased to achieve excellent
sealing? Clearly, insufficient oversizing of a stent-graft will result in incomplete
seal with subsequent proximal Type | endoleaks, or inadequatefixation with the
potential risk of migration. On the other hand, excessive oversizing may increase
the risk of complications, such asstent-graft infolding or dilatation of the aneurysm
neck, with subsequent migration and endoleak (Schurink et al 1999; Connersetal
2002; Sternbergh et al 2004). So, it is fair to assumethat different aortic neck
lengths require different oversizing to achieve excellent sealing. Further studyis
needed to approve or disapprove this assumption. It is also importantto
understandthe relationship betweenoversizing and aneurysm necklength. Only
then is it possible that an adequate seal can be determined, by optimising the
percentage oversizing.
2.7.5 Migration
Migration is described as the longitudinal movementof the stent-graft or
attachmentsystem relative to anatomic landmarksortoits original deployment
site. However, there is no general agreementas to howfara stent-graft has to
movein orderforit to be considered to have migrated. Sofar it has been
suggested that the migration distance should be at least 5mm (Lifeline Registry
Participants, 2001) or at least 10mm (Ahnetal, 1997; Chaikof et al, 2002:
Greenberget al, 2004).
Stent graft migration is one of the most serious late complications after EVAR
(Zarins et al. 2003; 2003; Hobo.et al. 2006). Migration may lead to aneurysm
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repressurisation and rupture. It also maylead to stent-graft kinking, thrombosis
and lowerlimb ischaemia.
Migration has occurredin all commercially available stent-grafts (van Marrewijk et
al. 2005; Drury et al. 2005), and has been extensively reported in manyclinical
studies. The reported prevalence of migration was from under 3% to 28%
(Tonnessenet al. 2005; Zarins et al. 2003; van Herwaardenetal. 2007). The
factors affecting migration were the type of stent-grafts used, aortic aneurysm
morphological characteristics and the length of study follow-up time (Tonnessen et
al. 2005; Zarins et al. 2003; van Herwaardenetal. 2007). The proximalaortic
neck length, diameter and angle seem to have greatinfluence onthe risk of
proximalstent-graft migration after EVAR. (Tonnessenetal. 2005; Zarinsetal,
2003; Fulton et al, 2006; Albertini et al, 2000; Leurs et al, 2005). The otherrisk
factors that have also been studied are maximum aneurysm diameter, stent-graft
configuration (aortic tubes, aortomonoiliac, bifurcation grafts), the type of proximal
stent-graft fixation (suprarenal/ infrarenal, with / without hooks and barbs) and the
extent of stent-graft oversizing (SternberghIII et al. 2004; Waasdorpetal. 2005;
Mohanet al 2002; Leurs et al.2005; Faries et al.2002; Reschet al.2000).
Clinical studies into the relationship between proximal oversizing and graft
migration have produced conflicting results. Some studies suggestthere is no
significant association between oversizing and migration (Sampaio et al, 2005;
Cao. et al, 2002).
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There are experimentalstudies investigating the relationship between oversizing
and the required force for stent-graft displacement. Malina et al. used cadaveric
aortas to measure the longitudinaldistraction that was required to dislodge Zenith-
stents from the aorta (Malinaet al, 1998). This study suggestedthat stent-graft
oversizing had noeffector only slightly increased the required force for
displacementof stent-grafts with or without barbs, respectively. However, the
limitation of this study wasthat the percentage of oversizing was not accurately
determined, the aorta was not pressurized as it would be in vivo, and the exact
modeof migration was not described.
Experimental, and someclinical data suggest that the adequate proximalfixation
strength is the most important factor to prevent stent-graft migration. However,
clinical studies have produced conflicting and even confusing results regarding
whetheroversizing plays anyrole in creating adequatefixation strength (van
Prehnaet al, 2009). Migration is a recognised and acknowledged complication,
but the mechanismis still unclear. So there is clearly a need for further studies to
investigate the exact mechanismsof migration and the effect of oversizing on
migration.
Whena stent-graft is implanted, it will be subject to forces dueto the effect of
pulsatile blood pressure and blood flow, both of which can producelongitudinal
haemodynamicforce. This force will tend to constantly push the stent-graft down-
stream from its proximal attachmentsite. To resist these forces and prevent
migration, the implanted stent-graft needs to have sufficient fixation strength.
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The longitudinal haemodynamic force exerted on stent-grafts in vivo has been
estimated previously using analytical mathematical models (Liffman et al. 2001,
Mohanetal, 2002, Morris et al. 2004). Mohanet al showedthat hypertension,
aneurysm geometry andiliac angulation, amongstotherfactors, were significantly
associated with stent-graft migration. These findings were validated using a simple
one-dimensional analytical model based on momentum equation, not accounting
for the pulsatility of blood flow and the viscosity of the fluid. It was shownthat
undercertain conditions, the longitudinal force (LF) on a stent-graft due to blood
flow and pressure may exceedthefixation force causing stent-graft migration.
Since the analytical models neglect the effects of blood viscosity and the pulsatility
of blood flow and blood pressure, further studies are needed to determine whether
or not these parameterssignificantly affect the longitudinal haemodynamic force
acting on the bifurcated stent-graft.
2.8. Summary
Endovascular aneurysm repair is by now a well-established treatment conceptthat
has dramatically changed the overall approach to AAA repair. With the
improvementin stent-graft design and moreclinical experience gained, the
complications of EVAR havefallen significantly in recent years. The benefits of
endovascularrepair for the large abdominal aortic aneurysm (>5.5cm), in short
and midterm, are less controversial. However, dueto lack of predictive preclinical
scientific research, most of the improvementsin stent-graft performance resulted
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from the findings ofclinical observation. EVARis associated with its own unique
problemsafter implantation and those problemsare largely not understood.
Endoleak and stent-graft migration are the two mostsignificant complications
leading to failure of EVAR.It is vitally important to understand these two
phenomenasothe future design of the stent-graft can be improved upon. The long
term durability of EVAR will continue to be challenged as long as these two
complications remain unresolved.
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CHAPTER3
FENESTRATED ENDOVASCULAR ABDOMINAL AORTIC
ANEURYSM REPAIR (FEVAR)
3.1. Introduction
Standard EVAR has becomeanestablished alternative to open surgical treatment
of abdominal aortic aneurysm. However, anatomicallimitations for standard
EVARhaveprecludedits application to all infrarenal aortic aneurysms. The main
reasonfor the ineligibility for standard EVARis short aortic neck length. A study
suggests that 55% patients were considered suitable for EVAR and 45% patients
deemedineligible. The most common anatomical reasonforineligibility was a
short infrarenal neck (44%) (Arko et al 2004). Similarly, Carpenter et al reported
short aneurysm neck accounts for up to 54% of all causesforineligibility for
standard EVAR (Carpenteret al, 2001).
Manystudies of conventional commercial aortic stent-grafts have demonstrated
that short or compromised proximal aortic necks can lead to inadequate proximal
seal thereby increasing the risk of proximal endoleak, device migration, and
aneurysm rupture (Hovsepianet al, 2001; Morrisey et al, 2002; Mohanetal,
2002). These results have led to a generally accepted anatomic requirementfor a
proximal neck length of 15 mm for most commercially available stent-grafts for
EVAR.
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It has been well studied that the operative mortality and morbidity rates associated
with elective open repair of AAA with short aortic neck length are higher than for
standard infrarenal aneurysm (Jean-Claude et al 1999; Sarac et al 2002; Westet
al 2006). To reduce the operative mortality and morbidity rates in open repair, a
minimal invasive endovascular treatment is needed totreat this group of patients.
As this group of patients has short or compromised proximal aortic necks, the
covered sealing stent has to be placed abovetheorifices of the renal, and possibly
the superior mesenteric (SMA) and coeliac arteries to secure the proximalseal.
Fenestrated endovascular aneurysm repair (FEVAR)offers a solution in this
situation.
Fenestrated stent-graft is an extension of the application of EVAR.It was designed
to overcomethelimitation of short infrarenal neck length in aortic aneurysm repair.
With the fenestrated technique, it was estimated that about 80% ofinfrarenal aortic
aneurysmscould be treated with an endovascular approach (Carpenteret al,
2001).
With fenestrated EVAR, the fenestrated stent-graft is placed proximal to the side
branchesthereby providing a good length for the sealing zone. Since the side
branchesareintentionally covered, it is necessary to provide fenestrations in order
to restore perfusion through the use of stents (Figure 3.1).
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Figure3.1: This is a diagram to show the difference in proximal landing zone between the conventional
(A) andfenestrated (B) EVAR.
3.2. Development and Configuration of Fenestrated EVAR
Fenestrated aortic grafts were first described in 1996,in 2 patients with infrarenal
aortic aneurysms(Parket al, 1996). Developmentandclinical utilization of these
grafts was led by Lawrence-Brownand associates (Browneet al 1999).
A fenestrated stent-graft is a composite device based on the Zenith system (Cook,
Brisbane, Australia), which has a self-expanding modular design with an
uncovered Gianturco Z-stent (Cook Europe, Bjaeverskov, Denmark) for proximal
fixation in the standard configuration (Figure 3.2A). It consists of a straight tubular
proximal portion, a bifurcated distal portion and a contralateral iliac limb. The
proximalpart of the graft is fitted with diameter reducing ties to allow only partial
deploymentprior to catheterization of the side branches andfinal orientation of the
stent-graft (Figure 3.2 A-C)
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 Figure3.2: Picture of fenestrated stent-graft, (A) components of composite body, the proximalportion
of stent-graft with two small fenestrations (B) and partially deployed proximalportion of graft with
reducingties (C).
A fenestrated stent-graft is custom designed and manufactured according
to individual anatomyincorporating accurately placed holesin the stent-graft that
align with renal/visceral vessel ostia. Stents are placed through
the fenestrations. There are three types of possible fenestrations: scallops, large
and small fenestrations (Figure 3.3 A-C). Each fenestration is marked by 3 (for
scallop) or 4 (for a small or large fenestration) radiopaque markers to enable
accurate alignment. Each tubegraft is fitted with anterior and posterior markers to
facilitate orientation during insertion and deployment.
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 Figure 3.3: Pictures to show thethree types of fenestration. Scallop (A), small fenestration (B) and
large fenestration (C).
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Figure 3.4: This is a plain abdominalx ray to show two small fenestrations with stents.
A further evolution in design of the fenestrated deviceis to reinforce fenestrations
and scallops with nitinol rings (Figure 3.5). The reason for this is to hold the
fenestration and scallop open for catheterization in the middle stages of
deployment whenthe body ofthe stent-graft is still in a partially compressedstate.
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 Figure 3.5: Photographsof fenestrations reinforced with Nitinol rings.
3.3. Indication and Planning for Fenestrated EVAR
The indications for fenestrated EVAR vary accordingto individual institutions, but
there appears to be a general acceptance that aneurysmswith diameter above
5.5cm andshort, hostile aortic neck are suitable for fenestrated EVAR.
Planning and deployment of Fenestrated EVARare technically more challenging
than for standard EVAR. It requires advancedcatheterskills and much more
training when compared with standard EVAR. The approachisalsodifferent in
dealing with late secondary interventions. Planning a fenestrated stent-graft
requires detailed analysis of aortic anatomy, in particular the proximal landing
zone. The information required includes the diameterof the aorta at the level of
the target vessels, the orientation of each target vessel along the circumferenceof
the aortic cross section, orthogonal separation betweenthe different target vessels
and the desired size of each fenestration. The configuration and orientation of
each vessel should also be studied to plan a strategy for the operation.
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Figure 3.6: Three-dimensional computed tomographic reconstructions of a juxtarenal abdominal
aortic aneurysm (A) before and (B)after fenestrated endovascular aneurysm repair.
3.4. Short and Midterm Outcomesof Fenestrated EVAR
Sincetheinitial report in 1996 (Park et al, 1996), fenestrated EVAR devices have
been implanted in over 1,500 patients worldwide (O'Neill et al, 2006) and are now
commercially available (Kristmundssonetal, 2009) to all centres that have the
necessary technicalskills and equipment to perform this procedure. Since mostof
the published results are from single centre series, it is difficult to make
comparableresults.
3.4.1 Mortality
Reported mortality from individual institutions ranged from less than 1% to more
than 2%. Cumulative mortality following fenestrated EVAR was 1.4% (Nordon
2009). Causes of mortality included mesenteric ischaemia (Muhsetal, 2006;
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O'Neill et al, 2006) and myocardial infarction (MI) (Semmenset al 2006; Scurr etal
2008) with no intraoperative deaths.
3.4.2 Renal impairment
An overall perioperative renal impairmentrate of 14.9% (Cl 11.5-18.7) has been
reported. However, mostof these wereearly, transient renal failures which
completely recovered. About 1.4% of patients required permanentdialysis from
renal failure (Anderson et al 2001; Halak et al 2006; Muhset al 2006; O’Neill et al
2006; Ziegler et al 2007; Scurr et al 2008; Bicknell et al 2009).
3.4.3 Primary endoleak
Primary Type | andIII endoleaks represent a failure to completely exclude the
aneurysm. The reported Type| or TypeIII endoleak rate was 6.9% at immediate
postprocedural imaging. These were managedby additional Palmazstenting,
balloon expandable stenting or conservative observation. Not all studies have
reported TypeII endoleak, although it may beofless clinical significance (Halaket
al 2006; Muhsetal 2006; O’Neill, Semmenset al 2006; Ziegler et al 2007; Scurr et
al 2008; Bicknell et al 2009).
3.4.4 Target vessel patency
Target vessel patency is a measure of primary technical success and fenestrated
EVARstability. All the studies have reported primary technical branch fenestration
success, and mostreported target vessel patency. At follow-up, 96.6% oftarget
vessels were preservedwithin the perioperative period (in hospital and within 30
days post-surgery). In the studies with median follow-up more than 1 year, one-
year patency had reduced to 92%. In this period, no patient developed new
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dialysis- dependentrenal failure (Halak et al 2006; Muhset al 2006; O’Neill
Semmensetal 2006; Ziegler et al 2007; Scurr et al 2008; Bicknell et al 2009;).
3.4.5 Secondary re-intervention
Most studies reported re-intervention after fenestrated EVAR was by endovascular
means,apart from laparotomyfor ischaemic viscera. The indications for
secondary re-interventions included endoleaks, complications with access vessels
and surgical excision of ischaemic viscera. The reported re-intervention rate in the
first year following fenestrated stent-graft deployment was 15% with range 0-24%.
Nearly half of cases (48%) were for endoleaks (Type | 21%, TypeII 8%, TypeIII
19%). The remaining half of cases (52%) were angioplasty of visceral or
peripheral vessel stenoses, access and wound vessel complications and
laparotomy for mesenteric ischaemia (Halak et al 2006; Muhset al 2006; O’Neill
Semmenset al 2006; Ziegler et al 2007; Scurr et al 2008; Bicknell et al 2009).
3.5 Unresolved issues in fenestrated EVAR
Since migration has occurredin all commercially available stent-grafts (van
Marrewijk et al 2005; Drury et al 2005),it is not surprising that it can also happen
in fenestrated EVAR.
In fenestrated EVAR, patency of target vessels (vessels whoseperfusionis
preserved via the fenestrations or scallops) remains a source of concernin the
short and the long term. Stent-graft movementof less than 5mm maynot cause
concernin the majority of standard stent-grafts. However, with a fenestrated stent-
graft, migration of even this magnitude can result in distribution of shear forces to
the interface between the target vessel stent and the fenestrated bodyofthe stent-
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graft. Their hoop strength may notbe sufficient to withstand these forces,
resulting in crushing or even fracture of stents and possible occlusion. It remains
unknown whetherthe hoopstrength of the fenestration stent can increase the
overall proximalfixation strength.
Stents that are usually placed into target vessels were not primarily designed to
withstand high levels of asymmetric stress. However,it is not clear whethertheir
presencesacrossthe proximal main body of the device can affect the overall
fixation strength of the insitu stent-graft.
A fenestrated stent-graft is designed to treat the infrarenal aortic aneurysm with a
short infrarenal neck length. However,it is not certain what minimum infrarenal
neck length is required to achieve a secure sealin fenestrated EVAR, whether
bare stents should be usedupto a certain length of aortic neck, or covered stents
should be usedin all cases. In addition, what degree of optimal oversizingis
required for secure seal in fenestrated EVAR remains undefined.
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CHAPTER 4
RATIONALE AND SUMMARYOFINVESIGATIONS
The aim of endovascularrepair of aortic aneurysm (EVAR)is to permanently
exclude the blood flow and pressure to the aneurysm wall, therefore eliminating
the risk of aneurysm rupture.
Proximal Type | endoleak and migration of endovascular stent-graft are the two
commonestand most important causesof failure after EVAR (Harris et al, 2000;
Vallabhaneni et al 2000; Marrewijk et al 2002; Zarins et al 2003; Hobo.et al.
2006).
The aim of oversizing is to achieve an adequate proximal seal. However, the long
term security of the seal is reliant on the graft’s proximalfixation against migration.
There are manyfactors which can influence the tendency for endovascular stent-
graft migration, such as morphological features of the aortic aneurysm, the
characteristics of the selected endovascular stent-graft, and the downstream force
created by the longitudinal haemodynamicforce.
In clinical practice, there remains controversy overthe effect of oversizing on
migration (van Prehnetal; 2009). The hypothesis is that stent-graft oversizing has
a significant effect on the proximalfixation strength, and the maximum effectis
reached at a certain percentage of oversizing; beyond which, further oversizingwill
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not bring any further benefits. Stent-grafts with fixation bare stents and barbs have
higherfixation strength than those without (Chapter6).
Fenestrated EVARis designed forinfrarenal aortic aneurysms with a short neck.
The purposeof stenting the branch vessels are to retain their patency, but a
secondary result of branch vessel stenting may be anincreasein the overall stent-
graft fixation strength. Stent-graft migration is frequently observedin clinical
practice, but the mode of migration was not known before. The hypothesisis that
standard and fenestrated stent-graft migration occurs in phases (Chapter 7). The
fenestrated stent-graft configuration confers greater proximalfixation strength than
conventional devices (Chapter7).
The aim of stent-graft oversizing is to obtain an effective seal. It is not necessary
and canberisky to excessively oversize the aortic neck beyond the optimal
degree of oversizing requirement.It is also unknown whetherthe same degree of
oversize is neededfor different aortic neck lengths. The hypothesisis that the
optimal degree of oversizing is aneurysm aortic neck length dependent; the
shorter the neck length, the greater the degree of oversizing neededfor an
effective seal (Chapter8).
The longitudinal haemodynamic force (LF) is a downstream draggingforce,
created by blood flow. Thefixation strength of any commercially available stent-
graft should therefore exceed the LF acting onit- to safeguard against migration.
The LF exerted on stent-grafts in vivo. has been estimated previously using
mathematical models (Liffman et al. 2001, Mohanet al, 2002, Morris et al. 2004).
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However, these findings were only validated in a simple one-dimensional
analytical model based on momentum equation, not accounting for the pulsatility
of blood flow, and the viscosity of the fluid. The hypothesis was that undercertain
conditions, the LF on a stent-graft due to blood flow and pressure may exceed the
fixation force, thus causing stent-graft migration (Chapter9).
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CHAPTER 5
Experimental Methodologies
5.1 Introduction
In this chapter the methodologies adopted in the experimentsto: 1) investigate the
relationship between optimal oversizing and proximal fixation strength, 2) compare
the fixation strength of standard and fenestrated stent-grafts and 3) investigate the
optimal oversizing required for an effective seal in standard and fenestrated
EVAR,4) measurethe longitudinal haemodynamicforce in a bifurcated stent-graft
model, are described. The results of these experiments are presented in Chapters
6, 7, 8 and 9, respectively.
The abdominalportions of fresh bovine aortas were obtained, and all adherent
non-vascular tissue removed. For the experiments with fenestrated stent-graft,
larger branches (5-6 mm wide whenpressurized) were identified for stenting. A
length of at least 3cm was provided to accommodatethe stent. For the
experiments with standard stent-graft, marks were madeat 3.0cm intervals along
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the length of the aortic segment as measurementpoints. All the measurements
were taken at those measurementpoints.
Wepressurised the freshly prepared bovine aorta with normalsaline, so the aortic
diameter could be changed by changing the applied pressure. In all our
experiments, the aortic internal diameter was used andit was calculated through
external diameter and volumeofaortic wall in any particular segment.
After insertion of the proximal portion of stent-graft, the oversizing of stent-graft
overaorta could then be accurately determined by changing the pressure applied
to the aorta.
Zenith stent-grafts were usedin all experiments with barbs and the proximal bare
stent was removedfor experiments without barbs. Since all experiments were
concerned with proximalfixation or seal, the stent-grafts were truncated leaving
only the proximalportion. In experiments with fenestrated stent-graft, a single
6mm fenestrated stent-graft was constructed. The fenestrations were not
reinforced. The stent-grafts were sealed and tested for waterprooffor the
experimentof oversizing and seal.
To investigate the optimal oversizing required to achieve adequate proximal
fixation strength, force was applied to the stent-graft to causeit to migrate within
the aorta, the peak force was recorded and analysed. In comparison of the
fixation strength of standard and fenestrated stent-grafts, a fenestrated stent-graft
79
was constructed, and the force to causeit to migrate was compared with that for a
standard stent-graft. The same methods were usedin creating accurate oversizing
and force measurement.
In the experiments to investigate the optimal oversizing required for an effective
seal in standard and fenestrated EVAR, the same methods were used to
determine the stent-graft oversizing. Standard and fenestrated stent-grafts were
initially sealed to waterproof and then partially deployed into bovine aorta at an
appropriate site at certain length and then connected to a purposebuilt system
which could generate pulsatile flow. The system can mimic humaninfrarenal
blood flow. The pressure and flow settings were generated from elderly patient
blood pressure andinfrarenal blood flow. Fluid of the sameviscosity as normal
human blood serum was used. The system was connected to a computerfor
controlling and monitoring pressure and flow. Any leak betweenthe aorta and the
stent-graft was observed.
To measurethe longitudinal haemodynamicforce acting on the stent-graft, a
bifurcated stent-graft model was machined, using aluminium tubesjoined with
metal-loaded epoxyresin, to form a bifurcation. The main trunk internal diameter
was 30 mm,and wall thickness was 4 mm. Wethinned a segment 30 mm long to
0.1 mm wall thickness on the main trunk. The thinned segment increased the
level of strains locally, so that the strain could be easily measured. Twostrain
gauges were bondedonto this section. After calibrating the strain gauges, the
model was placed onto the samepulsatile flow system. The longitudinal
haemodynamic force was then measured and converted to Newtons.
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5.2 Experimental Methodologiesof Investigating the Relationship
Between the Optimal Oversizing and Proximal Fixation Strength and
Comparison of the Fixation Strength of Standard and Fenestrated Stent-graft
for EVAR in Chapters 6 and 7.
5.2.1 Development and designs of experimental methods of measurement
of displacementforcein relation to stent-graft oversizing
The experimentwasinitially designed to place the bovine aorta in an upright
position. After the aorta was sealed and pressurised with saline, known weights
were placedonthe stent-graft through a connecting system. After a test run of
over 20 tests, we found that the results were notreliable and repeated
experiments could not produce the same results. This was due to the columnar
pressure from the saline adding extra pressure inside the aortic lumen and
creating unevenintraluminal pressure. Furthermore, this pressure kept changing,
with changing aortic internal diameter. As the results of this, we changed the
position of the aorta from upright to horizontal, replaced the weights to a calibrated
digital force gauge and placed onto a linear drive to make sure the force applied
onto the stent-graft waslinear.
The bench top experiment (Figure 5.1) for the measurementofdistraction force
comprised a pressurised bovine aorta into which the proximal portion of a standard
or fenestrated Zenith stent-graft (Cook Europe, Bjaeverskov, Denmark) was
deployed. Force was applied to the stent-graft to causeit to migrate within the
aorta, underobservation; this displacement force was measured with a calibrated
digital force gauge. Since the experiment in chapter 6 was to determine the
relationship between the oversizing and proximal displacementforce (the force
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required to displace the stent-graft), a wide range of oversizing was used (5%,
10%, 20% 30%, 40% and 50%).
In chapter 7 however, the aim was to discover the mode of displacement and to
comparethe displacementforce betweenthe fenestrated and standard stent-graft,
and so oversizings of 5%, 10%, and 20% were used.
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Figure 5.1: Diagram of experimentalset up
5.2.2 Selection and preparation of the aortic specimens
Conducting this experiment with human cadaverinfrarenal aorta would be the
ideal Use of humanaortic tissue would have been the obviousfirst choice.
However, since there is legislation in place regarding obtaining humantissue for
scientific research in United Kingdom,it has proven that any application for such
purposesis extremely complicated, and approvaltakes at least two years on
average. This would have been impossible for us.
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The second choice would be using porcine aorta, but the problem with that is since
foot and mouth disease, all the olderpigs’ tissue is destroyed for safety, and only
the youngerpigs’ tissue can be obtained. After measurementof youngerpig’s
aorta, we found that porcine aorta has a much smallersize for the available Zenith
stent-graft to produce any meaningfuloversize.
Finally, fresh bovine aorta was used and obtained from an abattoir, after a
pressure test run, we found that the bovine aorta can sustain much higher
pressure without compromisetoits integrity, it is compliant and can produce
reliable diameter change, under repeated pressures.
The abdominalportion was retained and all adherent non-vasculartissue,
removed. For the experiments with fenestrated stent-graft, larger branches (5-6
mm wide whenpressurized) wereidentified for stenting. A length of at least 3cm
was provided to accommodate the stent. For the experiments with standard stent-
graft, marks were made as measurementpoints at 3.0cm intervals along the
length of the aortic segment. All the measurements were taken at the
measurementpoints (Figure 5.2).
83
 Figure 5.2: Prepared bovineaorta for the experiments with fenestrated stent-graft (A) and standard
stent-graft (B).
Any leaking areas were oversewn using 4-0 Vicryl sutures. The aortas were
stored in normalsaline at 4°C for a maximum of 24 hours after preparation, during
which the experiments were conducted.
5.2.3 Stent-graft oversizing
The “oversizing” was created by changing the aortic luminal pressure. Thus the
internal diameter of aorta at the measurementpoint was changed. Byaltering the
luminal pressure, the appropriate internal diameter was determined for the desired
oversizing. Initially, we placed theaorta vertically. After sealing both endsof the
aorta, known weights were placedat the distal end of the aorta and pressure
applied. We soon found outthat the results of the measured aortic external
diameter were not accurate and not reproducible; this was clearly due to the
difference of columnarpressure from the intraluminalfluid at different
measurementpoints. To avoid this error, we placed the aorta horizontally, so the
pressure atall measurementpoints remained the same. However, another
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problem wasobserved; whenthe aorta waspressurized, this not only increased its
diameter, butalsoits length; and the higher the pressure, the longerthe aorta
became.Asa result, the aorta becameslack, soit madeit impossible to measure
anylinearfixation force along its lumen. To avoid this problem, we fixed both ends
of the aorta at the highestintraluminal pressure range, to keep the aorta straight at
all times.
After correcting the above problems, we then determined the internal diameterof
the pressurized bovine aorta from the relationship of the internal diameter to
pressure overthe range 60 to 160 mmHgfor the experiments in chapter 6.In this
pressure range, there were far fewer sites with branchessuited for fenestration,
with desired oversizing. Therefore in chapter 7, we increased the pressure range
from 60 to 190 mmHg,sothat we could recruit more sites for the experiments with
fenestrated stent-graft. For the experiments with standard stent-graft, the interval
between the measurementpoints was 3.0 cm along the length ofthe aortic
segment. The wall thickness at each axial location was measuredusing digital
callipers. The aorta was then plugged at both ends, and the lumen was
pressurized with saline to a pressure of 160 mmHgforthe study in chapter 6, and
190 mmHgfor chapter 7. The length of the aortic segmentat this pressure was
measured. The endsof the aorta were then securely clampedsothat the length of
the aorta remained constant during the experiment. The external diameters of the
aorta over the range 60 to 160, or 190 mmHgpressure were determined at each
markedlocation using the digital callipers (Figures 5.3 & 5.4).
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 Figure 5.3: Picture of external diameter measurementof a bovine aorta.
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Figure 5.4: This is a diagram to show the experiment of aortic diameter-pressure relationship study set
up.
From knownexternal diameter at the measurementpoints, the respective internal
diameter can be calculated, through the differences between the external and
internal columnarvolumes.
As we know,to calculate the volume (V) of any given circular columnstructure,
when diameter (D) and length (L) are known, the volume(V)is given as
y= nls) (Equation 5.1)
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Although the bovine aorta was tapered overits full length, each 3cm segment
between the marks wasconsidered to be a straight tube, whose diameter wasthe
average of the proximal and distal end diameters of that particular segment
(Figure 5.4). So, the total external luminal volumeof a particular segmentof
length L, proximal external diameter Dp, and distal external diameter Dg. can be
calculated as
Dp, +Dd,V =aL( y (Equation 5.2)
Similarly, the intraluminal volume of the particular segmentof length L, proximal
internal diameter D,;, and distal internal diameter Dg; can be calculated asfollows:
Dp, + Dd,V=mL(—— (Equation 5.3)
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Figure 5.5: This is a diagram to explain how the internal diameters werecalculated.
Assuming that the volumeofthe aortic wall remains constant at any luminal
pressure,the internal diameter can be calculated from the external diameter. The
volume V of the aortic wall is represented by the formula
87
D, Dd Dp, Dd.Bo nate yp _ (Pt d | (Equation 5.4)
For convenience and easier understanding, the formula can be expressed as the
 
following
y-2|Oe= y2 —(PP SS | (Equation 5.5)
The subscript o denotes external, and subscript i, the internal dimensions.
Knowing the external diameter D,, the internal diameter can then be calculated by
the following formula:
Di= 3D AV (Equation 5.6)
Oncethe relationship betweenthe luminal pressure and the internal diameterof
the aorta was determined, it was possible to establish the segmentin the aorta
wherein a stent-graft of a certain diameter should be deployed, as well as the
pressure that should be applied to achieve a knownoversizing.
88
5.2.4 Stent-graft construction and deployment
Zenith stent-grafts (Cook Europe, Bjaeverskov, Denmark) have a proximal bare
stent with fixation barbs located midwayalong alternate stent struts. This stainless
steel stent segmentis fixed to the main trunk of the stent-graft with monofilament
sutures. Stent-grafts of 28, 30, and 32 mm nominal diameter were deployed within
different aortic segments under appropriate pressure to achieve the desired
degreeof oversizing. We keptthe bare stentintact for the experiments with barbs;
and removedthe bare stent for the experiments without barbs.
Since the study in chapter 6 aimed to measure the proximalfixation strength with
relatively short necks,all stent-grafts were truncated within the main bodyat 36
mm from the fabric edge, with the first internal stents intact, but removing the
second stent from the fabric graft. The actual contact length betweenstent-graft
and the aorta was 17 mm.All stent-grafts were crimped using a nooseto introduce
them into the aorta; and deployed at the predeterminedsite, underdirectvision
(Figure 5.6).
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Figure 5.6: Truncated stent-graft with barbs (A) and without barbs (B). The main body at 36 mm from
the fabric edge, with thefirst internal stent intact, but removing the secondstent from the fabric graft.
The actual contact length between stent-graft and the aorta was 17 mm.
Similarly, for the experiment in chapter7, all stent-grafts were truncated within the
main body. Fenestrated stent-grafts were constructed with a single 6 mm-wide
fenestration at a distance of 21 mm from the fabric edge (Fig. 5.7 B). The
fenestrations were not reinforced. Since the study aimed to compare the proximal
fixation strength between the fenestrated and standard stent-graft, all stent-grafts
were truncated within the main body at the same length of 53 mm from the fabric
edgeleaving the bare stent and the first 2 internal stents intact but removing the
third external stent from the fabric graft (Fig. 5.7 A). The actual contact length
between both stent-graft types and the aorta was 36 mm.
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 Figure 5.7: (A) Standard, (B) Fenestrated stent-grafts and a 6mm AVEstent(C). All stent-grafts were
truncated within the main bodyat the same length of 53 mm from the fabric edge leaving the bare
stent and thefirst 2 internal stents intact but removing the third external stent from the fabric graft.
Theactual contact length between both stent-graft types and the aorta was 36 mm. Fenestratedstent-
grafts were constructed with a single 6 mm-wide fenestration at a distance of 21 mm from thefabric
edge. The fenestrations were not reinforced.
All stent-grafts were compressed using a nooseto introduce them into the aorta
and deployed at the predeterminedsite, underdirect vision. The fenestrated
stent-graft was deployedto align the fenestration with the ostium of a selected side
branch with an external diameter of 5mm. A 6x20 mm balloon-expandable bare
stent (Figure 5.6C) (Medtronic AVE, Santa Rose, CA, USA) wasplaced, under
direct vision, through the fenestration, into the side branch and deployed; the stent
wasthenflared with a 12 mm angioplasty balloon.
Becauseof the natural taper of the bovine aorta, the vessel was reversedin the
experiments so that the stent-graft was made to migrate from the narrow segment
to the wide segment. Hence,the bare stent was oriented toward the narrower
segmentof aorta, which was sealed at the end using an internalplastic plug and
external gasket arrangement. This plug contained a Luer connection for controlled
pressurization of the aortic lumen andalso a port to introduce a rigid endoscope
(for observing stent-graft behaviour during the experiment). The caudal or
unstented portion of the graft was connected to a 0.46 mm diameterstainless steel
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wire with a 16 mm diameterplastic plug, which was narrowerthanthe aortic lumen
to ensure that only the proximalportion of the stent-graft was in contact with the
aorta. The wire wasthen brought to the exterior of the aorta through a holein
anotherplastic plug that sealed the end of the aorta toward the caudal end of the
stent-graft. This hole contained an O-ring seal to allow free linear movementof the
wire, while being leak-proof. The wire was connectedto a digital force gauge
(Model FG-5000; RS Components, Corby, UK) mounted securely on the moving
stage of a manuallinear drive, operated by the turn of a wheel. Clockwiserotation
of the wheel caused the stage to movetotheleft, thereby exerting a force on the
Stent-graft, which wascontinuously displayed on the force gauge. This gauge was
equipped with a “peak-hold”facility to preserve the highest reading should a
sudden drop occurin the force being measured. The force gauge wascalibrated
with known weights, and the maximum deviation was found to be + 0.05 N.
Oncethe aorta was pressurized to the predeterminedlevel, the linear drive was
engaged, and anyslack within the connecting wire was removed.A flag was
placed onthewireto facilitate ready identification and measurementof anystent-
graft movement. The hand wheel wasthen rotated slowly whilst continuously
recording the distraction force. The stent-graft behaviour during this period was
observed through the endoscope.
Each segmentof aorta was usedonly onceto avoid errors due to potential
mechanical damageofthe aorta during the experiment. Stent-grafts were reused
only whenfree from deformation on visual inspection, including the alignment of
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fixation barbs. Stent-grafts were also reused only once,to avoid potential errors
due to metal fatigue and unidentified deformation. Results were grouped
according to the degree of oversizing for standard and fenestrated stent-grafts.
5.2.5 Statistical analysis
The data were presented as the mean displacement force (m-DF) and standard
deviation (SD). The force was measured in Newtons (N). They wereall
represented by a normaldistribution of the values within the population. One-way
Anova with multiple comparisons (with Bonferroni correction) was used for linear
trend regression analysis and to compare the m-DFatdifferent oversizing.
Two-way Anova repeated measurements were used to comparedifferences in m-
DF betweenthe groups with and without hooks. Significant difference was defined
as P< or = 0.05.
5.3 Experimental Methodologies of the Study to Identify Optimal stent-
graft oversizing in chapter8:
Chapter 8 was designedto identify the optimal stent-graft oversizing to achieve an
effective proximal sealat different aortic neck lengths, in a pulsatile fluid system.
5.3.1 Experimental Design
The in-vitro model (Figures 5.8 & 5.9) consisted of a sealed, truncated stent-graft
which wasdeployed into the pre-determined measurementpoint of the bovine aortic
section. In a fenestrated stent-graft, a 6 mm AVEstent was usedto insert through
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the fenestration, into a side branch of the bovine aorta. A purposebuilt system
generated pulsatile flow, mimicking infrarenal aortic flow. It consisted of a piston
pump(self assembled) to provide pulsatile flow, and a gear pump (HG 0024 Micro
pump INC, Vancouver, WA, USA), to provide steady flow. 40% glycerol solution with
physiological viscosity was used ascirculating fluid. A pressure sensor and an
ultrasonic flow meter (Transonic HT107/HT207 Medical Flowmeter, Ithaca, NY
14850 USA) measured pressure and flow continuously during the experiment. The
system was connected to a computer for controlling and monitoring the pressure
andflow.
Pressure Flow meter
Graft sensor e  
 
Flow probe
 
  PistonPump
   
   
 
Calming
Chamber
 
Glycerol Gear
solution Pump
Figure 5.8: Diagram of experimental set up
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Figure 5.9: Fenestrated stent-graft was deployed into the bovine aorta and connected to thepulsatile
flow circuit.
5.3.2 Tissue preparation and stent-graft oversizing
The aortas were prepared using the same method as described in section 5.2.2
and 5.2.3.
5.3.3 Stent-graft construction and sealing
Stent-grafts (Zenith, COOK Europe, Bjaereskov, DK) of 32 mm diameter were
usedin this study. Since this study considered proximal seal, only the main trunk
was used. Each stent-graft was truncated to a fabric covered stent length of 60
mm (figure. 5.10A). Fenestrated stent-grafts (Cook Europe, Bjaeverskov,
Denmark) were constructed with a single 6 mm-wide fenestration at a distance of
21 mm from the fabric edge (figure 5.10B). The 6 mm AVEstent(bare stent) was
used (figure 5.10C). The fenestrations were not reinforced. As for the standard
stent-grafts, each stent-graft was truncated to a fabric covered length of 60 mm.
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Then the stent-grafts were sealed with 15% gelatine solution and cross-linked with
1% glutaraldehyde solution to secure the coating. The stent-graft was then
pressurized with normalsaline at static pressure ranging from 60 mmHg to 190
mmbg,to makesure the seal was water-tight.
 
Figure 5.10: Picture of constructed standard(A), fenestrated stent-grafts (B), and 6 mm AVEstent (C).
5.3.4 Definitions of parametersettings
“Endoleak” was defined as any leak between the stent-graft and aorta, observed
overfive minutes, in each experimentalsetting.
“Optimal oversizing” was defined as the minimal degreeof oversizing at the pointat
which an effective seal was achieved; -just before the “endoleak” occurs.
“Aortic seal zone length” was defined as the overlapping area between the aorta
and the fabric covered stent-graft length. We set the seal zone length at 10 mm, 15
mm, 20 mm, 30 mm and 40 mm for experiments with standard stent-graft and 5
mm, 10 mm, 15 mm and 20 mm with fenestrated stent-graft (Figure 5.11).
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Figure 5.11: Diagram to explain the definition of seal zone length (L).
“Oversize” was defined as a function of stent-graft diameter as shown below (Figure
5.12).
Oversiz@%) = = —1)X100.i
 
 
Figure 5.12: diagram to explain the definition of stent-graft oversize.
The percentage oversize ranged from 4% to 26%.
The meanflow rate (1.5 L/min) and flow waveform (Figure 5.13) was taken from
normal humansubjectinfrarenal aortic blood flow waveform on duplex scan.
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Figure 5.13: Flow waveform wastaken from normal humansubject infrarenal aortic blood flow
waveform on duplex scan.
The pulsatile pressure range wassetat “diastolic” pressure from 46 mmHgto 92
mmHg and “systolic” pressure from 60 mmHg to 190 mmHg. The pressure
waveform also represented the normal human subject blood pressure waveform
(Figure 5.14)
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Figure 5.14: Pressure waveform represents normal humansubject blood pressure waveform.
The frequencyof the pulsatile flow was set to 60 beats/min, representing normal
heart rate.
5.3.5 Protocol of the experiment
The stent-graft and aorta were placed in the system. From the aortic pressure
diameter study we know,the aortic internal diameteris a function of aortic internal
pressure. Therefore the oversizewill be different at diastolic and systolic
pressures. Maximum oversize occurs at diastolic pressure and minimum oversize
at systolic pressure. Westarted with lowest possible systolic and diastolic
pressure, by gradually increasing the pressures, the corresponding oversizing was
reduced until leaks betweenthe aorta and the stent-graft occurred. The systolic
pressuresat the points just before and after leak occurred were recorded sotheir
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corresponding oversizings are knownfrom the pressure-diameterrelationship
study. The experimentlasted five minutes at each setting, and was repeated a
minimum of three times.
In order to determine whetherpressure alone can cause leak, we conducted a
separate experimentin the samepulsatile flow system. Similarly, we deployed a
truncated stent-graft into a bovine aorta and covered the aorta with a rigid sleeve
to eliminate oversize variation. We set the seal zone length at 20 mm,oversize at
20% and the pulsatile pressure in the range of diastolic pressure from 60 mmHg to
128 mmHg andsystolic pressure from 167 mmHg to 235 mmHg. The experiment
lasted five minutes at each setting, and was repeated three times.
5.4 Experimental Methodologies of the Study to Measure the Longitudinal
Haemodynamic Forcein a Bifurcated Stent-graft Model in Chapter 9
5.4.1 Introduction
The purposeof the study in chapter 9 was to develop an experimental method to
measurethe longitudinal haemodynamicforce (LF) in a bifurcated model of a
stent-graft under pulsatile flow of a viscousfluid, and compare the experimental
data with the analytical predictions.
In this experiment, we placed a bifurcated stent-graft model into a purpose built
pulsatile flow system; any LF exerted on the modelcould be detected and
measured.
The model was machinedusing aluminium tube,joined with metal-loaded epoxy
resin to form a bifurcation. The main trunk internal diameter was 30mm,and wall
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thickness, 4mm. Wethinned a segment 30 mm long to 0.1 mm wall thickness on
the main trunk. The thinned segmentincreasedthe level ofstrains locally, so that
the strain could be easily measured. Two strain gauges were bondedontothis
section. After calibrating the strain gauges, the model was placed onto the same
pulsatile flow system. The longitudinal haemodynamic force was then measured
and converted to Newtons.
The pulsatile flow system could mimic humaninfrarenal blood flow. The pressure
andflow settings were generated from elderly patient blood pressure and
infrarenal blood flow.
Theviscosity of the viscousfluid was the sameas that of normal human blood
serum,so the potential effect of viscosity of flow could be eliminated.
5.4.2 Stent-graft material selection
Selection of the correct material to make the stent-graft model wasa key factorin
the success of the experiment.
One requirementfor the materialis that it should be able to produce the same
strain each timeit is under the samestress with no hysteresis; that is, the material
should be elastic and stable. Another requirementis that the strain should be
easily measuredusing strain gauges.
Weinitially selected acrylic tube of 30 mm diameter and measuredits tensile
strength to see whetheracrylic is a reliable material to reproduce the samestrain
when underthe samestress.
101
The results showed that acrylic material has significant hysteresis. The hysteresis
range is from 6.09% to 14.2%. It is not suited for our experiments.
One ofthe test results are shownin Figure 5.15.
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Figure 5.15: Oneofthe test results of tensile strength.
5.4.3 Aluminium stent-graft model
Following the unfavourable results from the acrylic tube, aluminium was selected
for the experiments.
The model was machined from aluminium tubes joined with metal-loaded epoxy
resin to form a bifurcation. The actual bifurcation was constructed from a
bifurcated graft. The main trunk internal diameter was 30 mm,and wall thickness
was 4mm. Wethinned a segment 30 mm long to 0.1 mm wall thickness (Figure
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5.16). The thinned segmentincreasedthelevelof strains locally, so the strain
could be easily measured.
Plastic pipe connector
Thinnedsection
Figure 5.16: Aluminium model ofbifurcated stent-graft showing the thinned section. It is provided
with plastic pipe connector of the sameinternal diameteras that of the aluminium tubein orderto
facilitate connection to the flow circuit.
 
Two strain gauges (CEA-13-250UN-350, Vishay Micro-Measurements, Reading,
UK) from the same batch were bondedonto the thinned section using
cyanoacrylate glue (M-Bond 60, Vishay Micro-Measurements, Reading, Uk).
These gauges are 10.54 mm long by 3.05mm wide and they were placed so that
their long axis was parallel to the longitudinal axis of the main cylindrical section.
As the modelis fixed at its proximal end, the force f will result in a longitudinal
strain that can be determined by meansofthe strain gauges. The strain gauges
were connectedin a half-bridge configuration and two 350Q high stability precision
resistors (S-350-01, Vishay Micro-Measurements, Reading, UK) were used to
complete the Wheatstone bridge (Figure 5.17). To minimise the effectof self-
heating of the strain gauges,a relatively low dc bridge supply voltage of 2.5 V,
provided by voltage reference (LM4140BCM-2.5, RS, Corby UK) wasselected.
Figure 5.17 showsa photographof the instrumented stent-graft model.
103
 Figure 5.17: Picture of strain gauges bonded on the model. The two 350Q
bridge completion resistors are also shown.
5.4.4 Measurementof longitudinal Haemodynamicforce in an instrumented
model of a bifurcated stent-graft
The main bodyof the stent-graft is subjected to the net longitudinal force f,, which
includes the pressure force in the main trunkin the direction of the flow and the
iliac limbs in the opposite direction to the flow, and the force due to the momentum
change (Figure 5.17). In this case, since a viscousfluid is used, f, will also include
a viscous drag force. This longitudinal force f, will cause a proportional longitudinal
strain in the model(as a result causing the model to elongate), which can be
measured. In orderto facilitate recording of the strain, the model was thinned
locally, as shownin Figure 5.16, thereby increasing the strain level. The graft
modelwasinstrumented by meansof strain gauges bondedonto the external
surfaces of the thinned portion of the cylindrical segment.
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Thinned section
   2.5V + To instrumentation3502 [? amplifier   
Figure 5.18: Strain gauges were bonded onto opposite sides of the thinned section of the stent-graft
model. The proximalsection of the model wasfixed and the force f, caused a longitudinal strain which
could be measured by meansofthe strain gauges. The Wheatstonebridgecircuit at the bottom shows
the connection of the two active strain gauges andthefixed resistors.
5.4.5 Strain Gauge amplifier
The outputs from the strain gauges were fed to a custom-built amplifier, based on
a single-chip integrated circuit instrumentation amplifier (INA128, Texas
Instrument, RS Corby UK). This amplifier was chosen becauseit is simple to use
and its gain G, can besetby selecting a single resistor Rg according to the
formula (Equation 5.9):
The complete instrumentation amplifier circuit including the bridge voltage supply
is shownin Figure 5.19.
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Figure 5.19: Diagram of the signal conditioning circuit, consisting of 2.5V Wheatstone bridge supply
and instrumentation amplifier. The output voltage Vout = G(V4.y — Vn)
5.4.6 Calibration of the stent-graft model
Whena force is applied on the model, a strain, predominantly on the thinned
section, will be produced. This strain will be detected by the strain gauges and
after amplification, the strain gauges’ output will be expressed asvoltage. In order
to determinethe relationship betweenthe force applied and the output voltage, a
calibration procedure was used.A series of known weights, from 50 g to 1 kg (at
increments of 50 g), was applied to the model as shownin Figure 5.20; and the
resulting amplifier voltage outputs were recorded. The experiments were repeated
12 times, and the results are plotted in Figure 5.21.
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Figure 5.20: Picture of stent-graft model calibrated with a series of known weights.
Calibration results
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Figure 5.21: Graph showing the relationship between the applied force (in Newtons) and the output
voltage (in Volts).
The results of the stent-graft model calibration suggested thatthis particular strain
gauge could producereliable and constant voltage, and it was suited for the LF
measurements.
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5.4.7 Flow circuit
After calibration, as described above, the model wasplacedin a pulsatile flow circuit
as shownin Figure 5.22. Pulsatile flow, with waveform similar to that obtained in the
abdominal aorta, was generated by a custom-built servo-controlled piston pump and
a gear pump (Micropump, Vancouver, WA, USA). Thecirculating fluid was a 40%
aqueoussolution of glycerol with dynamic viscosity similar to that of blood (dynamic
viscosity 3.3 x 10° Pa s and density 1098 kg m? at room temperature). An
ultrasonic flow probe (24N, Transonic System Inc., Ithaca, NY, USA) wasplaced at
the inlet pipe section to record the pulsatile flow. The pressure waveform just
upstream of the aluminium model wasalso recorded using a pressure transducer
(26PC, SensorTechnics UK, Rugby, UK). The pressure wasset to physiological
values by adjusting the resistances of the needle valves and the volumeof air in the
proximal and distal compliance chambers. longinlet length of approximately 2 m
was placed between the calming chamber and the stent-graft model, to ensure
laminar flow developed, going into the model. The strain gauge voltage supply and
instrumentation amplifier were switched on at least 2 hours prior to the experiment,
to allow the strain gauges to reach thermal equilibrium. The pressure, the flow and
the longitudinal force waveforms were each sampled at 100 samples/s and saved to
a PC for subsequent analysis. To improve the signal to noise ratio, the data were
recorded for 590 complete cycles and the average waveform wasthen determined.
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Figure 5.22 Diagram ofthe flow circuit.
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CHAPTER6
INVESTIGATING THE RELATIONSHIP BETWEEN THE
OPTIMAL OVERSIZING AND PROXIMALFIXATION
STRENGTH IN EVAR
6.1. Introduction
The aim of endovasculartreatment of aortic aneurysmisto isolate the aneurysm
from the restof the circulation, by achieving a seal betweenthe aortic aneurysm
and the stent-graft. The seal needs to be maintained against the downstream
blood flow. If the stent-graft cannot withhold its position, it may movedistally
(migration) to cause aneurysm repressurisation and rupture.
Migration is defined as stent-graft movementin a distal direction for more than 5
mm.It is one of the commonestcausesof late aneurysm rupture and
reintervention (Zarins et al. 2003; Conners et al. 2003; Hobo.et al. 2006).
It is clinical practice to stent-graft oversize the aneurysm neckin order to achieve
the seal. It has been suggested that appropriate oversizing can prevent stent-graft
proximal Type one endoleak, by improving the proximal seal (Mohanetal. 2001).
Mostof the manufacturers recommend a device oversize of 10% to 20%greater
than the minoraxis of the aortic neck, to achieve the optimal seal.
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It is not clear whether appropriate oversizing can prevent stent-graft migration. So
far, there is neither convincing data nor manufacturers’ recommendations on the
optimal oversizing in relation to stent-graft migration.
6.2 Aim
The aim ofthis studyis to identify the relationship between optimal oversizing and
stent-graft migration in EVAR.
6.3. Methods
The bench top experimental model consisted of freshly prepared abdominal
portion of bovine aortas, proximal portion of standard Zenith stent-grafts (Cook
Europe, Bjaeverskov, Denmark), a self assembledlineardrive, a calibrated digital
force gauge and a pressure supplying system. The oversizing was created by
pressurising the aorta, in the range of human physiological blood pressure. Any
changein oversizing was producedby changingthe aortic pressure. The
experimental model wasset up by deploying the stent-graft into the pressurized
aorta and then onthelinear drive. By applying the force onto the stent-graft to
causeit to migrate within the aorta under observation, the force could be
measured with a calibrated digital force gauge. The rangesof oversizing used
were 5%, 10%, 20% 30%, 40% and 50%. Further details of the methods were
described in Chapter5.
6.4 Results
The results of the pressure (mmHg), external (ED) and internal diameter
(ID) relationship study are shownin Figure 6.1. This study provides the
information of aortic internal diameters at the measurementpoints andit is
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pressure related. The oversizing calculation in the next experimentwill be base on
the internal diameter provided from this expeirment.
Pressure with ED and ID relationship in one bovine aorta
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Figure 6.1: Chart of pressure v external diameter (ED); and internal diameter(ID).
In experiments using stent-grafts with barbs, the m-DFat oversizing by 5, 10, 20,
30, 40 and 50%, were 2.066+0.60N, 3.685+1.54N, 6.04741.93N, 7.162+2.05N,
7.6144+2.28N and 9.801+3.45N respectively (Table 6.1 and Figure 6.2). The m-DF
showedsignificant difference at oversizing by 5, 10 and 20%, (P<0.05) and no
differences at oversizing by 20, 30, 40 and 50%.
 
 
Oversize 5% 10% 20% 30% 40% 5ersize:.
m-DFSD(N)  2.06640.60 3.68541.54 6.04741.93 7.162+2.05 7.614#2.228 9,80143.45
P-Value 0,003 0.005 0.169 0.357 0.116
Table 6.1: The results of m-DF+SD (N-Newton) in stent-grafts with barbs.
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Relationship between displacement force and oversizing
in stent-graft with supra-renal barbs
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Figure 6.2: Chart of the results of the m-DF+SDin stent-grafts with barbs.
In experiments using stent-grafts without barbs, the mean DFs (m-DF)at
oversizing by 5, 10, 20, 30, 40 and 50%, were 1.038+0.439 N, 2.724+1.0N,
4.238+40.80N, 4.642+0.78N, 4.83740.78N, and 5.199+0.83N respectively (Table
6.2 and Figure 6.3). The m-DF showedsignificant difference at oversizing by 5,
10, 20 and 30% (P<0.05) and nodifferences at oversizing by 30, 40 and 50%.
 
  
Oversize 5% 10% 20% 30% 40% 50%
m-DFSD(N) 1.03840.44 2.72441.0 4.238+0.80 4.74240.78 4.83740.78 5.19940.83
P-Vaule 0.001 0.004 0.003 0.199 0.058
Table 6.2: The results of m-DF+DS (N-Newton)in stent-grafts without barbs.
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Therelationship between displacement force and oversizing
in stent-graft without barbs
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Figure 6.3: Results of the m-DFin stent-grafts without barbs.
Compare the m-DF betweenZenith stent-grafts with and without barbs. The m-DF
recorded wassignificantly higher in stent-grafts with barbs than without, atall
percentage oversizing. (Table 6.3 and Figure 6.4).
 Oversize 5% 10% 20% 30% 40% 50%
With(+)/W/out(-) barbs + : + : + - + “ + ‘ +
m-DF£SD(N) 2.066 1.037 3685 2724 6047 4.239 7.162 4642 7.614 4837 9.801 5.2
P-Value 0.001 0.004 0.005 0.003 0.003 0.004
Table 6.3: Comparing the m-DFin both groups
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Compare the m-DFatdifferent percentage oversize
in stent-graft with and without barbs
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Figure 6.4: Comparing the m-DF +SDin stent-grafts with and without barbs.
Noneof the experiments produced any macroscopicinjury to the aortic wall after
displacement(Figure 6.5). The only structural deformity noted within the stent-graft
after forced displacement was upward distortion of the fixation barbs (Figure 6.6).
Figure 6.5: Picture of intima of an opened bovine aorta after experiment, showing no obvious
macroscopic damage.
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 Figure 6.6: Picture showing thestent-graft after experiment, note the upward distortion ofthe fixation
barbs.
The barbs on the bare stent were not embeddedinto the aortic wall atinitial stent-
graft deployment. Stent-graft migration occurred when the applied displacement
force caused the barbs to embedin the aortic wall.
Weneedto point out that the total covered graft length was 17mm. This
represents a suprarenalfixation device with an infrarenal neck length of 17mm.
6.5 Discussion:
Migration has occurredin all commercially available stent-grafts (van Marrewijk et
al. 2005; Drury et al. 2005), and has been extensively reported in manyclinical
studies. The reported prevalence of migration was from under 3% to 28%
(Tonnessenetal. 2005; Zarins et al. 2003; van Herwaardenet al. 2007). The
factors affecting migration were type of stent-grafts used, aortic aneurysm
morphological characteristics and the length of study follow-up time (Tonnessenet
al. 2005; Zarins et al. 2003; van Herwaardenet al. 2007). The proximal aortic neck
length, diameter and angle seem to have great influence on therisk of proximal
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stent-graft migration after EVAR. (Tonnessenetal. 2005; Zarins et al. 2003, Fulton
et al. 2006; Albertini et al. 2000; Leurs et al. 2005 ). The otherrisk factors that
have also been studied are maximum aneurysm diameter, stent-graft configuration
(aortic tubes, aortomonoiliac, bifurcation grafts), the type of proximal stent-graft
fixation (suprarenal/ infrarenal, with / without hooks and barbs) and the extent of
stent-graft oversizing (SternberghIII et al. 2004; Waasdorpet al. 2005; Mohanet
al 2002; Leurs et al.2005; Faries et al. 2002; Reschet al. 2000).
Clinical studies into the relationship between proximal oversizing and graft
migration have produced conflicting results. Some studies suggestthere is no
significant association between oversizing and migration (Sampaio et al. 2005;
Cao et al. 2002).
In somelarge multicentre studies with implantation of the Zenith, AneuRx and
different types of stent graft studies (Zarins et al. 2003; SternberghIII et al. 2004;
Mohanetal. 2002), only Sternbergh et al found a significant association. >30%
oversizing significantly increased the risk of migration compared with <30%
oversizing (14% v 1%, oddsratio 18.4; p=0.002) (SternberghIII et al. 2004).
Mohanetal. investigated the EUROSTAR multicentre database (N = 2,862) and
found 99 patients with migration (3.5%). Univariate analysis revealed no
association between oversizing and graft migration, and the migration incidence
did notdiffer significantly between several types of stent-graft (Mohanet al. 2002).
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There are experimental studies investigating the relationship betweenoversizing
and the required force for stent-graft displacement. Malina et al. used cadaveric
aortas to measure the longitudinal distraction that was required to dislodge Zenith-
stents from the aorta (Malina et al.1998).
This study suggestedthat the stent-graft oversizing had noeffect or only slightly
increased the required force for displacementof stent-grafts with or without barbs,
respectively.
Lambert et al. investigated the longitudinal load needed for 5 mm dislodgementof
24 mm nitinol self-expandable stent-grafts in cadaveric aortas. Wider aortas with
relatively less oversized stent-grafts needed less load to dislodge the stent-grafts
comparedwith smaller aortas with relatively more oversizing, respectively
(Lambert et al.1999). A second experiment measured an increasedradial
depression of the stent with an increasing applied radial load. More deformation of
the graft generates a greaterradial force, which therefore is a benefit of oversizing
(Lambert et al. 1999).
Our study investigated the longitudinal force needed for 5 mm displacementof
Zenith stent-grafts in bovine aortas with a relatively short neck (17 mm). A much
wider rangeof oversizing was used in our study (5, 10, 20, 30, 40 and 50%). The
results suggest that in stent-grafts with barbs, the m-DF showedsignificant
difference at oversizing by 5, 10 and 20% and nodifference at oversizing by 20,
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30, 40 and 50%. In stent-grafts without barbs, the m-DF showedsignificant
difference at oversizing by 5, 10, 20 and 30% andnodifference at oversizing by
30, 40 and 50%.
Comparing the m-DF betweenstent-grafts with and without barbs, the m-DF
recorded wassignificantly higher in stent-grafts with barbs than without,at all
percentage oversizing.
Thesefindings suggest that oversizing has significant effects on stent-graft
migration. In stent-grafts with barbs, optimal oversizing of 20% is needed to
producea beneficial effect against stent-graft migration, and 30% in stent-grafts
without barbs. The barbsincrease the overall proximal fixation strength against
migration.
Another important observation from this study was none of the experiments
produced any macroscopicinjury to the aortic wall after displacement. This was
due to the barbs from the bare stent not actually embeddinginto the aortic wall
after deployment. Further study is needed to explore further into this phenomenon.
Since our experiment wasa benchtop laboratory experiment, someof the
necessary in-vivo parameters were not reproduced. This has led to numerous
limitations in the study. The aortas used werestraight, healthy bovine aortas,
Ai
therefore the other factors such as aortic neck angulations, thrombosis,
calcifications, associated with stent-graft migration in the group of elderly human
population with diseased aortas were not considered. We recorded the DFin one-
off migration of the stent-graft. In vivo however, migration is the result of repetitive
forces exerted on the stent-graft over a considerable length of time by pulsatile
blood flow (Reschet al. 2000; Malina et al. 1998). Clinical study has suggested
thatthe iliac fixation also has a significant impact on proximal stent-graft migration
during EVARfollow-up (Waasdorp 2009). Since we truncated the stent-graft to the
proximal portion only, the effect ofiliac fixation was not considered. As the
different stent-grafts may have different designedfixation strength, the “fact value”
of the m-DF cannot representany other stent-graft device. Though oversizing was
accurately produced, it was nottrue stent-graft oversizing; the oversizing was
“created” by changing the aortic diameter.
6.6 Summary
In summary, optimal proximal oversizing hasa significant effect on proximal
fixation strength, and therefore on stent-graft migration. To produce the maximal
proximalfixation strength, the optimal oversizing required for stent-grafts with
barbs is 20%, and for stent-graft without barbs, is 30%. Barbs increase the overall
proximalfixation strength.
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CHAPTER 7
COMPARISONOFTHE FIXATION STRENGTH OF STANDARD AND
FENESTRATED STENT-GRAFT FOR EVAR
7.1 Introduction
Since endovascular abdominal aortic aneurysm (AAA) repair (EVAR) was
introduced more than a decade ago,the technique has been widely accepted,
worldwide. Clinical trials have demonstrated short-term survival benefit over open
repair of large AAAs (Greenhalghetal. 2004; Prinssen et al. 2004). Although
stent-graft design and EVARtechniques have much improved, the durability of
stent-grafts still raises concerns. One of the most important complications affecting
the long-term successis stent-graft migration; that is, movementof a fully
deployedstent-graft relative to the vascular anatomy, which hasthe potentialto
cause attachment-site endoleak and even aneurysm rupture (Greenhalghetal.
2004; Prinssen et al. 2004; Alimi et al, 1998; Torsello et al.1998; Lumsdenet
al,1995 ). Deployed stent-grafts constantly face physiological forces (Liffman et
al.2001, Mohanetal, 2004, Morris et al, 2002) that can initiate migration, and
these devices should be designedto resist such displacement.
Fenestrated stent-grafts have been introduced to extend the applicability of EVAR
to patients with an aneurysm neckthatis too short to satisfactorily position a
conventional stent-graft (Politz et al 2000; Zarins et al 2000). A fenestrated stent-
graft has fabric that extends to a level above one or morevisceral arteries.
Perfusion of the visceral arteries below the fabric margin is preserved via one or
more fenestrations in the stent-graft fabric that are incorporated during
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manufacture and positioned accurately at the time of deployment. Usually stents
are placed through the fenestration into the visceral arteries to provide additional
anchorageto the stent-graft, although they are not intended primarily for this
purpose.
7.2 Aim
The aim of this study was to compare the proximalfixation strength of standard
and fenestrated stent-grafts in an in vitro bovine aortic model.
7.3 Methods
The bench top experimental modelconsisted of freshly prepared abdominal
portion of bovine aortas with branches, proximal portion of a standard Zenith stent-
graft (Cook Europe, Bjaeverskov, Denmark), or self-constructed fenestrated stent-
graft, self assembledlinear drive, a calibrated digital force gauge and a pressure
supplying system. The oversizing was created by pressurising the aorta in the
range of human physiological pressure. Any changesin oversizing were produced
by changing the aortic pressure. The experimental model wasset up by deploying
the standard and fenestrated stent-graft into the pressurized aorta; the fenestration
wascreated by deploying a 6mm AVEstentinto the suited branch. The aorta and
stent-graft assembly wasthen placed onthelinear drive. By applying the force
onto the standard and fenestrated stent-grafts to cause them to migrate within the
aorta underobservation, the force could be measured, with a calibrateddigital
force gauge. Fenestrated stent-grafts were constructed with a single 6 mm-wide
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fenestration at a distance of 21 mm from the fabric edge (Figure. 6.6 B). The
fenestrations were not reinforced. The oversizing used was 5%, 10% and 20%.
Further details of the method are described in Chapter5.
7.4 Results
Figure 7.1 showsthe results of an aortic intraluminal pressure and aortic internal
diameterrelationship study.
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Figure 7.1: Chart shows howtheaortic internal diameter increases with intraluminal pressure.
With gradually increasing distraction force, the stent-graft migration was noted to
occurin 2 distinct phases. There wasaninitial yield, corresponding to a
displacement up to about 5 mm, which wasattributed to embedding of the barbs
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into the aortic wall. Once this phase was complete, the stent-graft was able to
resist migration for a period until a second yield occurred with increasing force,
followed by movementof the stent-graft in relation to the aorta. The peak
displacementforces (Table 7.1) corresponding to the 2 phases were described as
initial displacement force (IDF) and final displacement force (FDF), respectively.
For standard stent-grafts, the mean values of both IDF and FDF at 20% oversizing
were significantly greater than the corresponding values at 10% oversizing
(p<0.001), whichin turn were greater than those at 5% oversizing (p = 0.02).
Results with fenestrated stent-grafts show a similar trend with the exception of a
lack of significant difference between 20% and 10% oversizing levels (p = 0.054).
Boththeinitial and final displacementforces were significantly higher with
fenestrated stent-grafts than with standard stent-grafts (p<0.001) at any degree of
 
oversizing.
5% Oversizing 10% Oversizing 20% Oversizing
IDF FDF IDF FDF IDF FDF
Standard 3,39+0.37 8,100.92 4.32+0.63 10.764 1.74 7,691.18 16.82+0.92
Fenestrated 10.48% 1.23 22.562 1.60 11.45+ 1.48 28.24+ 1.56 12.12+ 1.42 33.014 1.75
¢ ¢
* p<0.001 for standard vs. fenestrated at each oversizing level.
TABLE7.1: Comparisonof Initial Displacement Force (IDF) and Final Displacement Force (FDF) for
3 Oversizing Levels in Standard and Fenestrated Stent-Grafts.
The meaninitial and final displacementforces in standard and fenestrated stent-
grafts for oversizing of 5%, 10%, and 20% are showngraphically in Figure 7.2
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Figure 7.2: Graph showing the meaninitial and final displacementforces in standard and fenestrated
stent-grafts for oversizing of 5%, 10%, and 20%.
Noneof the experiments produced any macroscopicinjury to the aortic wall after
displacement (Figure 7.3A). The only structural deformity noted within the stent-
graft after forced displacement was upwarddistortion of the fixation barbs (Figure
7.3B). The AVE stents appeared compressed and bentafter the experiments
(Figure 7.3C).
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 Figure 7.3: There is no macroscopic injury to the aortic wall after displacement experiment (A). The
only structural deformity noted within the stent-graft after forced displacement was upwarddistortion
of the fixation barbs (B). Appearanceof the AVEstentafter final displacementof the stent-graft (C).
During the experiments, we also observed that stent-graft migration was notin a
straightline with the direction of force applied. When migration occurred, the
opposite fenestration stent side of the stent-graft migratedfirst.
7.5 Discussion
Traditional stent-graft designs rely upon physicalattributes of a deployed stent-
graft, such as columnarstrength and radial force, to maintain a durablefixation.
Fixation appendages, such as hooksorbarbsincorporated at attachmentsites,
and aortic neck length also increasefixation strength (Lambert et al, 1999;
Veerapenet al. 2003; Resch et al, 2000, Malina et al. 1998). The main factors
predisposing to late migration are late dilatation of the aneurysm neck,
haemodynamic forces acting uponthe stent-grafts, and mechanicaldisintegration
of the device. Poor quality of the vessel at the proximalfixation zone and
underutilization of the infrarenal neck at the time of graft deployment also reduce
the fixation strength and predispose to migration (Wolf et al. 2001; Sternberghetal
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2002; Matsumuraet al. 2000, Frankoetal. 1998). Fenestrated stent-grafts were
introduced primarily to preserve renal or mesenteric branch vessel perfusion while
recruiting the aortic wall at the level of these branches,to provide proximal seal
andfixation (Andersonetal, 1999; Browneet al 2001). Stents are routinely placed
from the aortic lumeninto the visceral arteries through the fenestrations, to
enhancethefixation strength of the stent-graft (Verhoeven et al. 2004). However,
migration of a fenestrated stent-graft could result in distortion of the visceral artery
stent and consequentloss of patencyof this vessel, in addition to the other
consequencesof migration. Althoughfixation strengths of standard stent-grafts
have been reported (Lambert et al. 1999; Veerapen et al. 2003; Reschetal.
2000, Malina et al. 1998), there have been noreports relating to fenestrated stent-
grafts. Furthermore,previous reports of fixation strength were based on
experiments conducted on nonpressurized aortas, an importantlimitation to
understanding the relationship betweenoversizing andfixation strength. As the
experiments reported here were conducted with pressurized aortas, the results are
likely to better representthe clinical situation.
An important observation of this study was the modeof migration of a stent-graft
designedwith fixation barbs.In the initial phase, a few millimetres of caudal
migration, usually not exceeding the length of the barb (5 mm), occurred at a lower
force as the barbs embeddedinto the aortic wall. More substantial force was
required to cause subsequent migration in the second phase.Theinitial phase of
migration is in accord with anecdotes from physicians familiar with similar stent-
graft systems; they report that the stent-grafts may “settle” a few millimetres
downwardsafter deployment. It is recognized that the Zenith stent-graft has a low
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incidence of migration, but we are unable to comparethefixation strength of
different devicesin our study, since only one makeof stent-graft was used (van
Marrewijk et al. 2005).
When comparingtheinitial displacementforce (for stent-graft migration by 5 mm)
with the results of stent-graft with barbs from Chapter 6 in standard stent-grafts,
the value was generally higher at the same percentageof oversizing. In Chapter
6, in experiments using stent-grafts with barbs, the m-DFat oversizing by 5% was
2.066+0.60N, 10% was 3.685+1.54N, 20% was 6.047+1.93N, the results of the
initial displacementforce at oversizing by 5% was 3.39+0.37N, 10% was
4.32+0.63N, 20% was 7.69+1.18N. The settings of these two experiments were
the same apart from the seal zone length in this experiment was 36mm, and
17mm in Chapter 6. Clearly, the longer seal zone length here produced a higher
initial displacementforce.
The final displacementforces in standard stent-grafts varied from 8.1 to 16.8 N,
depending on the percentage oversizing. These values are smaller than those
reported by Veerapenet al (Veerapen et al. 2003) and Reschetal (Reschetal.
2000). Although the former authors reported experiments with oversizing of 10% to
20%, Resch and colleaguesdid not provide this information.
The main difference with the present studyis that the oversizing was accurately
determined via known pressure-diameterrelationships of the bovine aorta. It
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should be pointed out that the pressure per se did not have an influence on the
displacementforces. The graft material was and remained porousto the saline
during the experiments, and the pressure in the graft lumen wastherefore similar
to that in the aorta. Consequently, there was no netforce acting on the graft due to
the applied pressure.
The discovery of biphasic movementof this type of stent-graft upon application of
a dislodging force raises some important issues. Full recruitment of the barbs into
providing fixation strength appears to involve caudal movementof the stent-graft
by a few millimetres, as the barbs embedinto the aortic wall. No such movement
is caused deliberately in standardclinical practice. Should it occur naturally after
deployment, the movementof a stent-graft by a few millimetres seldom causes
significant problems with standard stent-grafts. It may, however, havesignificant
implications for fenestrated stent-grafts. Since the barbs may notbe fully engaged
at the position ofinitial deployment, there is a risk of transferring some of the
haemodynamic migratory forces to the interface between the stent-graft and the
side-branch stent, immediately after completion of aneurysm repair. Small-
diameter stents that are suitable for side-branch placement are not designed to
withstand the resultant asymmetric hoop stress. Failure or significant distortion of
side-branch stents due to such stress can lead to loss of side-branch patency. A
mechanism bywhichtheinitial phase of migration could be eliminated or madeto
occurin a controlled manner would havethe potential to eliminate adverse effects.
Moulding of the fixation areas using a conformable balloon may cause embedding
of the barbs and eliminate theinitial phase of migration or stent-graft settling.
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Another importantfinding of this study wasa relationship between oversizing and
fixation strength; fixation strength increased with increasing oversizing up to 20%,
which supports routine oversizing with self-expanding stent-grafts. In the case of
fenestrated stent-grafts, however,thefixation strength did not increase
significantly above 10% oversizing. This may be dueto the fact that mostof the
fixation strength here was provided by the side-branchstent acting as an anchor,
rather than by the interaction between the stent-graft and the aortic wall.
Although the methodsofthis study represent an enhancement compared with
earlier in vitro studiesoffixation strength (Lambert et al, 1999; Veerapenetal.
2003; Resch et al. 2000, Malina et al. 1998), there are a numberoflimitations to
this study. The aortas used werestraight tubular segments from healthy animals,
and as such could not replicate someof the features of aneurysm anatomy, such
as neck angulations, conical shape, or presenceofcalcification, or thrombus. The
applied distraction force was incremented gradually and thus may be functionally
different from the repetitive forces that stent-grafts are subjected to in vivo (Zarins
et al, 2005). Because of the natural taper of the aorta, the vessel was reversed in
the experiment sothat the stent-graft was made to migrate from the narrow to the
wide segment, thereby potentially underestimating the fixation strength. Any error
is likely to be small, but we considered that the alternative orientation was a worse
option since this maypotentially result in falsely high fixation strengths.
Althoughthe length of the stent-graft used was 53 mmin both groups, only 36 mm
of the covered section of the stent-graft was actually in contact with the aortic wall.
This is at the upper end of the range of graft overlap with the aortic neckin vivo.
130
The experiments were designed to measure the displacementforce ofthe isolated
proximal portion of the stent-graft, so truncated devices were used. Werealize that
the use of a complete bifurcated device mayinfluence the measured forces, but
the modeluseddid not allow the effect to be investigated.
7.6 Summary
These experiments demonstrate that proximalfixation strength of a self-expanding
stent-graft with a proximal bare stent and barbs, increases, with increasing degree
of oversizing up to 20%, and that a fenestrated stent-graft configuration confers a
greater proximalfixation than conventional devices. With such stent-graft design,
full engagementof fixation barbs may cause movementof the stent-graft by a few
millimetres before the full fixation strength of the device comesinto action. This
observation may havesignificant implications for fenestrated stent-graft design.
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CHAPTER8
INVESTIGATION OF THE OPTIMAL OVERSIZING REQUIRED FOR AN
EFFECTIVE SEAL IN STANDARD AND FENESTRATED EVAR
8.1 Introduction
The aim of endovasculartreatmentof aortic aneurysmis to isolate the aneurysm
from the rest of the circulation; hence obtaining an effective seal between the
endoluminal stent-graft and the aorta, above and below the aneurysm. Failure to
achieve sealwill lead to endoleak and eventually aneurysm rupture.
Endoleakis defined as persistent blood flow outside the lumen of the Endoluminal
graft but within the aneurysm sac, as determined by an imaging study (Whiteet al
1996; White et al 1997).
There are four types of endoleak according to the origin and site. Type | endoleak
is defined as the persistence of a perigraft channel of blood flow caused by
inadequateorineffective seal at either the proximal (proximal Type | endoleak) or
distal (distal Type | endoleak) attachment zones (Chaikof et al 2002).
Proximal Type | endoleak mayresult in serious consequencesif it remains
untreated. Data from the EUROSTARregistry has suggested that proximal Type|
endoleak has muchhigherrisks of late conversion (Harris et al 2000; Vallabhaneni
et al 2001) and rupture (Marrewijk et al 2002). Also, compared with distal Type|
endoleak,the proximal Type | endoleak hasa significantly higher risk of aneurysm
rupture (Mohanet al 2001).
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In clinical practice, oversizing of aortic stent-grafts is an essential step to prevent
Proximal Type | endoleak. However, there is no consensus regarding the optimal
degree of oversizing needed,in particular, in relation to the aortic neck length.
8.2 Aim
This study is designed to investigate the optimal degree of oversizing required for
an effective seal in standard and fenestrated EVAR.
8.3. Methods
Thein-vitro model consisted of a sealed, truncated Zenith stent-graft (Cook Europe,
Bjaeverskov, Denmark) which wasdeployedinto the pre-determined measurement
point of the bovine aortic section. In a fenestrated stent-graft, a6 mm AVEstent
was usedto insert through the fenestration, into the side branch of bovine aorta. A
purpose built system generated pulsatile flow, mimicking infrarenal aortic flow. It
consisted of a piston pump (self assembled) to provide pulsatile flow, and a gear
pump (HG 0024 Micro pump INC, Vancouver, WA, USA), to provide steady flow.
40% glycerol solution with physiological viscosity was used ascirculating fluid. A
pressure sensorand an ultrasonic flow meter (Transonic HT107/HT207 Medical
Flowmeter, Ithaca, NY 14850 USA) measured pressure and flow continuously
during the experiment. The system was connected to a computerfor controlling and
monitoring the pressure and flow (Figure 5.8 & 5.9). Details of the methods are
described in Chapter5.
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8.4 Results
With gradually increasing pulsatile pressure, leaks occurred in an intermittent
fashion. Leaks were observedin the systolic pressure phase and stoppedin the
diastolic phase.
The results of all three tests in standard stent-graft are shownin figure 8.1. With
increasing seal zone length, the degree of “optimal oversize” required for a sealis
reduced. The “optimal oversize” at “aortic seal zone lengths” of 10 mm, 15 mm,
20 mm, 30 mm and 40 mm was 20.44%, 16.42%, 10.25%, 7.09%, 4.22% in test
run 1, 20.87%, 16.70%, 10.66%, 7.35%, 4.88% in test run 2 and 23.11%, 18.33%,
11.71%, 8.62%, 5.45% in test run 3.
25 
 
  
v @ Seal zone length (mm)vs Test run 1
© Seal zone length (mm)vs Test run 2
v__ Seal zone length (mm)vs Test run 3&20 +
= v
= @2N 15 -
2$3S v
10 8= ¥aOo Q :
0 T T T T T T T
5 10 15 20 25 30 35 40 45
Seal zone length (mm)
Figure 8.1: Chart of results of the “optimal oversize” in standardstent-graft.
The results of experiments on fenestrated stent-graft are shownin figure 8.2.
Similarly, with increasing seal zone length, the degree of “optimal oversize”
required for a seal is reduced. The “optimal oversize”at “aortic seal zone lengths”
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of 5mm 10 mm 15 mm and 20 mm was 19.12%, 14.72%, 9.41%, 5.61% in test
run 1, 20.71%, 15.87%, 10.44%, 6.11% in test run 2 and 20.43%, 15.42%,
10.89%, 6.04% in test run 3. However, when the seal zone length was reduced to
0 mm, endoleak was observedin the full range of oversizing.
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Figure 8.2: Chart of results of the “optimal oversize” in fenestrated stent-graft, the total seal zone
length will include the suprarenal length of 21mm.
The results of experiments with a rigid sleeve overthe aorta, to eliminate oversize
variation, showedthat no leak was observedin the pulsatile pressure range from
minimum diastolic pressure of 60 mmHgto the maximumsystolic pressure of 235
mmHg.
8.5 Discussion
Proximal Type | endoleak is the most important cause of abdominalaortic
aneurysm (AAA) rupture after EVAR (SchlosserJ et al 2009). It is also the most
commonreasonfor re-interventions (Hobo et al 2006).
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A three year study in regard to proximal Type | endoleak has suggested an
incidence of 4% (Sampaio et al 2004) and perioperative incidence from the
Eurostarregistry was 3.3% (Mohanet al 2001).
Clinical studies suggestthat the appropriate oversizing of stent-graft to aortic neck
can prevent proximal Type | endoleak and stent-graft migration. With effective
oversizing, a securedfixation and seal can be achieved. However,it is not clear
what the most appropriate oversizing is to achieve the optimal seal. Clearly, under
oversizing (or undersizing) of a stent-graft will result in incomplete and inadequate
apposition of the stent-graft to the aortic wall with subsequent proximal Type|
endoleakor inadequatefixation with the potential risk of migration. On the other
hand, excessive oversizing may increasethe risk of complications, such as stent-
graft infolding or dilatation of the aneurysm neck, with subsequentmigration and
endoleakof the stent-graft (Schurink et al 1999; Conners et al 2002; Sternberghet
al 2004).
The currently published studies have suggested the mechanismsby whichstent-
graft oversizing may induce,or prevent, proximal Type | endoleak. Excessive
oversizing may causestent-graft folding with subsequentrisk of proximal Type|
endoleak. Under oversizing (or undersizing) will result in an inadequate seal,
leading to proximal Type | endoleak (Matsumuraet al 1998; Petrik et al 2001; Dias
et al 2001; Sampaio et al 2004).
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In clinical practice, it has been recommendedthat to achieve an effective proximal
seal, the stent-graft oversizing should be 10%-20% in self expanding stent-grafts
(Mohanet al 2001; Greenberg et al 2004). However, there is currently no
consensuswith regard to the stent-graft optimal oversizing for EVAR. Neither isit
known whether the same degreeof oversize is needed for different aortic neck
lengths.
The aim of stent-graft oversizing is to obtain an effective seal. It is not necessary
and canberisky to excessively oversize the aortic neck beyond the minimal
degree of oversizing required (defined as optimal oversizing in our study). So our
studyis to identify the optimal degree of oversizing for effective seal and minimise
the risk of adverse effects of excessive oversizing.
Our study suggests that the optimal oversize for effective seal varies, dependent
on the length of aortic neck. In general, greater oversizing is required for shorter
aortic neck length in both standard and fenestrated EVAR.In experiments with
standard stent-graft, at aortic neck length of 40 mm, only 4% oversizing is needed
to achieve an effective seal. When aneurysm necklength is as short as 10 mm
however, 20% oversize is needed to achieve effective seal. In experiments with
fenestrated (with bare stent) stent-graft, at aortic neck length of 20 mm, only 6%
oversize is needed to achieve the seal. When aneurysm necklength is as short as
5 mm, 20% oversize is needed to achieveeffective seal.
In combining the results from fixation studies in chapter 6 and 7, the practical
recommendationsforclinical practice would be 10% to 20% oversizefor relatively
short seal zone length (17-20 mm)to achieve the best results both for seal and
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fixation. Whereasforrelatively longer seal zone length (36-40 mm), the oversize
can be ranged from 4% to 20%.
In our experiment, every effort was madeto simulate the in-vivo situation. Pulsatile
flow mimicked the infrarenal aortic flow. However, some of the otherin-vivo
parameters are moredifficult and even impossible to reproduce,in a bench top
model. This has led to numerouslimitations in this study. The aortas used were
straight tubular segments from healthy animals and as such cannotreplicate the
features of aneurysm anatomysuch as neck angulations, conical shape, and
presenceofcalcification or thrombus. There was no “aneurysm sac”therefore the
effect of aneurysm diameter and the pressure gradients were not considered.
Thougha pulsatile pressure system wasused, the purpose wasto generate
variations in oversize. The pressure range was beyond the normal human blood
pressure range. However, these factors are unlikely to overwhelminglylimit the
value of the conclusions that can be drawn from thesefindings.
8.6 Summary
In summary, the optimal oversize for appropriate seal is dependent on the aortic
necklength in both standard and fenestrated EVAR.In general, the optimal
oversizing is inversely related to seal zone length. We suggestthat with shorter
seal zone length moreoversize is required for an appropriate proximal seal. For
fenestrated EVARwith bare stent, a seal can be achieved atinfrarenal neck length
as short as 5 mm.
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CHAPTER9
MEASUREMENTOF PULSATILE HAEMODYNAMIC FORCESIN A MODELOF
A BIFURCATED STENT GRAFT FOR ABDOMINAL AORTIC ANEURYSM
REPAIR
9.1. Introduction
The success of EVAR dependsonsecurefixation of the sent-graft in the patient's
aorta. The degreeoffixation should be such that the device is able to withstand
the downward haemodynamicforces dueto pulsatile pressure and flow. The
fixation strength of stent-grafts has been estimated by measuring the longitudinal
displacementforce at the proximalfixation site of various commercially available
stent-grafts in a cadaveric model (Reschet al, 1999; Veerapenet al, 2003). The
averagefixation strength ranged from 4.5 N to 25 N, comparedto 150 N for the
hand sewn anastomosis of conventional repair.
Mathematical models have been developed previously to derive theoretical
estimates of the haemodynamic forces that may be exerted on stent-grafts in vivo.
(Liffman et al. 2001, Mohanetal, 2002, Morris et al. 2004). Mohan et al showed
that hypertension, aneurysm geometry andiliac angulation, amongstotherfactors,
weresignificantly associated with stent-graft migration, and consequentloss of
fixation (Mohanet al, 2002). These findings were validated using a simple one-
dimentional analytical model based on momentum equation, not accounting for the
pulsatility of blood flow and the viscosity of the fluid. It was shown that under
certain conditions, the longitudinal force (LF) on a stent-graft due to blood flow and
pressure may exceedthefixation force, thus causing stent-graft migration.
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9.2 Aim
The purposeof this study was to develop an experimental method to measure LF
in a modelof a stent-graft under pulsatile flow of a viscous fluid. A numberoftest
runs were carried out to assessthe feasibility of the technique and comparethe
experimental data with the analytical predictions.
9.3. Theoretical Model
Mohanet al (2002) considered a simple modelof an idealized bifurcated device
shownin Figure 8.1 to estimate the longitudinal force f, exerted on the EVAR
device. It is assumedthat the bifurcation is planar and symmetrical, and the blood
flow is distributed equally through twoiliac limbs of equal diameter(this is a
simplification of the situation in vivo where the stent-graft has to conform to
irregular three-dimensional geometry of the AAA). In addition the flow is assumed
to be steady andthefluid is assumedto beinviscid, i.e. the viscosity is zero.
The changein direction and velocity of flow due to the diameter change and the
bifurcation angle causes a changein the momentumofthe fluid. The momentum
change andthepressureforcesacting at the inlet and outlets result in a net
longitudinal force f, on the device which must be opposedto preventits distal
migration. Mohanet al (2002) derived the following expression (Equation 9.1) for
fy.
PA, —2P,A,cos0 — f, = po{Seos0+2cos0-U;) (9.1)
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Where P,, Ai, U1 and Pz, A2, U2 are the pressure, cross-sectional area and velocity
at the inlet and outlet, respectively; p is the density of the fluid and Q is the volume
flow rate. Thefirst two terms on theleft hand side of equation 9.1 represent the
pressureforcesat the inlet and outlets acting on areas A; and Ao, respectively.f,
is the axial componentof the force exerted by the bifurcation on thefluid. The
right hand side of equation 9.1 represents the rate of increase of axial component
of momentum.
Using Bernoulli's and continuity equations, the pressure P2 and velocity U2 at the
outlet can be expressed in terms of U,, P; and A; and the equationfor f, can be
re-written as follows:
2 A? 2 Uy A, ,f,=PA + pAU, mov) U,* cos@—2A, cos0 Rte ri (9.2)
f, can be readily calculated for a given device geometry and haemodynamic
conditions using equation 9.2. In the transverse direction, the pressure and
momentumforces cancel out because of the symmetry and equalflow distribution
and therefore f, = 0.
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Figure 9.3: Geometry andforces acting on a bifurcated stent-graft.
9.4 Methods
The experimental model was machined using aluminium tube, joined with metal-
loaded epoxyresin to form a bifurcation. The main trunk internal diameter was 30
mm, and wall thickness, 4 mm. We thinned a segment 30 mm long to 0.1 mm wall
thickness on the main trunk. The thinned segment increasedthe levelof strains
locally, so the strain could be easily measured. Two strain gauges were bonded
onto this section. After calibrating the strain gauges, the model was placed onto
the samepulsatile flow system as described in chapter 8. The longitudinal
haemodynamic force was then measured, and converted to Newtons. The
pulsatile flow system could mimic humaninfrarenal blood flow. The pressure and
flow settings were generated from elderly patient blood pressure andinfrarenal
blood flow. The viscosity of the viscousfluid was the sameasthat of normal
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humanblood serum,so the potential effect of viscosity of flow could be eliminated.
Details of the methodsare described in Chapter5.
9.5 Results
Five experiments werecarried out with the sameflow rate of 1.5 I/min, heart rate
of 60 beats per minute butdifferent pressure waveforms.
The average flow and pressure waveformsand netforce f, or LFfor all the five
experiments are shownin Figures 9.2 (A, B, C), 9.3 (A, B, C), 9.4 (A, B, C), 9.5 (A,
B, C) and 9.6 (A, B, C). Each waveform wasaveraged over 590 cardiac cycles.
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Figure 9.4A: Flow waveform in test run 3
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Figure 9.6C: Measuring the net force f, or LF in test run 5
Figure 9.7 shows the measuredf, waveform aswell as the theoretical values
calculated from eqn. 9.2 using the actual recorded pressure and flow waveforms.
The force and pressure waveformsappearto be almostin phaseindicating that
pressure has a greaterinfluence on the measuredforces thanthe flow. It can be
seen from Figure 9.7 that the measured forces were greater than those calculated
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from equation 9.2. The differences between measured and calculated forces
expressed as a percentage of the measured values are shownin Figures 9.8, 9.9,
9.10, and 9.11.
The rangeofthe differences was from about 6 to 18% of the measured values.
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Figure 9.7: Differences between measured andcalculated f, or LF.
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9.6 Discussion
Oneof the most important complications affecting the long term successof
endovascularrepair of aortic aneurysmsis stent-graft migration; that is, movement
of a stent-graft relative to the vascular anatomy, after complete deployment.
Stent-grafts depend on a numberof factors such asradial force, columnar strength
and the presence of hooksorbarbs to remain stable in position. Since they are
not sutured to the aortic wall, stent-grafts are susceptible to migration. This has the
potential to cause attachment-site endoleak and even a consequent aneurysm
rupture (Mohanetal, 2002; Alimi et al 1998; Torsello et al 1998; Lumsdenetal,
1995). A deployed stent-graft constantly faces physiological forces that tend to
causestent-graft migration and therefore stent-grafts should be designedtoresist
such migration. Thefixation strength of commercial stent-grafts has been
measuredby several authors. The longitudinal force LF required to completely
displace a stent-graft from an aorta has been found to range from 4.5 N to over 26
N depending on the design of stent-graft (Resch, et al, 1999; Veerapenetal,
2003).
The one-dimensional model (equation 9.2) was derived using a numberof
simplifying assumptions about the fluid and the geometry of the bifurcation. Morris
et al (Morris et al, 2004) and Li and Kleinstreuer (Li et al, 2006) have carried out
computationalfluid dynamic studies of pulsatile flow in bifurcated devices and
shownthat blood pressure had the most effect on LF. Blood flow did not affect LF
significantly. Li and Kleinstreuer (Li et al, 2006) also found that the shapeof the
pressure waveform wasa significant factor. Pressure waveforms with high
systolic slope produced higher LF than those with lowersystolic slopes. This was
attributed to large flow accelerations which affected the LF acting on the device.
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Using a gramometer, Volodosetal (Volodoset al, 2003) measured LFin a tubular,
non-bifurcated stent-graft subjected to pulsatile flow of water. More recently
Sutalo et al. measured LFin an acrylic model ofa bifurcated stent-graft under
steady flow of water (Sotalo et al, 2005). The LF was measured by meansof a
load cell attached to the model and found good agreementwith the predictions of
the simple one-dimensional model.
This study showsthat the measuredLFis in relatively good agreementwith the
simple one-dimensional steady inviscid model. Figure 9.8-9.11 show the
difference expressed as a percentage between measured andcalculated LF. It
can be seen that the maximumdifference occurs during the mid-systolic phase of
the pressure waveform. To obtain an estimate of the influence of the viscosity of
the fluid, the pulsatility of the flow and the momentumforces,wefirst evaluate the
pressureforces from the first two terms of equation 1, i.e., P;A;— 2P2Az2cose. This
is then subtracted from the measured LF. The viscosity, the momentum and
pulsatility therefore contributes approximately 0.2 to 1.2N to the measured LF,
which ranged from about 4 to 12 N.
In this experiment, two strain gauges connectedin the half-bridge circuit were
used (Figure 5.19). The advantage over a single active strain gauge in a quarter-
bridge configuration is greater sensitivity. However, the disadvantageforthis half-
bridge (and also the quarter-bridge configuration) is that the thermal effects do not
cancel out and the outputis therefore susceptible to temperature changes. To
minimize the thermaleffects, a low supply voltage of 2.5V was used, and the
bridge completion resistors consisted of high stability precision resistors (S350, 1
[33
ppm/°C, Vishay Measurements Group UK, Basingstoke, UK). Since the output
could be affected by thermalzerodrift, this was monitored before and after each
measurement. This was achievedbyisolating the stent-graft model from any
pressure load byclosing the three ball valves at the inlet and outlets and opening
the pressure port to atmosphere. Anydrift was zeroed using the bridge balance.
Provided that the strain gauge voltage supply and the instrumentation amplifier
were switched on at least 2 hours prior to the experimentto allow thermal
equilibrium to be reached, the zero drift over the duration of the experiment was
found to be < + 5 mV (corresponding to + 0.16 N).
The measuredLFin this experimentis strongly pressure dependent.In the
pulsatile pressure condition, the LF can reach 12 N at 160 mmHgpressure. This
is much greater than most of the measured proximalfixation strengths from
previous chapters. However,clinically, stent-graft migration has only happened
from under 3% to 28% (Tonnessenet al. 2005; Zarins et a. 2003; van Herwaarden
et al. 2007). Soit is fair to assume that other factors such asfixation strength from
the distal seal zone andbifurcation for some design of stent-graft, must have
contributed to the overall fixation strength.
9.7. Summary
In summary, the longitudinal force acting on a stent-graft can be determined
experimentally, using an instrumented device. LF is strongly dependent on
pressure. Thefluid viscosity, momentum andpulsatility contribute between 6 and
18% of the total LF. These results confirm that under certain conditions, LF can
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exceed the fixation force of some of the current endovascular stent-grafts and may
therefore lead to distal migration and its potentially serious consequences.
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CHAPTER10
CONCLUSIONS,IMPLICATIONS OF FINDINGS AND SUGGESTIONS FOR
FURTHER STUDY
Endovascular aneurysm repair is by now a well-established, evidence based
treatment of choice which has dramatically changed the overall approach to AAA
repair. With improvementin stent-graft design and moreclinical experience
gained, the complications of EVARhavefallen significantly in recent years.
Despite the improvementin overall outcomes of EVAR,the long term results are
still controversial. EVAR is associated with its own unique problemsafter
implantation and those problemsare largely not understood. Endoleak and stent-
graft migration are the two mostsignificant complications leading to EVARfailure.
It is vitally important to understand these two phenomenato enable future
improvementof stent-graft design. The long term durability of EVARwill continue
to be challenged as long as these two complications remain unresolved. Since
this research project is focused on these two most important areas, the results
have significant implications for clinical practice and future studies.
The study of relationship between optimal oversizing and proximalfixation strength
in EVAR hasrevealed that the oversizing has significant impact on stent-graft
proximalfixation strength. In stent-graft with hooks and barbs, the maximal force
wasreachedat oversizing by 20%; and 30% in stent-graft without hooks and
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barbs. Further oversizing will not bring further benefit in proximal fixation strength.
The barbs increase the overall proximal fixation strength. These results support
the clinical findings in stent-graft with hooks and barbs, andclarify the needed for
oversizing to maximize the proximal fixation strength. Migration is commonly seen
as a late complication after EVAR. It is the result of pulsatile longitudinal
haemodynamic force acting on the implanted stent-graft over a period of time,
often years. In future studies, it would be ideal to test migration in a morerealistic
model of the endovascular environment, in accelerated rates far higher than the
human endovascular environment; the goal is to compress the effects of yearsin
the humancirculation, into a few monthsor even daysof testing in laboratory
settings.
The study to comparethe proximalfixation strength between the standard and
fenestrated stent-graft discovered the modeof stent-graft migration is actually in
two phases. Phase oneis due to the barbs embeddinginto the aortic wall with
migration by a few millimetres which require much smaller force. Phase twois
whenthefull fixation strength of the device has been reached. Thesefindings
have implications in future Zenith stent-graft designs, in particular in fenestrated
stent-graft.
The degree of movementin phase one migration is unlikely to cause serious
consequenceswith the majority of standard stent-grafts. However, with a
fenestrated stent-graft, migration of even this magnitude can result in distribution
of shearforces to the interface betweenthe target vessel stent and the fenestrated
bodyof the stent-graft. The stents used in fenestrated EVARare not primarily
designed to withstand the force causing phase one migration.
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This meanstheir strength may not be sufficient to withstand this force, resulting in
crushing or evenfracture of stents, and possible occlusion of the target vessel.
Clinically, it is important to select stents which can withstand force sufficient to
potentially cause phase one migration, during fenestrated EVAR. Thestent with
opencell structure should best be avoided for this reason.
The study also found that the fenestrated stent-graft configuration confers a
greater proximalfixation than conventional devices. It is clear that the extra
portion of the strength is produced by the fenestration stent. But how much
strength is from the fenestration stent aloneis still unknown and warrants further
study. Furthermore, different commercially available stents such as Palmaz,
genesis, atrium, jomed ordifferent structured stents like open and closed cell stent
may producedifferent strengths, so by further study into fixation strength testing
this strength in different stents, the designed proximalfixation strength in
fenestrated stent-graft may be increased further, therefore reducing the chance of
migration.
It is routine clinical practice for stent-graft oversizing of the aortic neck, to obtain a
proximal seal. Butit is not clear how much oversizing is needed for an optimal
seal. Furthermore, whether the same percentageof oversizing is required to
obtain a sealin different seal zone lengthsis not clear.
The study into the optimal degree of oversizing required for an effective sealin
standard and fenestrated EVAR,revealed that the percentage of oversize needed
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to secure a Sealis inversely related to seal zone length both in fenestrated and
standard stent-graft. The shorter the seal zone length, the more oversizeis
required to achieve proximal seal. For fenestrated EVAR with bare stent, a seal
can be achievedat aortic neck length as short as 5 mm. Theclinical implications
of these results suggest that percentage of oversizing should not be the samefor
different aortic neck lengths. In general, the longer the neck length, the less
oversizing is needed for a secure proximal seal. As stated above,in fenestrated
EVAR,with bare stent, this can achieve a seal at neck length of 5 mm,at shortest.
A covered stent should be considered for neck length shorter than 5 mm.
However, since there is no aneurysm sacin this study, the pressure difference
betweentheintraluminal and extraluminalis at its greatest. This may have
exaggerated the endoleakat certain aortic neck length and pressuresetting.
Furthermore, the experiments studied the standard and fenestrated stent-graft at
different aortic neck length settings, so the results were not directly comparable
between these two experiments. Further study is need in a modelwith an
aneurysm sac,soit will closer mimic the situation in vivo. More study is neededto
compare betweenstandard and fenestrated stent-graft in exactly the same
settings, in order to elucidate the reason why fenestrated stent-graft can obtain a
seal in shorter aortic neck lengths.
The longitudinal haemodynamicforce is the force created by bloodflow (in the
aorta), this will tend to push the stent-graft distally, to cause stent-graft migration.
An implanted stent-graft on the other hand, should have designedfixation strength
exceeding the longitudinal haemodynamic force, to prevent migration occurring. In
the study of measurementof pulsatile haemodynamic forces in a modelof a
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bifurcated stent graft for abdominal aortic aneurysm repair, we measured the LFin
a bifurcated stent-graft model. The results suggestthat the LF is strongly
dependenton pressure. Thefluid viscosity, momentum andpulsatility contribute
between 6% and 18% of the total LF. These results confirm that undercertain
conditions, LF can exceedthefixation force of some of the current endovascular
stent-grafts and maytherefore allow migration, proximal Type | endoleak, and
other serious consequences. Further study is needed to determine the LF more
accuratelyin vivo.
All the findings from this research haveled to the conclusion that proximal
oversizing hasa significant effect on the proximalfixation strength. To achieve
maximal proximalfixation strength, 20% oversizing is neededin stent-graft with
hooks and barbs and 30% oversizing is neededin stent-graft without hooks and
barbs. The barbs increasethe overall proximalfixation strength. Stent-graft
migration occurs in two phases. Phase oneis due to the barbs embeddinginto the
aortic wall with migration of a few millimetres. Phase two is whenthefull fixation
strength of the device has been reached. The fenestrated stent-graft configuration
confers a greater proximalfixation than standard devices. In standard and
fenestrated EVAR,a different percentage of oversizing is needed to secure a
proximal seal in different aortic neck lengths. Shorter aortic neck lengths require
moreoversizing to secure a seal. In fenestrated EVARwith bare stent, a seal can
be achievedat aortic neck length as short as 5 mm. The LFis strongly dependent
on pressure. LF can exceedthefixation force of some of the current endovascular
stent-grafts and may therefore allow migration, proximal Type | endoleak and
aneurysm rupture.
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Fenestrated Stent-Grafts for Endovascular Abdominal
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SamuelS. N. Zhou, MRCS, MRCSEd’; Thien V. How, PhD’; S. Rao Vallabhaneni,
MD, FRCS2; Geoffrey L. Gilling-Smith, MS, FRCS2; John A. Brennan, MD, FRCS2;
Peter L. Harris, MD, FRCS2; and Richard McWilliams, FRCR?
1Departmentof Clinical Engineering, University of Liverpool, England, UK. Departments
of 2Vascular Surgery and 3Radiology, Royal Liverpool University Hospital, Liverpool,
England, UK.
4 ¢ 
Purpose: To determine whetherfenestrated stent-grafts provide better stability to resist
migration than standard non-fenestrated stent-grafts.
Methods: Truncated fenestrated stent-grafts with a single fenestration were deployed in
bovine aortic segments with a side branch. Balloon-expandable stents were then delivered
into the branches. Similarly, standard stent-grafts of the same dimensions were deployed
for comparison. The aorta was pressurized to achieve stent-graft oversizing of 5%, 10%, or
20%. The force required to cause distal migration was recorded by a digital force gauge
attached to the stent-graft.
Results: Displacement of the stent-grafts occurred in 2 distinct phases: an initial yield
during which the barbs embeddedin the aortic wall and a final displacement leading to
significant migration and dislodgementof the device. The displacementforce thatinitiated
each phase was dependentuponthe degree of oversizing of the stent-graft relative to the
aortic diameter. For 5%, 10%, and 20% oversizing, the mean displacement forces in the
initial displacement phase were 3.39+0.37, 4.32+0.63, and 7.69+1.18 N, respectively, in
non-fenestrated grafts and 10.48+1.23, 11.45+1.48, 12.12+1.42 N in fenestrated grafts. The
displacement forces in the final displacement phase were 8.10+0.92, 10.76+1.74, and
16.82+0.92 N for non-fenestrated and 22.56+1.60, 28.24+1.56, and 33.0141.75 N for
fenestrated stent-grafts. The differences in displacement forces between standard and
fenestrated stent-grafts were significant for both phases (p<0.001) at all oversizing levels.
Conclusion: Improvement in fixation strength was noted with increasing stent-graft
oversizing of up to 20%. Fenestrated stent-grafts offer higher ultimate fixation compared to
standard devices. However, the ultimate fixation strength was not recruited until an initial
phase of short migration occurred as the barbs engaged. While this movement is
inconsequential with standard stent-grafts, it has the potential to crush the stents placed
into aortic side branches with fenestrated endografts.
J Endovasc Ther 2007;14:168-175
Key words: abdominal aortic aneurysm, endovascularrepair, stent-graft, fenestrated stent-
graft, bovine aorta, displacementforce, migration
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Since endovascular abdominal aortic aneu-
rysm (AAA) repair (EVAR) was introduced
more than a decade ago, the technique has
been widely accepted worldwide. Clinical
trials demonstrated short-term survival bene-
fit over open repair of large AAAs.'? Al-
though stent-graft design and EVAR tech-
niques have much improved, the durability of
stent-grafts still raises concerns. One of the
most important complications affecting the
long-term success is stent-graft migration,
that is, movement of a fully deployed stent-
graft relative to the vascular anatomy, which
has the potential to cause attachment-site
endoleak and even aneurysm rupture.’> A
deployed stent-graft constantly faces physio-
logical forces®® that can initiate migration,
and these devices should be designed to
resist displacement.
Fenestrated stent-grafts have been intro-
duced to extend the applicability of EVAR to
patients with aneurysm necks that are too
short to satisfactorily position a conventional
stent-graft.2'° A fenestrated stent-graft has
fabric that extends to a level above one or
more visceral arteries. Perfusion of the vis-
ceral arteries below the fabric margin is
preserved via one or more fenestrations in
the stent-graft fabric that are incorporated
during manufacture and positioned accurate-
ly at the time of deployment. Usually stents
are placed through the fenestration into the
visceral arteries to provide additional anchor-
age to the stent-graft, although they are not
intended primarily for this purpose.
The aim of this study was to compare the
proximal fixation strength of standard and
Flag
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fenestrated stent-grafts in an in vitro bovine
aortic model.
METHODS
Experimental Design
The bench top experiment(Fig. 1) comprised
a pressurised bovine aorta into which the
proximal portion of a standard or fenestrated
Zenith stent-graft (Cook Europe, Bjaeverskov,
Denmark) was deployed. Force wasapplied to
the stent-graft to make it migrate within the
aorta under observation; this displacement
force was measured with a calibrated digital
force gauge. Since stent-grafts are oversized
in relation to the aneurysm neck in routine
clinical practice, the experiments were carried
out with oversizing of 5%, 10%, and 20% for
both types of stent-grafts. For each type of
device, 8 experiments were conducted at 5%
and 10% oversizing and 6 at 20% oversizing
for a total of 22 experiments per device type.
Tissue Preparation
Fresh bovine aortas were obtained from an
abattoir. The abdominal portion wasretained,
and all adherent non-vascular tissue was
removed. Small side branches were ligated
at ~3mm from the origin, and larger
branches (5-6 mm wide when pressurized)
were identified for stenting with the fenes-
trated grafts. A length of at least 3 cm was
provided to accommodate the stent. Any
leaking areas were oversewnusing 4-0 Vicryl
sutures. The aortas were stored in normal
saline at 4°C for a maximum of 24 hoursafter
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preparation, during which the experiments
were conducted.
Stent-Graft Oversizing
First, the internal diameter of the pressur-
ized bovine aorta was determined from the
relationship of the internal diameter to pres-
sure over the range 0 to 140 mmHg at
intervals of 2.5cm along the length of the
aortic segment. The wall thickness at each
axial location was measured using digital
calipers. The aorta was then plugged at both
ends, and the lumen was pressurized with
saline at a pressure of 140 mmHg.The length
of the aortic segment at this pressure was
measured. The ends of the aorta were then
securely clamped so that the length of the
aorta remained constant during the experi-
ment. The external diameters of the aorta
over the range 0 to 140 mmHg pressure were
determined at each marked location using the
digital calipers. Although the bovine aorta is
tapered over its full length, each 2.5-cm
segment between the marks was considered
to be a straight tube whose diameter was the
average of the proximal and distal end
diameters of that particular segment. Assum-
ing that the volumeof the aortic wall remains
constant at any luminal pressure, the internal
diameter can be calculated from the external
diameter. For a subsegment of length L,
proximal external diameter D,, and distal
external diameter Dg, the volume V of the
aortic wall is represented by the formula:
v = (03 - of)4
Where
D; = Dp; + Dd;
2
Dp = Dpo 5 Dd,
The subscript o denotes external, and sub-
script /, the internal dimensions.
Knowing the external diameter Dj, the
internal diameter can be calculated as:
2_ 4VvDj = DS - TE
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Figure 2 @ (A) Standard and (B) fenestrated stent-
grafts truncated to 53 mm in length.
Once the relationship between the luminal
pressure and the internal diameter of the
aorta was determined, it was possible to
establish the segment in the aorta wherein
a stent-graft of a certain diameter should be
deployed, as well as the pressure that should
be applied to achieve a knownoversizing (5%,
10%, or 20% in this study).
Stent-Graft Construction and Deployment
Zenith stent-grafts have a proximal bare
stent with fixation barbs located midway
along alternate stent struts. This stainless
steel stent segmentis fixed to the main trunk
of the stent-graft with monofilament sutures.
Stent-grafts of 28, 30, and 32 mm nominal
diameter were deployed within different aor-
tic segments under appropriate pressure to
achieve the desired degree of oversizing.
Fenestrated stent-grafts (Cook Europe, Bjae-
verskov, Denmark) were constructed with
a single 6-mm-widefenestration at a distance
of 21 mm from the fabric edge (Fig. 2B). The
fenestrations were not reinforced. Since the
study aimed to measure the proximal fixation
strength only, all stent-grafts were truncated
within the main body at 53mm from the
fabric edge, leaving the bare stent and the
first 2 internal stents intact but removing the
third external stent from the fabric graft
(Fig. 2A). The actual contact length between
both stent-graft types and the aorta was
36 mm.
All stent-grafts were crimped using a noose
to introduceit into the aorta and deployed at
the predetermined site under direct vision.
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The fenestrated stent-graft was deployed to
align the fenestration with the ostium of
a selected side branch with an external
diameter of ~5 mm. A 6-X20-mm balloon-
expandable stent (Medtronic AVE, Santa
Rose, CA, USA) was placed under direct
vision through the fenestration into the side
branch and deployed; the stent was then
flared with a 12-mm angioplasty balloon.
Because of the natural taper of the bovine
aorta, the vessel was reversed in the experi-
ment so that the stent-graft was made to
migrate from the narrow segmentto the wide
segment. Hence, the bare stent was oriented
toward the narrower segment of aorta, which
wassealedat the end using an internal plastic
plug and external gasket arrangement. This
plug contained a Luer connection for con-
trolled pressurization of the aortic lumen and
also a port to introduce a rigid endoscopefor
observing stent-graft behavior during the
experiment. The caudal or unstented portion
of the graft was connected to a 0.46-mm-
diameter stainless steel wire with a 16-mm-
diameter plastic plug, which was narrower
than the aortic lumen to ensure that only the
proximal portion of the stent-graft was in
contact with the aorta. The wire was then
brought to the exterior of the aorta through
a hole in anotherplastic plug that sealed the
end of the aorta toward the caudalend of the
stent-graft. This hole contained an O-ring seal
to allow free linear movement of the wire,
while being leak-proof. The wire was con-
nected to a digital force gauge (Model FG-
5000; RS Components, Corby, UK) mounted
securely on the moving stage of a manual
linear drive operated by the turn of a wheel.
Clockwise rotation of the wheel caused the
stage to move to the left, thereby exerting
a force on the stent-graft, which was contin-
uously displayed on the force gauge. This
gauge was equipped with a “‘peak-hold”
facility to preserve the highest reading should
a sudden drop occur in the force being
measured. The force gauge was calibrated
with known weights, and the maximum de-
viation was found to be + 0.05 N.
Once the aorta was pressurized to the
predetermined level, the linear drive was
engaged, and anyslack within the connecting
wire was removed. A flag was placed on the
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wire to facilitate ready identification and
measurement of any movementof the stent-
graft. The handwheelwasthenrotated slowly
while continuously recording the distraction
force. The stent-graft behavior during this
period was observed through the endoscope.
Each segmentof aorta was used only once
to avoid errors due to potential mechanical
damage of the aorta during the experiment.
Stent-grafts were reused only whenfree from
deformation upon visual inspection, includ-
ing the alignment of fixation barbs. Stent-
grafts were reused only onceto avoid poten-
tial errors due to metal fatigue and unidenti-
fied deformation. Results were grouped ac-
cording to the degree of oversizing for
standard and fenestrated stent-grafts. The
data are presented as the mean + standard
deviation for each group. Two-way ANOVA
with multiple comparisons (with Bonferroni
correction) was used to compare groups.
RESULTS
With gradually increasing distraction force,
the stent-graft migration was noted to occur
in 2 distinct phases. There wasan initial yield,
corresponding to a displacement up to about
5 mm, which wasattributed to embedding of
the barbs into the aortic wall. Once this phase
was complete, the stent-graft was able to
resist migration for a period until a second
yield occurred with increasing force, followed
by movementof the stent-graft in relation to
the aorta. The peak displacement forces
(Table) corresponding to the 2 phases were
described as initial displacement force (IDF)
and final displacement force (FDF), respec-
tively. For standard stent-grafts, the mean
values of both IDF and FDF at 20% over-
sizing were significantly greater than the
corresponding values at 10% oversizing
(p<0.001), which in turn were greater than
those at 5% oversizing (p=0.02). Results with
fenestrated stent-grafts show a similar trend
with the exception of a lack of significant
difference between 20% and 10% oversizing
levels (p=0.054). Both the initial and final
displacementforces were significantly higher
with fenestrated stent-grafts than with stan-
dard stent-grafts (p<0.001) at any degree of
oversizing.
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TABLE
Comparison ofInitial Displacement Force (IDF) and Final Displacement Force (FDF) for
3 Oversizing Levels in Standard and Fenestrated Stent-Grafts
5% Oversizing 10% Oversizing 20% Oversizing
IDF FDF IDF FDF IDF FDF
Standard 3.39+0.37 8.10+0.92 4.32+0.63 10.76+1.74 7.69+1.18 16.82+0.92
Fenestrated 10.48+ 1.23 22.56+ 1.60 11.45+ 1.48 28.24+1.56 12.12+1.42 33.0141.75
Sa Sg
* p<0.001 for standard vs. fenestrated at each oversizing level.
The mean initial and final displacement
forces in the standard and fenestrated stent-
grafts for oversizing of 5%, 10%, and 20% are
shown graphically in Fig. 3.
None of the experiments produced any
macroscopic injury to the aortic wall after
displacement. The only structural deformity
noted within the stent-graft after forced
displacement was upward distortion of the
fixation barbs (Fig. 4). The AVE stents ap-
peared compressed and bentafter the experi-
ments (Fig. 5).
DISCUSSION
Traditional stent-graft designs rely upon
physical attributes of a deployed stent-graft,
such as columnar strength andradial force, to
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Figure 3 @ Graph showing the mean initial and
final displacement forces in standard and fenes-
trated stent-grafts for oversizing of 5%, 10%,
and 20%.
maintain a durable fixation. Fixation appen-
dages, such as hooksorbarbsincorporated at
attachmentsites, and aortic neck length also
increase fixation strength.'"'* The main
factors predisposing to late migration are late
dilatation of the aneurysm neck, hemody-
namic forces acting uponthe stent-grafts, and
mechanical disintegration of the device. Poor
quality of the vessel at the proximal fixation
zone and underutilization of the infrarenal
neck at the time of graft deployment also
reduce the fixation strength and predispose
to migration.'*"8
Fenestrated stent-grafts were introduced
primarily to preserve renal or mesenteric
branch vessel perfusion while recruiting the
aortic wall at the level of these branches to
provide proximalseal and fixation.'®?° Stents
are routinely placed from the aortic lumen
into the visceral arteries through the fenestra-
tions to enhancethe fixation strength of the
stent-graft.2" However, migration of a fenes-
trated stent-graft could result in distortion of
the visceral artery stent and consequent loss
 
Figure 4 @ The only structural deformity noted
within the stent-graft after forced displacement
was upwarddistortion of the fixation barbs.
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Figure 5 @ Appearanceof the AVEstentafterfinal
displacementof the stent-graft.
of patency of this vessel in addition to the
other consequences of migration. Although
fixation strengths of standard stent-grafts
have been reported,''-"* there have been no
reports relating to fenestrated stent-grafts.
Furthermore, previous reports of fixation
strength were based on experiments con-
ducted on nonpressurized aortas, an impor-
tant limitation to understanding the relation-
ship between oversizing and fixation
strength. As the experiments reported here
were conducted with pressurized aortas, the
results are likely to better represent the
clinical situation.
An important observation of this study was
the mode of migration of a stent-graft de-
signed with fixation barbs.In the initial phase,
a few millimeters of caudal migration, usually
not exceeding the length of the barb (5 mm),
occurred at a lower force as the barbs
embedded into the aortic wall. More sub-
stantial force was required to cause sub-
sequent migration in the second phase. The
initial phase of migration is in accord with
anecdotes from physicians familiar with sim-
ilar stent-graft systems; they report that the
stent-grafts may “‘settle’’ a few millimeters
downwardsafter deployment. It is recognized
that the Zenith stent-graft has a low incidence
of migration, but we are unable to compare
the fixation strength of different devices in
our study since only one make of stent-graft
was used.”? The final displacement forces in
standard stent-grafts varied from 8.1 to 16.8 N
depending on the percentage oversizing.
These values are smaller that those reported
by Veerapen et al.’ and Resch et al.’?
Although the former authors reported experi-
ments with oversizing of 10% to 20%, Resch
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and colleagues did not provide this informa-
tion.
The main difference with the present study
is that the oversizing was accurately deter-
mined via known pressure-diameter relation-
ships of the bovineaorta. It should be pointed
out that the pressure per se did not have an
influence on the displacement forces. The
graft material was and remained porous to
the saline during the experiments, and the
pressure in the graft lumen wastherefore
similar to that in the aorta. Consequently,
there was nonet force acting on the graft due
to the applied pressure.
The discovery of biphasic movementofthis
type of stent-graft upon application of a dis-
lodging force raises some important issues.
Full recruitment of the barbs into providing
fixation strength appears to involve caudal
movement of the stent-graft by a few milli-
meters as the barbs embed into the aortic
wall. No such movementis caused deliber-
ately in standard clinical practice. Should it
occur naturally after deployment, the move-
ment of a stent-graft by a few millimeters
seldom causes significant problems with
standard stent-grafts. It may, however, have
significant implications for fenestrated stent-
grafts. Since the barbs may not be fully
engagedat the position of initial deployment,
there is a risk of transferring some of the
hemodynamic migratory forces to the inter-
face between the stent-graft and the side-
branch stent immediately after completion of
aneurysm repair. Small-diameter stents that
are suitable for side-branch placementare not
designed to withstand the resultant asym-
metric hoop stress. Failure or significant
distortion of side-branch stents due to such
stress can lead to loss of side-branch patency.
A mechanism by which the initial phase of
migration could be eliminated or made to
occur in a controlled manner would have the
potential to eliminate adverse effects. Mould-
ing of the fixation areas using a conformable
balloon may cause embedding of the barbs
and eliminate the initial phase of migration or
stent-graft settling.
Another important finding of this study was
a relationship between oversizing and fixa-
tion strength; fixation strength increased with
increasing oversizing up to 20%, which sup-
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ports routine oversizing with self-expanding
stent-grafts. In the case of fenestrated stent-
grafts, however, the fixation strength did not
increase significantly above 10% oversizing.
This may be due to the fact that most of the
fixation strength here was provided by the
side-branch stent acting as an anchor rather
than by the interaction between the stent-
graft and the aortic wall.
Limitations
Although the methods of this study repre-
sent an enhancement comparedto earlier in
vitro studies of fixation strength,'""* there
are a numberof limitations to this study. The
aortas used were straight tubular segments
from healthy animals and as such cannot
replicate some of the features of aneurysm
anatomy, such as neck angulation, conical
shape, or presence ofcalcification or throm-
bus. The applied distraction force was incre-
mented gradually and thus may befunction-
ally different from the repetitive forces that
stent-grafts are subjected to in vivo.?* Be-
cause of the natural taper of the aorta, the
vessel wasreversed in the experiment so that
the stent-graft was made to migrate from the
narrow to the wide segment, thereby poten-
tially underestimating the fixation strength.
Any error is likely to be small, but we
considered that the alternative orientation
wasa worse optionsince this maypotentially
result in falsely high fixation strengths.
Although the length of the stent-graft used
was 53 mm in both groups, only 36 mm of
the covered section of the stent-graft was
actually in contact with the aortic wall. This is
at the upper end of the rangeof graft overlap
with the aortic neck in vivo. The experiments
were designed to measure the displacement
force of the isolated proximal portion of the
stent-graft, so truncated devices were used.
We realize that the use of a complete bi-
furcated device may influence the measured
forces, but the model used did not allow the
effect to be investigated.
Conclusion
Our experiments demonstrated that proxi-
mal fixation strength of a self-expanding
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stent-graft with a proximal bare stent and
barbs increased with increasing degree of
oversizing up to 20% and that a fenestrated
stent-graft configuration confers a greater
proximal fixation than conventional devices.
With suchstent-graft design, full engagement
of fixation barbs may cause movementof the
stent-graft by a few millimeters beforethefull
fixation strength of the device comes into
action. This observation may havesignificant
implications for fenestrated stent-graft de-
sign.
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Measurementof pulsatile haemodynamicforces in a
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Abstract: The longitudinal haemodynamic force (LF) acting on a bifurcated stent graft for
abdominal aortic aneurysm repair has been estimated previously using a simple one-
dimensional analytical model based on the momentum equation which assumessteady flow of
an inviscid fluid. Using an instrumented stent-graft model an experimental technique was
developed to measure the LF under pulsatile flow conditions. The physical stent-graft model,
with main trunk diameter of 30mm and limb diameters of 12mm, was fabricated from
aluminium. Strain gauges were bonded on to the main trunk to determine the longitudinal
strain which is related to the LF. After calibration, the model was placed in a pulsatile flow
system with 40 per cent aqueous glycerol solution as the circulating fluid. The LF was
determined using a Wheatstonebridge signal-conditioning circuit. The signals were averaged
over 590 cardiac cycles and saved to a personal computer for subsequent processing. The LF
was strongly dependentonthe pressure butless so on the flowrate. The measured forces were
higher than those predicted by the simplified mathematical model by about 6-18 per cent
during the cardiac cycle. The excess measured forces are due to the viscous drag and the effect
of pulsatile flow. The peak measured LF in this model of 30mm diameter may exceed the
fixation force of some current clinical endovascular stentgrafts.
Keywords: migration, endovascular repair, strain gauges
1 INTRODUCTION
Abdominal aortic aneurysm (AAA) is a common
vascular disorder which affects up to 5 per cent of
the male population over 55 years of age in the West.
Surgical replacementof the diseased aortic segment
using a fabric graft has been the standard treat-
ment of AAA. Endovascular repair (EVAR) using an
endoluminal stent graft to exclude the AAA is an
alternative that is finding wide acceptance through-
out the world since it wasfirst used clinically in the
early 1990s [1]. Being minimally invasive, recovery of
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the patients is much quicker and obviates the need
for cross-clampingofthe aorta. The primary purpose
of EVARis to prevent death from aneurysm rupture.
The aim of EVAR is to isolate the aneurysm from the
aortic or systemic blood pressure while maintaining
blood flow to the lowerlimbs. Clinical trials of EVAR
showa significant improvementin 30 day mortality
over conventional repair, which is maintained over
the follow-up period of 4 years [2]. In the mid-
term, however, a number of complications such as
endoleak, distal migration of the device, thrombosis,
and occlusion have been noted,necessitating regular
surveillance of the patients. These complications
represent significant causes of surgical re-interven-
tions [3].
Pulsatile blood flow and pressure exert continual
downward forces on the stent graft and the fixation
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means, such as the radial force, hooks, barbs, and
the longitudinal columnar support of the device, are
designed to resist these downward forces. Inade-
quate fixation or excessively high haemodynamic
forces may cause distal migration and repressuriz-
ation of the aneurysm sac, resulting eventally in
rupture. Previous reports have shown that distal
migration, defined as a longitudinal movementofat
least 5mm [4] or 10 mm [5], occurs in between 3 and
4 per cent of patients. The fixation strength of stent
grafts has been estimated by measuring the long-
itudinal displacementforce at the proximal fixation
site of various commercially available stent grafts
in a cadaveric model [6, 7]. The median fixation
strength ranged from 4.5 N to 26.6 N, compared with
150N for the hand-sewn anastomosis in conven-
tional repair.
In a previousstudy, one of the present authors and
co-workers [4] showed that hypertension, aneurysm
geometry, andiliac angulation, amongst other fac-
tors, were significantly associated with stent-graft
migration [4]. These findings were validated using a
simple one-dimensional analytical model based on a
momentum equation, not accounting for the pulsa-
tility of blood flow norfor the viscosity of the fluid.It
was shown that under certain conditions, particu-
larly in large stent grafts and in hypertension, the
longitudinal force on a stent graft due to blood
pressure and blood flow may exceed thefixation
force causing stent-graft migration. The purposeof
this study was to develop an experimental method to
measure the longitudinal force (LF) in a model of a
stent graft under pulsatile flow of a viscous fluid. A
numberof test runs were carried out to assess the
feasibility of the technique and to compare the
experimental data with the simplified analytical
predictions.
2 THEORETICAL MODEL
A simple model of an idealized bifurcated device
shown in Fig. 1 is considered to estimate the long-
itudinal force f, exerted on the EVAR device.It is
assumed that the bifurcation is planar and sym-
metrical and that the blood flow is distributed
equally through two iliac limbs of equal diameter.
The change in direction and velocity of flow due to
the diameter change and the bifurcation angle
causes a change in the momentum ofthe fluid.
The momentum change and the pressure forces
acting at the inlet and outlets result in a net
longitudinal force f, on the device which must be
opposedto preventits distal migration. It has been
PA,
 —>pQu,
 
Fig. 1 Geometry and forces acting on a bifurcated
stent graft
shownpreviously that f,, can be estimated by [4]
PA, —2P2A2 Cos 0—f.
=10(Fost S* costU1) (1)
where P,, A;, and U, are the pressure, cross-
sectional area, and velocity respectively at theinlet,
P,, Az, and U> are the pressure, cross-sectional area,
and velocity respectively at the outlet, p is the
density of the fluid, and Q is the volumeflowrate.
Thefirst two termson theleft-hand side of equation
(1) represent the pressure forces at the inlet and
outlets acting on areas A, and A; respectively. f, is
the axial component of the force exerted by the
bifurcation on the fluid. The right-hand side of
equation (1) represents the rate of increase in the
axial component of momentum. Using the Bernoulli
and continuity equations, expressions for P2 and U2
can be obtained in termsof P;, U;, Ay, and Az, which
are then substituted into equation (1) to give an
equation for f,. as
Aefc=P1A1 +pA U? —p— Ujcosé2A2
2 AZ
—2A>cos0 [ros 0-3)| (2)
2:
fi, can be readily calculated for any device geometry
and haemodynamic conditions using equation (2).
In the transverse direction the pressure and mo-
mentum forces cancel out because of the symmetry
and equal flow distribution and therefore f, = 0.
 Proc. IMechE Vol. 222 Part H:J. Engineering in Medicine JEIM311 © IMechE 2008
Measurementof pulsatile haemodynamic forces 545
3 MATERIALS AND METHOD
3.1 Measurementofthe longitudinal force in an
instrumented modelof a bifurcated stent
graft
The main bodyof the stent graft is subjected to the
net LF f,,, which includes the pressure force in the
main trunk andtheiliac limbs, and the force due to
the momentum change(Fig. 2). In this case, since a
viscousfluid is used, f, also includes the viscous drag
force. The LF f, will cause a longitudinal strain in the
model which can be measured.In orderto facilitate
recording of the strain, the modelis thinnedlocally
as shown in Fig. 2, thereby increasing the strain
level. The graft model is instrumented by meansof
strain gauges bondedonto the external surfaces of
the thinned portion of the cylindrical segment. The
instrumented stent-graft model was calibrated by
applying a series of known weights to the model
while monitoring the output from the strain gauge
amplifier.
3.2 Stent-graft model
The model was machined from aluminium tubes
joined with metal-loaded epoxy resin to form a
bifurcation. The main trunk of internal diameter
30mm and wall thickness 4mm has a thinned
segment 30 mm long and with a 0.1mm wall
thickness. The thinned segment was provided in
order to increase the level of strains locally.
Two strain gauges (CEA-13-250UN-350, Vishay
Thinned section
2.5V 4
  
Micro-Measurements, Reading, UK) from the same
batch were bonded onto a thinnedsection using
cyanoacrylate glue. They were placedparallel to the
longitudinal axis of the main cylindrical section. As
the modelis fixed at its proximal end,the force f, will
result in a longitudinal strain that can be determined
by means of the strain gauges. The strain gauges
were connected in a half-bridge configuration and
two 350 Q high-stability precision resistors were
used to complete the Wheatstonebridge(Fig. 2). The
advantage over a single active strain gauge in a
quarter-bridge configuration is greater sensitivity.
However, the disadvantage for this half-bridge (and
also the quarter-bridge configuration) is that the
thermal effects do not cancel out and the outputis
therefore susceptible to temperature changes. To
minimize self-heating of the strain gauges a low-
voltage reference supply of 2.5V (LM4140BCM-2.5,
RS, Corby UK) wasused.In addition, high-stability
precision resistors (S350, 1 ppm/°C, Vishay Measure-
ments Group UK,Basingstoke, UK) were usedfor the
bridge completion resistors. Since the measure-
ments could be affected by thermal zero drift, the
signal output was monitored before and after each
measurement. This was achieved by isolating the
stent-graft model from any pressureload by closing
the three ball valves at the inlet and outlets and
opening the pressure port to atmosphere (see the
flow circuit later in Fig. 3). Any drift was zeroed
using the bridge balance. Provided that the strain
gauge voltage supply and the instrumentation
amplifier were switched on at least 2h prior to the
experiment to allow thermal equilibrium to be
   
 
f,
To instrumentation
amplifier
Fig. 2 Strain gauges bondedontothethinnedsectionof the stent-graft model. The proximal
section of the modelis fixed and the force f, causes a longitudinal strain which can be
measured by meansofthe strain gauges. The Wheatstone bridge circuit at the bottom
showsthe connection of the twoactive strain gauges andthefixed resistors
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Fig. 3 Diagram ofthe flow circuit
reached, the zero drift over the duration of the
experiment was found to be less than +5mV
(corresponding to + 0.16N).
3.3. Flow circuit
After calibration, as described above, the model was
placed in a pulsatile flow circuit as shown in Fig.3.
Pulsatile flow with a waveform similar to that
obtained in the abdominal aorta was generated by
a custom-built servo-controlled piston pump and a
gear pump (Micropump, Vancouver, Washington,
USA). The circulating fluid was a 40 per cent
aqueoussolution of glycerol with dynamic viscosity
similar to that of blood (a dynamic viscosity of
3.3x10-°Pas and a density of 1098kg/m* at room
temperature). An ultrasonic flow probe (24N,
Transonic System Inc., Ithaca, New York, USA) was
placedatthe inlet pipe section to record the pulsatile
flow. The pressure waveform just upstream of the
aluminium model was also recorded using a pres-
sure transducer (26PC, SensorTechnics UK, Rugby,
UK). The pressure waveform was set to physiologi-
cally relevant values (diastolic pressure range, 60—
90mmHg; systolic pressure range, 130-160 mmHg)
by adjusting the resistances of the needle valves and
the volumeofair in the proximal and distal com-
pliance chambers. A long inlet length of approx-
imately 2m was placed between the calming
chamber and the stent-graft model to ensure that
laminar developed flow in the model. The strain
gauge voltage supply and instrumentation amplifier
were switched onatleast 2h prior to the experiment
to allow the strain gauges to reach thermal equili-
brium.The pressure, the flow, and the LF waveforms
were each sampled at 100samples/s and saved to
a personal computer for subsequent analysis. To
improve the signal-to-noise ratio, the data were
recorded for 590 complete cycles and the average
waveform was then determined.
4 RESULTS
Five experiments were carried out with the same
flowrate of 1.51/min, the same heart rate of 60 beats
per minute but different pressure waveforms. The
average flow waveform, the average pressure wave-
form, andthe netforce f, for a typical experimentare
shown in Figs 4, 5, and 6 respectively. Each wave-
form was averaged over 590 cardiac cycles. Figure 6
shows the measured f, waveform as well as the
theoretical values calculated from equation (2) using
the actual recorded pressure and flow waveforms.
The measured force ranged from 3.4N in diastole to
12.0N at peak systole with an average value over the
whole cycle of 5.5N. The force and pressure wave-
forms appear to be almost in phase, indicating that
pressure has a strong influence on the measured
forces. It can be seen from Fig. 6 that the measured
forces were greater than those calculated from
equation (2). The difference between the measured
and calculated forces expressed as a percentage of
the measured values ranges from about 6 to 18 per
cent of the measured values (Fig. 7).
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Fig. 4 Flow waveform
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5 DISCUSSION
One of the most important complications affecting
the long-term success of EVAR of aortic aneurysmsis
stent-graft migration, i.e. movementof a stent graft
relative to the vascular anatomy after complete
deployment. Stent grafts depend upon a number
of factors such as the radial force, the columnar
strength, and the presence of hooks or barbs to
remain stable in position since they are not sutured
to the aortic wall and hence they are susceptible to
migration. This has the potential to cause attach-
ment-site endoleak and even a consequent aneur-
ysm rupture [3, 4, 8-10]. A deployed stent graft
constantly faces physiological forces that tend to
causestent-graft migration and therefore stent grafts
should be designedto resist such migration. Meas-
urements of the fixation strength of stent grafts
    WoreSayo   
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Time(s)
Fig. 6 Measured (solid curve) and calculated (dashed
curve) LFs
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Fig. 7 Difference between the measured LF (f,,) and
the calculated LF (f.), expressed as a percen-
tage of the measured value
indicate that commercial stent grafts can resist LFs
up to 4.5-26.5 N dependingonthe design [6, 7].
The one-dimensional model (equation (2)) was
derived using a numberof simplifying assumptions
aboutthe fluid and the geometry of the bifurcation.
Morris et al. [11], Li and Kleinstreuer [12], Klein-
streueret al. [13], and Howell et al. [14] have carried
out computational fluid dynamics studies of pulsa-
tile flow in bifurcated devices and showedthat the
blood pressure had a strong influence on the hae-
modynamic forces acting on the stent graft. The
contribution of blood flow velocity to these forces
wasrelatively smaller than that of blood pressure.Li
and Kleinstreuer [12] also found that the shape of
the pressure waveform was a significant factor.
Pressure waveforms with a high systolic slope
produced higher LFs than those with lowersystolic
slopes. This was attributed to large flow accelera-
tions which affected the forces acting on the device.
Using a gramometer, Volodoset al. [15] measured
the LF in a tubular non-bifurcated stent graft
subjected to a pulsatile flow of water. Morerecently,
Sutalo et al. [16] developed an acrylic model of a
bifurcated stent graft to measure LFsin a steady flow
of water. The forces were measured by means of a
load cell attached to the model and good agreement
was found with the predictions of the simple one-
dimensional model.
This study shows that the measured LF is in
relatively good agreement with the simple one-
dimensional steady inviscid model. Figure 7 shows
the difference expressed as a percentage of the
measured values. It can be seen that the maximum
difference occurs during the midsystolic phase of the
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pressure waveform. To obtain an estimate of the
influence of the viscosity of the fluid and the
pulsatility of the flow, first the pressure forces
are evaluated from thefirst two terms of equation
(1), i.e., PLA; — 2P2A2 cos 6. (Using the Bernouilli and
continuity equations, it can be shown that 2P2A2cos@
= 2Acos0{P; + p(U?/2)[1—A%/(4A3)]}. This is then
subtracted from the measured LF andtheresults are
shown in Fig. 8. The fluid viscosity and pulsatility of
the flow therefore contributes approximately 0.2-
1.2 N to the measured LF which ranged from about 4
to 12N.
There are several limitations to this study. First,
the modelstent graft was fabricated from aluminium
and therefore the compliance of the actual stent
graft was not replicated. However, the basic geome-
try of a typical aortic stent graft is replicated in terms
of the dimensions of the main trunk andtheiliac
limbs andthe angle of bifurcation. In patients, the
stent graft must conform to the anatomy of the
aneurysmal aorta which in the majority of cases is
complex with various degrees of non-uniformity.
The forces in an actual stent graft in a patient may
therefore be different and will depend on its
geometrical configuration in the aneurysm. Second,
the luminal surface of the model was smooth while
the blood-contacting surface of the graft is rough.
The dimensionsof the roughness are determined by
the size of the yarn used in fabricating the fabric
graft, which is usually of a woven construction. The
diameter of the yarn is typically of the order of
0.1mm [17]. The surface roughness will have an
influence ontheresistanceto flow andwill therefore
contribute to the LF on the stent graft. Within a
relatively short period after surgery, however, a thin
layer of thrombuswill form on the luminal surface of
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Fig. 8 LF due to viscous drag and pulsatility
the fabric andthis will be transformed into a smooth
organized fibrin which is firmly supported by the
fabric structure [17]. Finally, the highly simplified
one-dimensional inviscid model can provide only
rough estimatesof the forces to which a stent graft is
subjected. Nevertheless, this modelis still useful in
providing acceptable estimates, as shown by reports
based on computational fluid dynamics studies (11-
14).
In conclusion,the LF acting on a stent graft can be
determined experimentally using an instrumen-
ted device. The LF is strongly dependent on the
pressure. The fluid viscosity and pulsatility contri-
bute between 6 and 18 per centof the total LF. In
vivo, however, these values maybe different because
of the compliance, the surface roughness of the
actual stent graft, and the complex anatomyof the
aortic aneurysm. These results indicate that, under
certain conditions, the LF can exceed thefixation
force of some of the current endovascular stent
grafts and maytherefore lead to the distal migration
andits potentially serious consequences.
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